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Abstract 
-
Amoebic gill disease (AGD) is the most significant health issue affecting the culture of 
Atlantic salmon (Salmo salar L.) in Tasmania, Australia. Recent research has suggested 
that heritable variation in AGD resistance exists within the Tasmanian Atlantic salmon 
population. Subsequently, enhancing this resistance through selective breeding has 
become a major research focus in Tasmania. The mechanisms controlling this 
commercially important trait remain poorly understood. To this end, an investigation of 
the molecular mechanisms controlling AGD resistance was conducted. 
\ 
Due to their high polymorphism and important immune function genes of the major 
histocompatibility complex (MHC) - known as the MH genes in Atlantic salmon -
represent some of the best candidate loci with a possible influence upon AGD 
resistance. With this in mind, the amount of MH variation and its association with 
resistance to AGD was investigated. In contrast to what has been previously reported at 
non-coding microsatellite loci, a high l~vel of MH class II diversity has been maintained 
in the Australian Atlantic salmon population compared to the ancestral population. The 
use of an AGD challenge test with subsequent MH genotyping demonstrated that the 
presence of one MH class II ~lpha allele known as Sasa-DAA-3UTR 239 was 
significantly associated with reduced disease severity. Individuals containing a copy of 
this allele had 4.0% less gill filaments infected by AGD compared to individuals 
without this allele. 
11 
Next utilising a cDNA microarray with real-time PCR verification the transcriptional 
changes associated with AGD and AGD resistance were investigated. Comparing the 
gene expression profiles within the gill, liver and anterior kidney between naive and 
AGD affected (at 19 days post inoculation) Atlantic salmon suggests the host response 
to AGD upon acute first infection is largely suppressive and localised to the site of 
infection, the gill. Next, the gill transcriptome response between Atlantic salmon 
deemed putatively resistant and putatively susceptible to AGD following chronic 
natural infection was investigated. Results suggested that compared to the susceptible 
individuals, Atlantic salmon resistant to AGD demonstrate an up-regulation of adaptive 
immune genes and negative regulators of the cycle cell. Further characterisation of the 
full length mRNA sequence and expression distribution of one unkno~ transcript 
which was significantly up-regulated in both previous microarray experiments was 
investigated. 
This research has provided the first molecular assessment of resistance to AGD in 
Atlantic salmon. The implications of this research in terms of the understanding of the 
molecular mechanisms of AGD resistance and the ultimate development of genetic 
markers linked to resistance will be considered. 
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Chapter 1: General introduction 
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Resistance to amoebic gill disease (AGD) is a trait of high commercial importance. 
Exploiting this resistance through selection is a major breeding goal in Tasmania. The 
ability to accurately select desirable broods could be significantly enhanced through a 
better understanding of the mechanisms of resistance, and the ultimate development of 
marker assisted selection for AGD resistance. To this end, using a candidate gene and 
transcriptome profiling approach I investigate the molecular mechanisms 
influencing/controlling AGD resistance. 
1.1 Atlantic salmon aquaculture 
Aquaculture is one of the world's fastest growing industries (Tidemand-Johnannessen 
1999). Initially intended to substitute for shortfalls in wild fisheries, aquaculture has 
grown rapidly, and is now considered to be the future for seafood production. The 
culture of Atlantic salmon (Salmo salar, L.) is a leading example and is undertaken in 
many countries, with the majority of production based in Chile, Norway, Scotland and 
Canada (F AO Fisheries Department, 2006). 
In Australia, Atlantic salmon have been commercially cultured since the 1980s with the 
majority of production in Tasmania. Atlantic salmon are not native to Australia and 
were introduced in three individual imports of 100,000 ova each from the River Philip, 
Nova Scotia, Canada, in the mid-1960s (Ward et al. 1994). This founder population was 
first maintained in a freshwater landlocked hatchery located in New South Wales (Ward 
et al. 1994). During this time the population underwent a moderate genetic bottleneck 
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event and, despite poor hatchery records, anecdotal reports suggest breeding numbers 
reduced significantly. In the mid-l 980s three introductions from this founder population 
were made into Tasmania (Ward et al. 1994). No additional stock introductions have 
occurred in Tasmania or New South Wales following these initial importations. 
In Tasmania Atlantic salmon aquaculture is a major local industry. Annual production 
exceeds 20,000 tonnes with an estimated net worth of AUD$250M (Australian Bureau 
of Agriculture and Resource Economics; www.abareconomics.com). In 2003 this 
industry employed over 3,000 people, making it the largest employer of any aquaculture 
sector in Australia (Carington Smith and Wadley 2003). Despite continuing growth of 
Atlantic salmon aquaculture in Tasmania, this industry still faces a number of 
limitations. Disease, and in particular, a condition known as AGD, is the most 
significant limitation. 
1.2 Amoebic gill disease 
1.2.1 The aetiological agent 
AGD has been recorded in the Tasmanian Atlantic salmon population since the 
commencement of its marine culture in the mid-1980s (Munday 1986). Initially, it was 
believed to be caused by the amphizoic parasite Neoparamoeba pemaquidensis (Page) 
(Kent et al. 1988) and later also Neoparamoeba branchiphila Dykova, Nowak, Crosbie, 
Fiala, Peckova, Adams, Machackova et Dvorakova (Dykova et al. 2005). However, 
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more recent research has shown that the most predominant species associated with 
AGD pathology is a newly described species designated Neoparamoeba perurans 
Young, Crosbie, Adams, Nowak et Morrison (Young et al. 2007; Young et al. 2008c). 
At present no sub-strains of Neoparamoeba perurans have been identified. 
1.2.2 Affected species and distribution 
The salmonids Atlantic salmon and rainbow trout, Oncorhynchus mykiss (Walbaum), 
appear to be the species most susceptible to AGD (Munday et al. 2001), but this disease 
can also affect other teleosts such as· turbot Scophthalmus maximus (L.) (Dykova et al. 
1999), coho salmon Oncorhynchus kisutch (Walbaum) (Kent et al. 1988) and seabass 
Dicentrarchus labrax (L.) (Dykova et al. 2000). The majority of wild teleost species 
caught in and around commercial salmon farms in Tasmania do not appear to be 
susceptible to AGD (Douglas-Helders et al. 2002). One exception was a single 
specimen of blue warehou, Seriolella brama (Giinther) which presented significant 
AGD pathology along with the presence of Neoparamoeba spp. (Adams et al. 2008). 
While AGD is essentially endemic to Tasmania and certain locations in the USA (Kent 
et al. 1988), sporadic cases have also been recorded in Ireland, France, Spain, New 
Zealand, Norway, Chile and Scotland (Dykova et al. 1995; Rodger and McArdle 1996; 
Findlay and Munday 1998; Steinum et al. 2008; Young et al. 2008c). In Tasmania AGD 
is most prevalent in the summer months (December to February) coinciding with 
increasing water temperature. 
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1.2.3 Signs and symptoms of AGD 
Individuals affected by AGD display lethargy, respiratory distress, rapid opercular 
movement, and ultimately, if not treated, death will result (Munday et al. 1990). Gross 
examination of AGD affected gill tissue reveals raised white/grey multifocal mucoid 
lesions on the gill surface (Munday et al. 1990). Microscopically, gross lesions coincide 
with extensive morphological and cellular alterations in the gill epithelium. AGD is 
initiated by the attachment of trophozoites to healthy gill epithelial tissue. Following 
this attachment, localised tissue changes occur including epithelial desquamation and a 
moderate infiltration ofleucocytes within the central venous sinus (Adams and Nowak 
2004a). As the disease progresses, more pronounced cellular changes can be seen 
including lamellar fusion, extensive hyperplasia/hypertrophy, oedema and interlamellae 
vesicle formation (Adams and Nowak 2003). In such advanced lesions, an infiltration of 
leucocytes from the central venous sinus into the hyperplastic tissue is observed (Adams 
and Nowak 2004a). In some instances, leucocytes are found in close proximity to 
amoeba within the hyperplastic lesions (Bridle et al. 2003). 
1.2.4 AGD diagnosis and quantification of disease severity 
While a number of diagnostic tests for AGD have been developed (Zilberg et al. 1999; 
Douglas-Helders et al. 2001; Dykova and Novoa 2001; Young et al. 2008b), clinical 
diagnosis within commercial salmon farming operations is principally based upon the 
visual inspection of gross gill lesions. The advantage of this system is that the severity 
of infection is also estimated simply by quantifying the number of gross lesions on the 
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gill surface. A score between 0 and 5 is then assigned to each individual, where 0 
represents no lesions and 5 represents numerous lesions (Table 1.1). A strong 
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Infection Level Score Gross Description 
Clear 0 No sign of infection and healthy red colour 
Very Light 1 1 Neoparamoeba spp. spot, light scarring or undefined 
necrotic streaking 
Light 2 2-3 spots/small mucus patch 
Moderate 3 Established thickened mucus patch or spot groupings up to 
20% of gill area 
Heavy 4 Established lesions covering up to 50% of gill area 
Extreme 5 Extensive lesions covering most of the gill surface 
Table 1.1. Gross gill scoring system utilised by the Tasmanian Atlantic sahiion farming 
company, Tassal Group Limited, to estimate the severity of infection by AGD. This 
table was provided by R. Taylor1 and D. Cameron2• 
1 Mr Richard Taylor, University of Tasmania, CSIRO Food Futures Flagship 
2 Mr David Cameron, Tassa! Group Limited 
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relationship between the severity of AGD, estimated by this gross gill score, and fish 
survival time has been observed (R. Taylor, pers. comm). This non-destructive gross 
gill scoring method is employed by commercial salmon growers to estimate disease 
severity and then perform accordant treatment and management strategies. 
AGD diagnosis and the severity of infection can also be determined through 
histopathology (Munday et al. 2001). Diagnosis is based on the presence of both the 
causative agent, Neoparamoeba spp., and associated gill pathology (Adams and Nowak 
2004a; Young et al. 2007; Young et. al. 2008c ). The severity of infection is quantified 
by counting the proportion of primary lamellae displaying hyperplastic lesions. When 
destructive sampling is performed (generally only in research operations), 
histopathology is preferable to gross gill scoring because both the presence of the 
pathogen and the associated pathology can be observed. Moderate to good agreement 
between gross gill score and histology based gill score has been reported (Adams et al. 
2004; Taylor et al. 2007). 
1.3 Host response 
The host response, and in particular the immune response, to AGD has been the subject 
of a number of studies (Akhlaghi et al. 1996; Gross et al. 2004a; Gross et al. 2005; 
Bridle et al. 2006a; Bridle et al. 2006b; Morrison et al. 2006b; Morrison et al. 2007; 
Young et al. 2008a). Interestingly, despite the extensive morphological changes 
associated with AGD, this disease appears to stimulate only a modest local and systemic 
immune response. 
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1.3 .1 The systemic immune response 
Previous studies have shown that total plasma protein and lysozyme levels do not 
increase following AGD infection in Atlantic salmon (Gross et al. 2005). Furthermore, 
respiratory burst by phagocytes isolated from the anterior kidney of AGD affected 
Atlantic salmon is suppressed during advanced stages of disease (Gross et al. 2004b; 
Gross et al. 2005). Conversely, an increase in the chemotactic and phagocytosis 
function - albeit variable - of phagocytes derived from AGD affected Atlantic salmon 
has also been reported (Gross et al. 2005). Respiratory burst of AGD affected derived 
phagocytes can be enhanced in vitro through stimulation with beta (P)-glucans (Bridle 
et al. 2005). Di~tary application of p-glucans, however, does not increase protection 
against AGD (Bridle et al. 2005). 
The adaptive immune response to AGD has also been investigated. While the presence 
' 
of anti-Neoparamoeba spp. antibodies in the serum of both Atlantic salmon and 
rainbow trout has been demonstrated, evidence of their protective properties remains 
inconclusive (Findlay et al. 1995; Akhlaghi et al. 1996; Findlay and Munday 1998; 
Zilberg and Munday 2001; Gross et al. 2004a; Vincent et al. 2006). The presence of 
anti-Neoparamoeba spp. antibodies has been demon'.strated in both laboratory induced 
AGD challenge trials (Vincent et al. 2006) and under commercial culture conditions 
(Gross et al. 2004a). In the commercially cultured Atlantic salmon, the antibody activity 
did not appear to be influenced by the infection history or the number of Neoparamoeba 
spp. present on the gills (Gross et al. 2004a). Only one study has found evidence to 
suggest anti-Neoparamoeba spp. antibodies may be protective against AGD in Atlantic 
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salmon (Vincent et al. 2006). In this study, previously exposed and nai'.ve Atlantic 
salmon were re-infected with AGD and their serum anti-Neoparamoeba spp. antibodies 
measured in surviving fish. The authors reported that fish previously infected with AGD 
showed a significant increase in resistance to subsequent re-infection (Vincent et al. 
2006). This resistance was believed to be associated with circulating anti-
Neoparamoeba spp. antibodies which were present in 50% of the surviving individuals 
previously exposed to AGD, but not detected in any individuals exposed only once 
(Vincent et al. 2006) . 
. ~ .3 .2 Localised immuno-inflammatory response 
Gene expression of candidate immune related genes has been investigated in both 
rainbow trout (Bridle et al. 2006b) and Atlantic salmon (Bridle et al. 2006a; Morrison et 
al. 2007; Yolln.g et al. 2008a) and, for the most part; the results from these studies agree 
. with the hypothesis that AGD affected salmonids display only a minor immune 
response. Many immune related genes do not demonstrate increased expression 
following infection by AGD. Examples of such genes include serum amyloid A, serum 
amyloid P-like pentraxin (Bridle et al. 2006a), transforming growth factor beta, 
cyclooxygenase 2, major histocompatibility (MH)3 (Sasa-DAB), T-cell receptor beta ' 
(Bridle et al. 2006b) and tumour necrosis factor alpha (Bridle et al. 2006a; Morrison et 
al. 2007). AGD affected rainbow trout, however, demonstrate an up-regulation of the 
pro-inflammatory cytokine interleukin-1 beta (IL-1~) and inducible nitric oxide 
3 In regards to Atlantic salmon (Salmo salar) the major histocompatibility complex (MHC) genes are 
designated the "MH" genes throughout this thesis in line with Stet et al. (2002). Where the acronym 
MHC is used in this thesis it refers to species other than Atlantic salmon. 
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synthase (iNOS) in the gills at both 7 and 14 days post inoculation (DPI) (Bridle et al. 
2006b). Atlantic salmon also display a significant up-regulation ofIL-1~ at 14 DPI 
within the gill but there are no changes to iNOS (Bridle et al. 2006a; Morrison et al. 
2007). Moreover, the up-regulation of IL-1 ~ appears to be lesion-restricted (Morrison et 
al. 2007). This research suggests the host immune response to AGD is not only minor, 
but also extremely localised. 
It has become evident that processes other than the immune response are important in 
AGD pathogenesis. Indeed, transcriptome profiling of both the early and intermediate 
stages of AGD within the gill has provided valuable insight into the host response. 
Utilising a 16k salmonid specific microarray produced by the Genomic Research on 
Atlantic Salmon Project (GRASP), Morrison et al. (2006a) examined the transcriptome 
response of the gill to AGD at four time points up to 8 DPI. While a number of 
biologically significant findings were observed, the down-regulation oftumor 
suppressor p53 and concurrent up-regulation of Atlantic salmon anterior gradient-2 (an 
inhibitor of p53) and proliferating cell nuclear antigen suggests that genes involved in 
cellular proliferation are important in AGD pathogenesis. 
1.4 Treatment 
At present the only commercially feasible treatment for AGD is a freshwater bath for 2-
6 h (Clark and Nowak 1999; Munday et al. 2001). Bathing in freshwater significantly 
reduces the prevalence of gross mucoid lesions and the number of viable 
Neoparamoeba spp. on the gill (Parsons et al. 2001). Generally, this practice is repeated 
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approximately six times per sea-cage during the Tasmanian industry's two year 
production cycle (R. Taylor pers. comm). Due to the high labour and financial costs 
associated with freshwater bathing, this practice, at least in its current design, is not 
considered a practicable long term solution to AGD. Studies to improve the 
effectiveness of freshwater bathing are on-going. Water hardness appears to be an 
important contributing factor to the effectiveness of freshwater bathing, with soft 
freshwater being more efficacious for the alleviation of AGD compared to hard 
freshwater (Roberts and Powell 2003). 
1.5 Genetic resistance to AGD 
Resistance to AGD is undoubtedly a complex trait. Typically, resistance is defined as 
\ 
reduced gill pathology (quantified through either gross gill score or histopathology gill 
score) and/or increased survival time following infection (with no subsequent 
treatment). In commercial culture operations, however, resistance may be variously 
defined as time to first treatment, time between treatments or even the ability to tolerate 
AGD by demonstrating growth performance during infection. For the purpose ofthis 
thesis, resistance is' defined as reduced gill pathology unless otherwise stated. 
AGD resistance in Atlantic salmon was first documented by Bridle et al. (2005) who 
inadvertently discovered that a subpopulation of individuals were able to survive for an 
extended period under experimental challenge conditions. More recently, experiments 
based on Atlantic salmon family lines have suggested AGD resistance is significantly 
genetically influenced. This study examined the variation in gill pathology measured 
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through histology and gross gill scoring between 30 full-sibling families within a 
laboratory based AGD challenge trial (See appendix 1.1; Taylor et al. 2007). 
Considerable variation between families was observed. The estimate of broad sense 
heritability (H2) ranged between 0.16 ± 0.07 and 0.30 ± 0.09 for the different scoring 
method~ utilised. These results suggest AGD resistance is indeed a genetically 
influenced trait. Results from the Tasmanian commercial Atlantic salmon selective 
breeding program continue to sho'Y that AGD resistance is a moderately heritable trait 
(P. Kube pers. comm4). Consequently, the prospect of breeding for AGD resistance 
appears promising, potentially relieving commercial reliance on cost-intensive 
freshwater bathing. 
1.6 Selective breeding and marker assisted selection 
The aim of any selective breeding program is to cross one individual that has a desirable 
trait (i.e. increased disease resistance) with another individual also displaying that trait, 
so that the trait is passed to the next generation (Fjalestad et al. 2003). Such selection 
causes phenotypic changes by altering the allele frequencies at loci controlling the 
desired trait. Genetic gains in progeny are generally retained and improvements in the 
following generation are additive. Atlantic salmon selective breeding programs are now 
common in many of the salmon producing countries (Fjalestad et al. 2003). Traits under 
selection in such programs include growth rate, age at sexual maturity, flesh qualio/ and 
disease resistance (Fjalestad et al. 2003). In Tasmania a selective breeding program for 
4 Dr Peter Kube, CSIR.O Marine and Atmospheric Research. 
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Atlantic salmon begun in 2004 (P. Kube pers. comm). This program selects for AGD 
resistance, among other traits. 
While simple selection based on phenotype may be adequate for traits that have high 
heritabilities or easily observed phenotypes, selection for traits in which the phenotype 
is not easily quantified, or whose quantification is prohibitively expensive, may benefit 
from the use of molecular technologies. Marker assisted selection (MAS) is one strategy 
of enhancing selective breeding programs through the integration of molecular 
technologies (Beaumont and Hoare 2003). In this approach genetic markers linked to or 
residing within loci that code for the desirable phenotype are identified. These 
quantitative trait loci (QTL) (i.e. the region of a genome that affects the trait in 
question) can then be examined within potential broodstock and appropriate broods 
selected based on their genotype. MAS can also be further enhanced through the 
identification of the gene in which the variation resides. This allows direct selection to 
be made on that causative loci and will increase selection accuracy. This type of 
extension of MAS is known as gene assisted selection or GAS. 
MAS has the potential to contribute to many traditional breeding programs because it 
more easily quantifies desirable, but difficult to measure traits compared to 
conventional phenotype based selei:;tion. While th,is approach has proven successful 
with many plant breeding programs (Zhou et al. 2003) its full potential is yet to be 
realised within many aquaculture sectors. One exception is the recent development of a 
MAS program for resistance to infectious pancreatic necrosis in Atlantic salmon by 
Landcatch Natural Selection (www.landcatch.co.uk). 
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AGD resistance as a trait offers an excellent candidate for marker assisted selection for 
a number of reasons. Resistance to AGD is not easily measured; its measurement either 
requires laboratory based challenge trials or large scale field infections, both of which 
are expensive and labour intensive. Furthermore, Tasmanian biosecurity protocols 
restrict the transfer of potential hroodstock from marine grow-out sites back to the 
freshwater hatcheries. Thus most broodstock are never actually exposed to the marine 
environment or to the causative agent of AGD. In this situation selection is based on 
' 
sibling information rather than broodstock performance. The ability to select broods 
based on genotype rather than sibling phenotype performance could greatly enhance the ' 
accuracy of selection. 
1.7 Identifying molecular mechanisms of resistance to AGD 
If AGD resistance is to be considered a candidate for marker assisted selection, genes 
(or linked markers) which influence this trait must be identified. Typically, ·such a task 
would be conducted using a genome scan approach by examining hundreds, if not 
thousands, of polymorphic markers in segregating informative families. However due to 
the infancy of the Tasmanian Atlantic salmon selective breeding program, large 
numbers of segregating families were not available at the time of this research. Instead, 
a candidate gene and transcriptome approach was utilised. 
1. 7 .1 Candidate gene approach 
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The candidate gene approach examines a small number of genes whose function is 
known and biologically relevant to the trait in question. Accordingly, the 
immunologically important major histocompatibility (MH) genes are an excellent 
candidate for identifying mechanisms of disease resistance. The MH genes are highly 
polymorphic and encode proteins responsible for the presentation of antigenic peptides. 
A large number of associations between variation in th~ MH genes and disease 
resistance in salmonids have been reported (Langefors et al. 2001; Palti et aL 2001; 
Arkush et al. 2002; Lohm et al. 2002; Grimholt et al. 2003; Miller et al. 2004; Kj0glum 
et al. 2006; Glover et al. 2007; Kj0glum et al. 2008). Langefors et al. (2001) reported 
one of the first associations between variation in the MH class II~ chain (Sasa-DAB) 
and disease resistance in Atlantic salmon. This study found broods containing a certain 
Sasa-DAB allele had a 12-fold higher chance of becoming resistant to furunculosis 
compared to broods without this allele (Langefors et al. 2001 ). This association was 
further validated through challenge trials of juveniles with this allele (Lohm et al. 
2002). An association between MHC class II heterozygosity and resistance to infectious 
hematopoietic necrosis virus has also been reported in Chinook salmon Oncorhynchus 
tshawytscha (Walbaum) (Arkush et al. 2002). However, perhaps some of the most 
compelling studies are those of Grimholt et al. (2003), Kj0glum et al. (2006) and 
Kj0glum et al. (2008) who reported highly significant associations between variation in 
the MH class I and class II and increased survival of Atlantic salmon to both 
furunculosis and infectious salmon anaemia (ISA) following laboratory challenge trials. 
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1. 7.2 Transcriptome profiling 
The ability to conduct a genome-wide analysis of the transcriptome has been facilitated 
by the advent of cDNA microarray technology. Essentially, microarrays allow the 
simultaneous expression of thousands of genes to be compared betWeen two samples. A 
number of microarrays have been developed for salmonids, including the 3. 7 and 16k 
GRASP platforms (Rise et al. 2004b~ von Schalburg et al. 2005b) and a 17k 
TRAITS/SGP platform (produced by the Transcriptome Analysis of Important Traits in 
Salmon (TRAITS) and Salmon Genome Projects) (Martin et al. 2007a). In salmonids, 
microarrays have been used to examine responses to stress (Krasnov ef.al. 2005), 
bacterial infection (Rise et al. 2004a; Ewart et al. 2005), maturation (von Schalburg et 
al. 2005a), vaccination (Purcell et al. 2006) and cytokine stimulation (Martin et al. 
2007a; Martin et al. 2007b). 
The use of microarrays to examine the transcriptional changes associated with disease 
resistance is gaining interest in several animal species. For ~stance, this strategy has 
proven successful to identify genes and pathways differentially expressed between lines 
of sheep resistant and susceptible to gastrointestinal nematode infestation (Diez-Tasc6n 
et al. 2005). In a similar study DNA microarrays were used in combination with genetic 
mapping to identify loci .and a putative QTL conferring resistance to Marek's disease in 
chickens (Liu et al. 2001). Using DNA microarrays to identify the mechanisms of 
disease resistance in salmonids may provide valuable insight into the genes and 
pathways controlling this phenotype. Further research can then be directed at 
identifying the genetic parameters controlling these gene pathways. 
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1.8 Aims of this thesis 
The identification of a genetic basis for AGD resistance (Taylor et al. 2007) and its 
subsequent inclusion in the Tasmanian Atlantic salmon selective breeding program has 
increased opti~sm for controlling AGD in Tasmania. The discovery of the molecular 
. . 
mechanisms influencing AGD resistance may enable a more effective exploitation of 
this trait through a better identification of the desirable genotype. Identifying these 
mechanisms is the key aim of my thesis. 
Due to their high level of p9lymorphism and important immune function, genes of the 
MH represent some of the best candidate loci associated with disease resistance in 
vertebrates. The MH class II is particularly relevant for ectoparasite resistance because 
proteins encoded by these loci are responsible for the presentation of exogenously 
·derived peptides (Stomi and Bachmann 2004). I therefore conducted two studies which 
aimed to determine: 
1. how much genetic variation at the MH class II has been retained in the 
Australian Atlantic salmon population; and, 
2. was variation at the MH class I or class II genes associated with AGD severity? 
The impetus for the first aim was derived from previous reports of reduced genetic 
variation within the Tasmanian Atlantic salmon population, supposedly caused by a 
genetic bottleneck event following importation into Australia (Elliott and Reilly 200~; 
Innes and Elliott 2006). This research is presented in Chapter 2. To address the second 
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aim, I utilised a laboratory based AGD challenge model and conducted MH genotyping 
to investigate the association between specific MH alleles/genotypes and resistance to 
AGD quantified through histopathology. This work is presented in Chapter 3. 
Transcriptome profiling through the use of DNA microarrays has become a popular 
strategy for the identification of genes associated with disease resistance in livestock 
species (Liu et al. 2001; Diez-Tasc6n et al. 2005). This strategy can also be used to 
investigate genes associated with disease resistance in salmonids, made possible by the 
development of a number of salmonid specific cDNA microarray platforms (Rise et al. 
2004b; von Schalburg et al. 2005b; Martin et al. 2007a). Utilising a newly developed 
Atlantic salmon cDNA microarray, I conducted two studies aimed to determine: 
3. which is the most transcriptionally active organ at a time when considerable 
variation in disease severity is present; and, 
4. which genes and pathways show differential expression between AGD resistant 
and AGD susceptible Atlantic salmon? 
To address this third aim I compared the transcriptome response in the gill, liver and 
anterior kidney between naive and AGD affected Atlantic salmon. Individuals used in 
this study were derived from the laboratory based AGD challenge model. This research 
is presented in Chapter 4. The fourth aim was achieved by comparing the gill 
transcriptomes of Atlantic salmon deemed to be putatively resistant or susceptible to 
AGD following natural infections. This is presented in Chapter 5. 
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In both transcriptome profiling experiments I observed one transcript of unknown 
identity which demonstrated particularly high differential expression between naive and 
AGD affected Atlantic salmon. Due to its significant up-regulation I hypothesise that 
this transcript may have an important role in AGD pathogenesis. A final study, 
described in Chapter 6, was conducted to elucidate the role of this transcript. More 
specifically, this study was aimed to determine: 
5. what is the full length mRNA sequence and expression characteristics of this 
unknown but highly differentially expressed transcript? 
Finally, Chapter 7 integrates and discusses the significance of the results obtained from 
the preceding five research chapters and proposes future research directions. 
1.9 Explanatory notes regarding thesis structure 
This thesis is structured as a series of separate published manuscripts. All research 
chapters, with the exception of Chapter 6, comprise an already published or a 
manuscript in preparation. In consequence, some textual overlap occurs in the chapters. 
Relevant research published after the publication of these research chapters will be 
considered in Chapter 7. The referencing style of Marine Biotechnology has been 
adopted and a single bibliography is presented at the end of the thesis. 
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Chapter 2: Diversity at the MH class II within domesticated 
Australian Atlantic salmon 
Published as: Wynne JW, Cook MT, Holmes BH, Elliott NG (2007) Allelic and 
haplotypic diversity at the major histocompatibility class II within domesticated 
Australian Atlantic salmon (Salmo salar L.). J Fish Biol 70:45-59 
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Abstract 
Variation within the major histocompatibility (MH) class II alpha gene (Sasa-DAA) was 
compared between domesticated Australian Atlantic salmon and their ancestral 
Canadian population. The level of Sasa-DAA and MH class II beta gene (Sasa-DAB) 
sequence variation was also examined within the Australian population and compared 
to that published for European Atlantic salmon populations. In contrast to variation 
previously reported for non-coding microsatellite loci, a high level ofMH class II allelic 
variation has been maintained within the domesticated Australian populations. 
Furthermore, a high level of Sasa-DAA and Sasa-DAB sequence diversity was also 
observed, and exceeded that reported for other cultured Atlantic salmon populations. 
The number of Sasa-DAB allele sequences (14) surpassed the number of Sasa-DAA 
allele sequences (9) to produce 14 unique class II haplotypes. We conclude the 
Australian Atlantic salmon populations show high MH class II allelic and haplotypic 
variation compared to both its ancestral Canadian population and other cultured Atlantic 
salmon populations. 
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2.1 Introduction 
Atlantic salmon (Salmo salar L.) were successfully imported from the River Philip, 
Canada to New South Wales, Australia, in the mid 1960s. Following importation, the 
population was maintained in a freshwater landlocked hatchery at Gaden, New South 
Wales. In 1984 a Tasmanian commercial aquaculture industry commenced from this 
Gaden stock (Ward et al. 1994), and has grown rapidly. Anecdotal comments about 
population bottlenecks have caused some ccmcem within the industry. Consequently, a 
number of studies, most of which concentrated on non-coding loci, have been 
conducted to assess genetic variation within the Australian Atlantic salmon populations 
(Reilly et al. 1999; Elliott and Reilly 2003; Innes and Elliott 2006). Although some 
inconsistencies have been observed, these studies have generally demonstrated 
reductions in both the number of alleles (Innes and Elliott 2006) and heterozygosity 
(Elliott and Reilly 2003) compared to the ancestral Canadian population. While these 
results suggest that some loss of genetic diversity has occurred, the direct functional 
relevance of reduced non-coding variation is unknown. This study posits that coding 
regions, such as the major histocompatibility complex (MHC) class II genes, may be 
more biologically relevant regions to examine, given that a reduction in MHC variation 
can have direct functional importance to disease resistance (0' Brien et al. 1985) and so 
to survival. 
Genes of the MHC represent the most polymorphic genes in the vertebrate genome 
(Marsh et al. 2000). The classical MHC genes encode cell surface glycoproteins 
responsible for the presentation of self and non-self peptides to T lymphocytes (T cells). 
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In most cases, presentation and recognition of foreigrr peptides elicits a humoral or cell 
mediated immune response. Polymorphism within the MHC enables different allelic 
variants to bind and present unique sets of antigenic peptides, functionally resulting in 
differences in disease resistance. 
In contrast to other vertebrates, the teleost MHC has undergone extensive genomic 
reorganisation (Nonaka et al. 2001). The MHC class I and class II genes form a tightly 
linked complex in most vertebrates (Nonaka et al. 1997; Kaufman et al. 1999). 
However, in teleosts the class I and class II genes remain on different linkage groups 
(Sato et al. 2000; Nonaka et al. 2001; Shum et al. 2001). As the MHC genes in Atlantic 
salmon do not form a complex, they are often designated the MH genes (Stet et al. 
2002). Some linkage between the Atlantic salmon MH genes still exists. For instance, 
genes encoding the MH class II alpha (Sasa-DAA) and beta (Sasa-DAB) genes are 
tightly linked and co-segregate as composjte haplotypes (Stet et al. 2002). Furthermore, 
in some cultured Atlantic salmon populations the same number of alleles are observed 
at the Sasa-DAA and Sasa-DAB loci and combine to produce an equivalent number of 
unique class II composite haplotypes (Stet et al. 2002). Another interesting feature of 
Sasa-DAA is the presence of a polymorphic minisatellite embedded within the 3' 
untranslated (UT) region (Grimholt et al. 2000; Grimholt et al. 2002; Stet et al. 2002). 
In some cultured Atlantic salmon populations, each unique MH class II composite 
haplotype (Sasa-DAA/Sasa-DAB) is characterised by a unique minisatellite marker 
allele from this 3' UT region (Stet et al. 2002). 
Pathogen mediated balancing selection through either overdominant (Hughes and Nei 
1989) or negative frequency dependent selection (Takahata and Nei 1990) is suggested 
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to be the major evolutionary force maintaining and promoting polymorphism within the 
MHC genes (Jeffery and Bangham·2000; Bernatchez and Landry 2003; Sommer 2005). 
Evidence for both overdominant (heterozygous advantage) and negative frequency 
dependent selection has been found within salmonid populations. For instance, chinook 
salmon (Oncorhynchus tshawytscha) heterozygous at their MHC class II beta locus 
have increased survival following challenge by infectious haematopoietic necrosis virus 
(Arkush et al. 2002). Moreover, specific MH class I and class II alleles have been 
associated with increased resistance to furunculosis (Langefors et al. 2001; Grimholt et 
al. 2003) and infectious salmon anaemia (Grimholt et al. 2003). Such results suggest a 
loss of MH variation either as reduced heterozygosity or allelic diversity may have 
adverse affects on a population's ability to resist disease. 
' ' 
In the present study we investigated whether previously reported losses in non-coding 
variation in the Tasmanian Atlantic salmon population are reflected within the coding 
MH class II genes. This was done first by comparing variation within a Sasa-DAA 
minisatellite repeat (known as Sasa-DAA-3UTR) in two domesticated Australian 
Atlantic salmon populations with their ancestral Canadian population, and then by 
sequence analysis of the Sasa-DAA and Sasa-DAB genes within'the Tasmanian 
\ 
· population, and comparison with European populations. 
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2.2 Materials and Methods 
2.2.1 Population samples for Sasa-DAA-3UTR analysis 
Three populations of Atlantic salmon were analysed for Sasa-DAA-3UTR variation. The 
first sample comprised archived scale samples (n= 63) from wild Atlantic salmon from 
the ancestral population in the River Philip, Nova Scotia, Canada. Collection details for 
these samples, captured in 1971 and 1972, are described by Innes and Elliott (2006). 
This population was considered to represent natural MH diversity in the population at 
the time of importation into Australia. The second sample was muscle tissue (n= 78) 
from the Gaden, New South Wales (NSW) population (Reilly et al. 1999) and the third 
was muscle tissue (n= 80) from the 2002 year class of the Tasmanian commercial 
population. 
2.2.2 DNA isolations 
Genomic DNA (gDNA) isolation from the Canadian archived scale samples is 
previously described by Innes and Elliott (2006) and followed a modified protocol of 
Adcock et al. (2000). Briefly, scales (1-2 per sample) were incubated in extraction 
buffer at 55°C overnight. DNA was then extracted twice with phenol and once with 
chloroform isoamyl alcohol (24:1, v:v), washed twice with 100% ethanol and 
resuspended in MilliQ water. gDNA from the Tasmanian and New South Wales muscle 
samples were isolated using a modified CTAB protocol outlined by Ward et al. (1994). 
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2.2.3 Sasa-DAA-3 UTR genotyping 
Variation was assessed within the previously described Sasa-DAA minisatellite (Sasa-
DAA-3 UTR), which resides in the 3' UT region on the MH class II alpha gene 
(Grimholt et al. 2000; Stet et al. 2002). Sasa-DAA-3UTR was amplified using the 
fluorescently FAM labelled sense primer (5' -GATGGCAAAGAGGAAAGTGAG-3 ') 
and anti-sense primer (5'-TTGTTATGCTCTACCTCTGAA-3') (St~t et al. 2002). PCR 
reactions were performed in a total volume of 12.5 µL, containing .10-50 ng of gDNA, 
1.25 µl of 1 OX buffer, 200 µM dNTPs, 2.5 mM MgCh, 200 nM of each primer and 1 
unit of Taq polymerase (Applied Biosystems, Foster City, USA). Cycling was 
performed in an ABI 9600 thermal cycler (Applied Biosystems) with the following 
parameters: 95°C for 10 min, 35 cycles of94°C for 1min52°C for 1 min and 72°C for 
lmin and a fmal extension of72°C for 7 min. Resulting products were diluted (1/5), 
denatured in HiDi formamide (Applied Biosystems) and analysed using a ABI 3100 
capillary sequencer (Applied Biosystems). Allele size was determined using the internal 
size standard, Genescan-500 LIZ, and the program Genemapper ver3.5 (Applied 
Biosystems). 
2.2.4 Sasa-DAA and Sasa-DAB sequencing 
Full length sequences of expressed Sasa-DAA alleles and their co-segregating Sasa-
DAB alleles were obtained from individuals comprising the 2002 commercial 
27 
Tasmanian year class. Sequences were obtained from three to eight individuals 
presenting a unique Sasa-DAA-3UTR allele. Total RNA was isolated from anterior 
kidney using RNAwiz (Ambion, Austin, USA) as per the manufacturer's instructions. 
Approximately 2-5 µg ofRNA was reverse transcribed using Superscript III 
(Invitrogen, Mount Waverly, Australia) to generate first strand cDNA. Coding regions 
for the Sasa-DAA locus were amplified using the primers DA66F (5' -
TGCTGGCAGGTGTATGCAGAA-3~) and DA1054R (5'-
TTGTTATGCTCTACCTCTGAA-3') (Stet et al. 2002). The Sasa-DAB locus was 
amplified using the primers DB40F (5'-ATGTCGATGTCTATCTTCTG-3') and 
DB684R (5'-CAGACCAGACGCACCGATGGC-3') (Stet et al. 2002). The PCR 
reactions were identical for both loci and were perfohned in a total volume of 50 µL 
containing approximately 5 µ11 OX buffer, 1.5 mM MgCh, 200 µM dNTPs, 200 nM of 
each primer, 2 units of Taq pol)'merase (Applied Biosystems) and 1 µL of cDNA 
template. Amplification was performed in a GeneAmp 9700 thermal cycler (Applied 
I 
Biosystems) using the following cycling profile: 10 min at 95°C, 25 cycles of 1 min at 
94°C, 30 sec at 58°C and 1 min at 72°C, and a final extension step for 7 min at 72°C. 
PCR products were purified using the QIAquick PCR purification kit (Qiag~n, 
Doncaster, Australia) and ligated into pGEM-T easy vector (Promega, Armadale, 
Australia). Constructs were transformed into an ele'ctrocompetent strain of DHlOP as 
per the manufacturer's instructions (Promega). Eight to ten. clones from each PCR 
amplification were picked, on-grown and plasmid purified using the QIAprep spin 
miniprep kit (Qiagen). By sequencing multiple clones (8 tolO), PCR errors could be 
identified and eliminated from analysis. Both strands of each plasmid was sequenced 
using the ABI Prism Bigdye Terminator Cycle Sequencing Ready Reaction kit (Applied 
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Biosystems) using the T7 and Sp6 primers. Sequencing products were purified using the 
CleanSEQ Sequencing Reaction Clean-Up system (Agencourt Bioscience, Beverly, 
USA). Purified sequencing products were analysed on an ABI 3100 capillary s~quencer 
(Applied Biosystems). 
2.2.5 Sequence and data analysis 
All sequences were visualised in ChromasPro verl.2 (Technelysium, Tewantin, 
Australia) and alleles were defined based on their amino acid sequence as in previous 
studies (Grimholt et al., 2002; Stet et al., 2002). Alignments were performed using 
ClustalW in the program MEGA ver3.0 (Kumar et al. 2004) and BioEdit ver7.0.5 (Hall 
1999). Phylogenetic analysis was performed on both the Sasa-DAA and Sasa.:.DAB loci 
using the neighbour-joining method in the program MEGA ver3.0 (Kumar et al. 2004). 
Topology was tested using 1,000 bootstrap iterations and only values over 50% are 
shown. Expected and observed heterozygosity and subsequent conformance to Hardy-
Weinber.g equilibrium was tested using Genepop ver3.2 (Raymond and Rousset 1995). 
Genetic differentiation and paitvyise Fst values were calculated using Arlequin ver3.0l 
(Excoffier and Schneider 2005). Allelic richness was calculated using FSAT ver2.9.3.2 
(Goudet 1995). 
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2.3 Results 
2.3.1 Sasa-DAA-3UTR variation 
Eight Sasa-DAA-3 UTR alleles were identified across the three populations of Atlantic 
salmon (Table 2.1). In most cases alleles were at 9 to12 base pair (bp) intervals and 
ranged in size from 207bp to 307bp. With one exception, all Sasa-DAA-3UTR alleles 
were shared between the three populations. The exception was the Sasa-DAA-3UTR 
_,allele 307, which was only found (at a low frequency) in the Canadian sample. 
Significant allelic differentiation was observed between all populations. Pairwise Fst 
estimates indicated the greatest differentiation was between Canada and NSW (Fst 
=0.025, p<0.001) and the least between NSW and Tasmania (Fst =0.013, p<0.001). In 
both the Tasmanian and NSW samples the Sasa-DAA-3UTR alleles 229 and 259 were 
the most common, while in the Canadian sample the Sasa-DAA-3UTR allele 239 
followed by 229 were the most common. Only a small decrease in Sasa-DAA-3UTR 
allelic richness was observed within the Australian samples compared to the Canadian 
sample. High heterozygosity was observed in all samples and no significant deviations 
from Hardy-Weinberg equilibrium were detected. 
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Locus Allele (bp) Canada New South Wales Tasmania 
Sasa-DAA-3UTR 207 0.159 0.147 0.162 
229 0.206 0.205 0.250 
239 0.302 0.173 0.144 
250 0.016 0.006 0.038 
259 0.167 0.340 0.206 
279 0.063 0.026 0.125 
298 0.048 0.103 0.075 
307 0.040 
n 63 78 80 
Ho 0.74 0.83 0.83 
He 0.81 0.78 0.82 
p 0.512 0.170 0.128 
AR 8.000 6.807 7.000 
Table 2.1. Sasa-DAA-3UTR allele frequencies. (n) number of individuals scored; (H0 ) 
observed and (He) Hardy-Weinberg expected heterozygosity estimates; (p) probability 
of conformance to Hardy-Weinberg equilibrium; (AR) allelic richness; (-) allele not 
detected. 
31 
2.3.2 Sasa-DAA sequences 
Sequencing of full length Sasa-DAA clones revealed the presence of nine expressed 
allele sequences, four of which were novel (Figure 2.1). The four novel allele sequences 
were designated Sasa-DAA *0802, Sasa-DAA *0902, Sasa-DAA * 1002 and Sasa-
DAA * 1102 according to the nomenclature used by Shum et al. (2002). These four 
sequences were deposited in GenBank and assigned the accession numbers AM259956 
to AM259959. The five previously described allele sequences detected were, Sasa-
DAA*lOOl (Grimholt et al. 2000) Sasa-DAA*0201, Sasa-DAA*0601 (Stet et al. 2002) 
Sasa-DAA *0303 and Sasa-DAA * 1201 (Consuegra et al. 2005a). In all cases the 
predicted Sasa-DAA-3UTR fragment size was found within the expressed Sasa-DAA 
sequence, verifying that the Sasa-DAA-3UTR alleles were derived from the expressed 
Sasa-DAA locus and little or no genotyping/sequencing error was evident. An alignment 
of the amino acid sequences demonstrates the majority of variation between allele 
sequences resides within the alpha-1 domain. In total, 20 of the 225 possible amino acid 
residues were polymorphic, with 15 of these positions occurring within the alpha-1 
domain. No individuab expressed more than two allele sequences. 
Phylogenetic analysis of the alpha-1 domain ( exon 2) nucleoticle sequences with other 
published (European Atlantic salmon populations) Sasa-DAA sequences (Grimholt et al. 
2000; Stet et al. 2002; Consuegra et al. 2005a) demonstrate the existence of three 
possible allelic lineages (Figure 2.2). The nine observed sequences in this study were 
spread across all three lineages. The four unique Tasmanian sequences (Sasa-
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Alpha-1 domain 
1 10 20 30 40 50 60 70 80 
Sasa-DAA*0201 CWQVYA EHKVLHIDLYISGCSDSDGLDMYGLDGEEMWYADFNKGEGVVALPPFADPFTFPGFYEGAVGNQGVCKANLAVNIKAYKNPEEKI 
Sasa-DAA*0303 ••••••••••••••• V.T .•.•.•.. N ........••.•...•.•.• MP ......... Y .. A .•.•...•. I •.••.. TC ...•..•.•.• 
Sasa-DAA*0601 
Sasa-DAA*0802 
Sasa-DAA*0902 
Sasa-DAA*lOOl 
Sasa-DAA*l002 
Sasa-DAA*1102 
Sasa-DAA*1201 
...•..... V ...•••.•. V •.•..•......•.•.•.•.• MP .•....... Y .. A .• Q •••••••••••••••••••••••••• 
••••••••• V .T ••••••••••••••••••••••••• Q •••••••••••••••••••• Q ••••••••• G ••• KC ...•....•.• 
••••••••• V ••••••••• V ••••••••••••••••••••••••••••••••••• A •• Q •••••••••••••••••••••••••• 
•.....•.• A.T .•.•..•. N ....•............•.....•..•.•.•.•.•.. Q ..•.••.••.••. TS ...•..•.•.. 
....•. K .•.. T ..••..•.•..•.•.•...................•.•...•.•.. Q ..•.....•...•. TC .•....•.••. 
•.....•.• A.T ..•.•.• V .•.•.•.....•.•.•.•.........•.•.....•.. Q .....•..• G .•. TS •...•...... 
......... H.T ....•.. VE •....•.•....•.....•. MP •..•..... Y •• A •• Q •••••• I ••••••••••••••••••• 
Alpha-2 domain 
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Sasa-DAA*0201 DPPHSSIYPRDDVDLGVENTLICHVSGFHPAPVRVRWTRNNQNLTEGVRLSTPYPNADFTLNQFSSLPFTPEEGDIYGCTVEHKGLAEPLTRIW 
Sasa-DAA*0303 A ••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
Sasa-DAA*0601 A ••••••••••••••••••••••••••• Y ••••••••••••••••••••••••••••• V.F •.•........•..•.•..•..•..•.•...•. 
Sasa-DAA*0802 .••••.••.•.•.••.•.•.••.••••• F ••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
Sasa-DAA*0902 A ••••••••••••••••••••••••••• F ••••••••••••••••••••••••••••• v. F ••••••••••••••••••••••••••••••••• 
Sasa-DAA*lOOl A ••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
Sasa-DAA*l002 A ••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
Sasa-DAA*l102 A ••••••••••••••••••••••••••• Y: •••••••••••••••••••••••••••• V.F ................................ . 
Sasa-DAA*1201 
CP/TM/CYT 
180 190 200 210 
Sasa-DAA*0201 EPEVIQPSVGPAVFCGVGLTVGLLGVAAGTFFLIKGNQCN 
Sasa-DAA*0303 ••.•••..•••••••••••• L ••••••••••••••••••• 
Sasa-DAA*0601 •••••••••••••••••••• L ..••.•.•••...•••••• 
Sasa-DAA*0802 •••••••••••••••••••• L ••••••.•••••••••••• 
Sasa-DAA*0902 •••••••••••••••••••• L ••••••••••••••••••• 
Sasa-DAA*lOOl •••••••••••••••••••• L •••••...••••.•••••• 
Sasa-DAA*l002 •••••••••••••••••••• L ••••••••••••.•••••• 
Sasa-DAA*ll02 
Sasa-DAA*1201 
/ 
Figure 2.1. Alignment of all MH class II Sasa-DAA amino acid sequences detected within our study. Dots denote identities to Sasa-
DAA*0201. (LP) leaderpeptide, alpha 1-domain, alpha-2 domain, (CP) connecting peptide, (TM) transmembrane and (CYT) cytoplasmic 
regions indicated according to Stet et al. (2002). 
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88 Sasa-DAA*1201 
Sasa-DAA *0601 
Sasa-DAA*0902 (Tas) 
....---- Sasa-DAA*0901 
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,___ ___ Sasa-DAA *0501 
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Figure 2.2. Phylogenetic analysis of Sasa-DAA allele sequences. Analysis was 
performed using the neighbour-joining method based on the alpha-1 domain nuCieotide 
sequences with 1,000 bootstrap iterations. Only bootstrap values of 50 or greater are 
depicted and genetic distance is shown below. The three rainbow trout allele sequences, 
Onmy-DAA *OJ to Onmy-DAA *03, were used as out-groups and were obtained from 
Grimholt et al. (2000). Sequences unique to Tasmania (Tas) are shown in Brackets. 
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DAA *0802, Sasa-DAA *0902, Sasa-DAA * 1002, Sasa-DAA * 1102) clustere4 within the 
three allelic lineages. 
Genotyping the Sasa-DAA-3UTR locus and sequencing expressed full length Sasa-DAA 
clones facilitated the examination of the association between Sasa-DAA-3UTR alleles 
and allele sequences. In most cases each unique Sasa-DAA sequence appeared to be 
characterised by a single Sasa-DAA-3UTR allele. For instance, Sasa-DAA-3UTR alleles 
207, 239, 250, 259 and 279 appeared linked to sequences Sasa-DAA *0201, Sasa-
DAA * 1001, Sasa-DAA *0303, Sasa-DAA * 1201 and Sasa-DAA * 1102, respectively 
(Table 2.2). However, Sasa-DAA-3UTR alleles 229· and 298 were each linked to two 
allele sequences. 
2.3.3 Sasa-DAB sequences 
Sequencing the Sasa-DAB locus revealed the presence of 14 allele sequences 
(Figure 2.~). Two of these sequences were previously described full length sequences, 
seven were previously described partial sequences (beta-1 domain) and five were novel. 
\ 
The two full length sequence identities were Sasa-DAB*0801 and Sasa-DAB*0401 (Stet 
et al. 2002). The seven partial identities were to alleles Sml lx, Sm5b, Sm12t, Sm6v, 
Sm9w, Sm2c and Sm4k (Landry and Bernatchez 2001) all of which were only exon 2 
sequences (beta-1 domain). For simplicity, our full length sequences of these alleles 
have been renamed Sasa-DAB*l704, Sasa-DAB*l602, Sasa-DAB*0402, Sasa-
DAB*l 502, Sasa-DAB*0303, Sasa-DAB*l 303 and Sasa-DAB*0403, respectively, 
according to the Immuno Polymorphism Database (IPD) 
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Sasa-DAA-3UTR Sasa-DAA sequence No. of Sasa-DAB sequence No. of 
fish fish 
207 DAA*0201 5 DAB*1704 4 
DAB*0403 1 
229 DAA*0802 3 DAB*0801 3 
229 DAA*1002 3 DAB*1602 3 
239 DAA*1001 8 DAB*0402 3* 
DAB*1502 3 
DAB*1705 
250 DAA*0303 3 DAB*0401 3 
259 DAA*1201 7 DAB*0702 5 
DAB*1706 
DAB*0103 1 
279 DAA*1102 3 DAB*0303 3 
298 DAA*0902 2' DAB*0603 2 
298 DAA*0601 1 DAB*1303 1 
Table 2.2. Sasa-DAA-3UTR alleles linked to Sasa-DAA allele sequences and their co-
segregating Sasa-DAB allele sequence for Tasmanian Atlantic salmon. Allele sequences 
shown in bold are newly described alleles (* note one co-segregating Sasa-DAB not 
detected in the 10 clones sequenced). 
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Sasa-DAB*0103 MSMSIFCVSLTLVLSIFSGTDG 
Sasa-DAB*0303 
Sasa-DAB*0401 
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Figure 2.3. Alignment of all MH class II Sasa-DAB amino acid sequences detected within our study. Dots denote identities to Sasa-
DAB*Ol03 and dashes indicate gaps within the alignment. (LP) leader peptide, beta 1-domain, beta-2 domain, (CP) connecting peptide, 
(TM) transmembrane and (CYT) cytoplasmic regions indicated according to Stet et al. (2002). 
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(www.ebi.ac.uk/cgi-bin/ipd/mhc) (Ellis et al. 2006). The five new alleles identified 
within this study have been designated Sasa-DAB*Ol 03, Sasa-DAB*0603, Sasa-
DAB*0702, Sasa-DAB*l705 andSasa-DAB*l706. Our full sequences for the five novel 
and seven partially described sequences were deposited in GenBank and assigned the 
accession numbers AM259944 to AM259955. An amino acid alignment demonstrates 
that almost all variation at the Sasa-DAB locus is restricted to the beta-1 domain. A total 
of 32 polymorphic amino acid positions were detected, with 31 of these residing within 
the beta-1 domain. Like the Sasa-DAA locus, no individual expressed more than two 
Sasa-DAB allele sequences. 
Phylogenetic analysis of the beta-1 domain with other published sequences (Hordvik et 
al. 1993; Stet et al. 2002) demonstrated the presence of one major allelic lineage 
containing 18 of the 20 sequences (Figure 2.4); One possible sub lineage containing the 
sequences Sasa-DAB*0301, Sasa-DAB*0303, Sasa-DAB*l303, Sasa-DAB*0601 and 
Sasa-DAB*0603 was identified within the major lineage and was supported by a high 
bootstrap value (91). Four of the newly identified Tasmanian sequences (Sasa-
DAB*0603, Sasa-DAB*0702, Sasa-DAB*l705 and Sasa-DAB*l706) were within the 
main allelic lineage. The other new sequence, Sasa-DAB*Ol03, along with Sasa-
DAB*Ol OJ, showed high divergence from the main lmeage. The seven sequences 
(Sasa.-DAB*l704, Sasa-DAB*J602, Sasa-DAB*0402, Sasa-DAB*l502, Sasa-
DAB*0303, Sasa-DAB*l303 andSasa-DAB*0403) which had been previously 
described only at the beta-1 domain from Canadian Atlantic salmon (Landry and 
Bernatchez 2001) showed no distinct clustering, nor did the sequences derived from 
Norwegian Atlantic salmon (Stet et al. 2002). 
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Figure 2.4. Phylogenetic analysis of Sasa-DAB allele sequences. Analysis was 
performed using the neighbour-joining method based on the beta-1 domain nucleotide 
sequences with 1,000 bootstrap iterations. Only bootstrap values of 50 or greater are 
depicted and genetic distance is shown below. Two rainbow trout sequences, Onmy-
DAB *01 and Onmy-DAB*02, were used as out-groups and were obtained from 
Glamann (1995). Sequences unique to Tasmania (Tas) are shown in Brackets. 
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The 14 Sasa-DAB sequences identified within this study combined with the nine Sasa-
DAA sequences to produce_ 14 unique MH class II composite haplotypes (Table 2.2). 
Variations in composite haplotype frequencies were evident. Five composite haplotypes 
were observed only within single fish while the remaining nine composite haplotypes 
were detected in two to five fish each. In some cases multiple Sasa-DAB allele 
sequences combined with single Sasa-DAA allele sequences (generally the most 
common alleles). In one individual, heterozygous for Sasa-DAA *0201/Sasa-DAA*1001, 
only one co-segregating Sasa-DAB allele (Sasa-DAB*1704) was detected within the 10 
clones. We suggest the Sasa-DAA * 1001 co-segregating Sas a-DAB allele was present, 
however was not detected within the 10 clones selected for sequencing. 
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2.4 Discu~sion 
Non-coding genetic variation within the Tasmanian Atlantic salmon population has 
been the subject of multiple studies (Ward et al. 1994; Reilly et al. 1999; Elliott and 
Reilly 2003; Innes and Elliott 2006). A general reduction in the number of 
microsatellite alleles, and to a lesser extent heterozygosity, has been detected within the 
Tasmanian population compared to its ancestral Canadian population. A moderate 
genetic bottleneck event during the early years of domestication has been hypothesised 
as responsible (Elliott and Reilly 2003). The present study was undertaken to test if this 
decreased non-coding variation was also reflected in coding genes. The MH genes were 
chosen due to their high polymorphism and direct functional relevance to disease 
resistance. 
Results from both the minisatellite and sequence analysis suggest high variation exists 
within the MH class II genes of Australian Atlantic salmon. Heterozygosity at the Sasa-
DAA-3 UTR locus was similar for both domesticated Australian populations (Tasmanian 
and NSW) and their ancestral Canadian population. Furthermore, only one Sasa-DAA-
3 UTR allele was missing within the Australian population, and this might well be 
attributed to the small sample size. High numbers of Sasa-DAA (9) and Sasa-DAB (14) 
allele sequences were observed within the Tasmanian Atlantic salmon population and 
exceeded that observed for a cultured Atlantic salmon population in Norway (Stet et al. 
2002). This Norwegian population, known as Gl, was originally founded from wild 
stock collected in 13 Norwegian rivers in 1973 (Gjedrem 2000). In this population, 
seven Sasa-DAA and seven Sasa-DAB alleles sequences were identified across 33 
families. Interestingly, these seven Sasa-DAA and Sasa-DAB alleles co-segregated to 
42 
produce seven unique class II composite haplotypes (Stet et al. 2002). In contrast, the 
nine Sasa-DAA and 14 Sasa-DAB allele sequences reported within our study combined 
to produce 14 unique class II composite haplotypes. At the time of conducting this 
study the Tasmanian Atlantic salmon population had never been selected for any 
production traits. 
The high level of MH class II heterozygosity and allelic/haplotypic diversity reported 
herein, contrasts the level of g~netic diversity reported at non-coding loci. Sighificant 
losses of non-coding microsatellite alleles (up to 21-43%) (Innes and Elliott 2006) and 
to a lesser extent heterozygosity (Elliott and Reilly 2003) has been reported within the 
Tasmanian Atlantic salmon population compared to the ancestral Canadian population. 
It seems likely that while a genetic bottleneck event may have reduced variation at 
many neutral non-coding loci in the Tasmanian stock, diversity at the MH class II has 
been maintained. A somewhat similar situation is observed for the San Nicolas Island 
fox, Urocyon littoralis (Baird). This species is extremely monomorphic at most non-
coding loci, yet displays high levels ofMHC variation, presumably maintained and 
promoted through intense pathogen mediated balancing selection (Aguilar et al. 2004). 
While, the extent to which balancing selection acts to promote MH variation within an 
aquaculture environment may be lower than in the natural state, as cultured fish 
experiencing disease tend to be quickly treated, pathogen mediated selection is still 
likely to be a significant evolutionary force. 
In our study, the seven unique Sasa-DAA-3UTR alleles were linked to nine Sasa-DAA 
allele sequences. This demonstrates that unique Sasa-DAA sequences are not always 
characterised by a single Sasa-DAA-3 UTR allele, in contrast to the findings in a 
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Norwegian cultured population (Stet et al. 2002). A similar situation was observed for 
the Atlantic salmon MH clas~ I (Sasa-UBA) locus, whereas many as seven Sasa-UBA 
allele sequences are characterised by a single Sasa-UBA-3UTR allele (Grimholt et al. 
2002). This fmding suggests not all variation at the Sasa-DAA locus was detected within 
our study. It is possible that additional Sasa-DAA allele sequences characterised by 
existing Sasa-DAA-3UTR alleles were also present. Such a situation would cause an 
underestimation of both the true number of Sasa-DAA alleles, and possibly the true 
heterozygosity. However, we considered the abundance of such "non-detected" alleles 
to be even across all populations and therefore did not bias our result. 
This study reported the existence of four novel Sasa-DAA sequences. The fact that these 
alleles have not been previously reported within either Irish or Norwegian Atlantic 
salmon may suggest these alleles &re unique to Tasmanian (or Canadian derived) 
Atlantic salmon. The phylogenetic analysis of these and other published Sasa-DAA 
allele sequences revealed the presence of three possible allelic lineages. The four novel 
Sasa-DAA alleles and the five previously reported alleles observed within our study 
were distributed across the three lineages. This result may suggest that the divergent 
Sasa-DAA allelic lineages observed within this study predate the separation of North 
American and European populations of Atlantic salmon. Interesting, in comparison, 
significant divergence between the North American and European populations have 
been reported previously by examining supposedly neutral microsatellite variation 
(King et al. 2001). A previous study by Consuegra et al. (2005a) also found low 
divergence between Irish and Norwegian Atlantic salmon populations at the MH class 
II. 
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In the case where different Sasa-DAA sequences were characterised by a single Sasa-
DAA-3 UTR allele (i.e. sequences linked to Sasa-DAA-3UTR alleles 229 and 298), no 
phylogenetic relationship between the sequences could be established. This suggests 
that the different sequences characterised by single Sasa-DAA-3UTR alleles are similar 
only by state, not necessarily by descent. A similar situation was sometimes observed at 
the MH class I Sasa-UBA locus where multiple allele sequences linked to single Sasa-
UBA-3 UTR alleles sometimes showed little similarity, however this was not always the 
case (Grimholt et al. 2002). Evidence against this hypothesis can also be observed 
within our results when compared to other studies. That is, in some instances when 
sequences were characterised by a similar Sasa-DAA-3UTR allele size, a close 
phylogenetic relationship can be established. For example, in Norwegian Atlantic 
salmon the Sasa-DAA-3 UTR allele 232 is linked to allele sequence Sasa-DAA *O I 0 I 
(Stet et al. 2002). This allele shows a high similarity to the allele Sasa-DAA *0802 
which in our study was characterised by the Sasa-DAA-3UTR allele 229. It therefore 
seems likely that while some alleles may just happen to be linked to the same 
minisatellite allele by chance, other alleles may be derived from the same origin. 
Our study also found considerable variation in the MH class II beta gene (Sasa-DAB). 
Although most alleles had been previously described, five novel alleles were also 
detected. In contrast to other studies, the number of Sasa-DAB alleles identified within 
the Tasmanian sample exceeded the number of Sasa-DAA alleles (Stet et al. 2002). A 
total of 14 Sasa-DAA/Sasa-DAB composite haplotypes were identified. In some cases 
multiple Sasa-DAB allele sequences appeared to combine with single Sasa-DAA allele 
sequences. For instance, Sasa-DAA *I 00 I appeared to combine with sequences Sasa-
DAB *0402, Sasa-DAB*J 502 and Sasa-DAB*l705 to produce three diverse composite 
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haplotypes. Moreover, the allele sequences Sasa-DAA *0201 and Sasa-DAA * 1201 also 
appear to combine with two and three Sa~a-DAB sequences each. One possible reason 
to explain this high level ofhaplotypic diversity may be that within a population 
multiple Sasa-DAB alleles can co-segregate with a single DAA allele. This leads to the 
question, has pathogen driven balancing selection promoted variation in the beta chain 
more so than the alpha chain within Canadian derived Atlantic salmon? It may be 
interesting to note that in some other teleost species, such as cichlids, the number of 
beta loci surpasses the number of alpha loci (Malaga-Trillo et al. 1998; Murray et al. 
2000). As a result it has been speculated that each class II alpha chain may combine 
with more than one beta chain to produce mature class II heterodimers (Murray et al. 
2000) . In humans, the class II alpha locus is generally less polymorphic than the class 
II beta locus (Marsh et al. 2000). The Sasa-DAB alleles reported within our study 
generally showed more polymorphic positions when compared to the Sasa-DAA locus, 
and this result was consistent with other studies on Atlantic salmon (Stet et al. 2002). 
To conclude, this study found no evidence of reduced variation at the MH class II Sasa-
DAA-3 UTR locus within the domesticated Australian Atlantic salmon population 
compared to its ancestral Canadian population. This result is in contrast to previous 
studies on non-coding microsatellites that have reported both significant loss of alleles 
and some loss ofheterozygosity. Sasa-DAA and Sasa-DAB sequence variation within 
the Tasmanian Atlantic salmon population was higher to that reported for other cultured 
populations of Atlantic salmon. Finally, the variation at the Sasa-DAB locus exceeded 
variation at the Sasa-DAA locus and combined to produce high MH class II haplotypic 
diversity. 
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Chapter 3: MH polymorphism associated with resistance to 
AGD in Atlantic salmon 
Published as: Wynne JW, Cook MT, Nowak BE, Elliott NG (2007) Major 
histocompatibility polymorphism associated with resistance towards amoebic gill 
disease in Atlantic salmon (Salmo salar L.). Fish Shellfish Immun 22:707-717 
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Abstract 
The association between major histocompatibility (MH) polymorphism and the severity 
of infection by amoebic gill disease (AGD) was investigated across 30 full-sibling 
families of Atlantic salmon. Individuals were challenged with AGD for 19 days and 
then their severity of infection scored by histopathological examination of the gills. Fish 
were then genotyped for the MH class I (Sasa-UBA) and MH class II alpha (Sasa-DAA) 
genes using polymorphic repeats embedded within 3' untranslated regions of the Sasa-
UBA and Sasa-DAA genes. High variation in the severity of infection was observed 
across the sample material, ranging from 0 to 85% gill filaments infected. In total, seven 
Sasa-DAA-3UTR and ten Sasa-UBA-3UTR marker alleles were identified across the 30 
families. A significant association between the marker allele Sasa-DAA-3UTR 239 and 
a reduction in AGD severity was detected. There was also a significant association 
found between AGD severity and the presence of two Sasa-DAA-3UTR genotypes. 
While the associations between MH allele/genotypes and AGD severity reported herein 
may be statistically significant, the small sample sizes observed for some alleles and 
genotypes means these associations should be considered as suggestive and future 
research is required to verify their biological significance. 
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3.1 Introduction 
Amoebic gill disease (AGD) is the most significant disease affecting Atlantic salmon in 
Tasmania, Australia (Munday et al. 2001). AGD is caused by the protozoan 
Neoparamoeba spp. which, actins as the primary pathogen, infect the gills of marine 
cultured salmonids (Wong et al. 2004; Dykova et al. 2005). Clinical signs of AGD 
include lethargy, respiratory distress, rapid opercular movement, and ultimately, if not 
treated, death (Munday et al. 1990). Histologically, AGD is initially characterised by 
attachment of amoeba to healthy gill epithelial tissue followed by the progression of 
lamellar fusion, epithelial desquamation and oedema, epithelial hyperplasia and 
interlamellar vesicle formation (Adams and Nowak 2003; Adams and Nowak 2004a). 
An infiltration of leucocytes into the central venous sinus is also observed adjacent to 
infected reg}ons and often increases with disease progression (Adams and Nowak 
2004a). In some cases, leucocytes are found in close association with amoeba within the 
hyperplastic tissue (Bridle et al. 2003). Significant variation in the severity of AGD 
infection is observed within the Tasmanian Atlantic salmon population. At present, the 
molecular mechanism of any resistance is yet to be elucidated. If genetically controlled, 
AGD resistance may be enhanced by selective breeding. The identification of genes 
which influence resistance may greatly improve the efficacy of such a breeding 
strategy. 
Genes of the major histocompatibility complex (MHC) represent the most polymorphic 
genes in the vertebrate genome (Marsh et al. 2000).The classical MHC genes encode 
cell surface glycoproteins responsible for the presentation of self and non-self peptides 
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to T lymphocytes (T cells). MHC class I molecules present endogenously derived 
peptides to cytotoxic CDS+ T cells, while MHC class II molecules present exogenously 
derived peptides to helper CD4+ T cells (Rammensee 1995). In most cases, presentation 
and recognition of foreign peptides elicits a humoral or cell mediated immune response. 
Typically, the highest level of polymorphism observed in the MHC genes is 
concentrated within the peptide binding regions (PBR). Polymorphism within the PBR 
enables different allelic variants to bind and present unique sets of antigenic peptides. 
Such variations in antigen presentations may functionally result in differences in disease 
resistance. 
In contrast to humans, the genomic organisation of the teleost MHC genes is considered 
relatively 'simple.' The most unusual feature of this simple MHC is the lack oflinkage 
between the classical class I and class II genes (Sato. et al. 2000; Shum et al. ~002), 
possibly facilitating independent divergence between the classes (Consuegra et al. 
2005a; Consuegra et al. 2005b ). As the MHC genes in Atlantic salmon do not form a 
complex, they have been renamed the MH genes (Stet et al. 2002). Interestingly, in 
salmonids at least, the class II alpha and beta loci (DAA and DAB) have remained 
linked, and co-segregate as composite haplotypes (Stet et al. 2002). Expression of both 
the classical class I and class II genes are characterised by a single dominantly 
expressed locus in Atlantic salmon and rainbow trout (Grimholt et al. 2002; Shum et al. 
2002; Stet et al. 2002). In Atlantic salmon, polymorphic repeats have been identified 
and characterised within the 3' untranslated (UT) regions of both the class I (Sasa-UBA) 
and class II alpha (Sasa-DAA) loci (Grimholt et al. 2000; Grimholt et al. 2002; Stet et 
al. 2002). In many instances, these unique marker alleles have been linked to unique 
allele sequences. For instance, Stet et al. (2002) showed in a cultured population of 
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Norwegian Atlantic salmon that each Sasa-DAA-3UTR marker allele was linked to a 
unique class II haplotype. From the same population, most Sasa-UBA-3UTR marker 
alleles were shown to be linked to one or two allele sequences (Grimholt et al. 2002). 
However, one Sasa-UBA-3UTR allele was linked to seven different allele sequences. 
Due to the polymorphic nature of the MHC it has been possible to associate certain 
alleles/haplotypes to increased disease resistance. For instance, in chickens, one MHC 
haplotype is significantly associated with resistance to Marek's disease (MD) (Bacon 
1987). Similarly, in Soay sheep (Ovis aries L.) MHC polymorphism was significantly 
associated with both juvenile survival and nematode parasitism (Paterson et al. 1998). 
Perhaps the most compelling examples in salmonids come from the studies by Grimholt 
et al. (2003), which found a highly significant association between MH polymorphism 
and resistance towards furunculosis and infectious salmon anaemia in Atlantic salmon. 
Moreover, increased resistance to infectious hematopoietic necrosis in Atlantic salmon 
has been associated with certain MH alleles (Miller et al. 2004). The aim of our study 
was to examine the correlation between MH polymorphism and the severity of infection 
by AGD in Atlantic salmon. 
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3.2 Materials and Methods 
3 .2.1 Animals and disease challenge trial 
Thirty full-sibling Atlantic salmon families were infected with AGD in a disease 
challenge. All fish were obtained from a commercial salmon hatchery and comprised 
the first generation of the Tasmanian Atlantic salmon selective breeding program. All 
families were unrelated and comprised of single parent crosses. The relatedness of 
parents was unknown. Briefly, each family was initially represented by 18 pre-smolt 
fish which were maintained in equal numbers in three 3000 L recirculating systems at 
the University of Tasmania. Following temperature and salinity acclimation, each tank 
offish was inoculated with 500 cells L-1 of Neoparamoeba spp. as described by 
Morrison et al. (2004). Fish were monitored daily for AGD mortalities until day 19 
post-inoculation when all individuals were euthanised using with 5 g L-1 Aqui-S (Aqui-
S NZ Ltd, Lower Hutt, New Zealand). The gill cage and a skeletal muscle sample was 
dissected from all individuals and stored in seawater Davidson's fixative and 95% 
ethanol, respectively. 
3.2.2 Gill histopathological scoring 
The second left anterior hemibranch was dissected for each fish, dehydrated, embedded 
in paraffin wax and sectioned at 5 µm. Sections were stained with haematoxylin and 
eosin and viewed with a light microscope (Zeiss, Oberkochen, West Germany) at 400X 
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magnification. The percentage of gill filaments (primary lamellae) displaying 
hyperplastic lesions were then counted for each section, as previously described by 
Adams and Nowak (2004b). Filaments were only counted when the central venous 
sinus was visible in at least two-thirds of the total length. All sections were also 
examined for the presence of Neoparamoeba spp. 
3.2.3 Sasa-DAA-3UTR and Sasa-UBA-3UTR marker analysis 
Variation within the MH class I and class II loci were examined using previously 
described polymorphic repeats identified within the 3' UT region of the Sasa-UBA and 
Sasa-DAA loci (Grimholt et al. 2000; Grimholt et al. 2002; Stet et al. 2002). Genomic 
DNA was isolated from approximately 5 mg of muscle tissue using Chelex chelating 
resin (Bio-Rad, Hercules, USA) as described by Walsh et al. (1991). The Sasa-UBA 
repeat was amplified using the fluorescently FAM labelled sense primer ( 5' 
GGAGAGCTGCCCAGATGACTT 3') and anti-sense primer (5' 
CAATTACCACAAGCCCGCTC 3') (Grimholt et al. 2002). The Sasa-DAA repeat was 
amplified using the fluoresce~tly FAM labelled sense primer (5' 
GATGGCAAAGAGGAAAGTGAG 3') and anti-sense primer (5' 
TTGTT ATGCTCTACCTCTGAA 3 ') (Stet et al. 2002). A duplex PCR reaction was 
performed in a total volume of 12.5 µl containing approximately 10-50 ng gDNA, 1.25 
µl of 1 OX PCR buffer, 1.5 mM MgCh, 200 µM dNTPs, 200 nM of each primer and 1 
unit of Taq polymerase (Applied Biosystems, Foster City, USA). Amplification was 
performed in a GeneAmp 9700 thermal cycler (Applied Biosystems) using the 
following cycling profile: 10 min at 95°C, 35 cycles of 1minat94°C, 1 min at 52°C 
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and 1 min at 72°C, and a final extension step for 7 min at 72°C. Resulting products 
were diluted (1/5), denatured in HiDi formamide (Applied Biosystems) and analysed 
using the ABI 3100 capillary sequencer (Applied Biosystems). Allele size was 
determined using the internal size standard, Genescan-500 LIZ, in the program 
Genemapper (Applied Biosystems). 
3.2.4 Statistical analysis 
All histopathology scores and MH genotypes were compiled into a database. Due to the 
restricted number of individuals comprising each family, this study could not examine 
the segregation of alleles associated with AGD on a family basis. Instead, we examined 
the marker-trait association at a population level (i.e. across the 30 families). The 
dependent variable within this study was the severity of infection measured as the 
percentage of gill filaments showing AGD lesions. The presence/absence ofMH alleles 
and genotypes were analysed as dichotomous independent variables, with individuals 
coded 1 for the presence of that allele or genotype and 0 for the absence of that allele or 
genotype. Power analysis was used to determine the minimum number of individuals to 
be included within the statistical tests. Given a significance threshold of 0.05 and power 
of 0.80 it was estimated a minimum of 20 individuals were required for both the single 
allele and genotype analysis. Multiple regression analysis was first used to test for a 
significant relationship between presence/absence of MH alleles and genotypes with the 
severity of infection. Next, any allele that was significant within the multiple regression 
was independently tested using an analysis of variance (AN OVA) model. When 
multiple tests were performed (i.e. during independent allele analysis) the significance 
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value (0.05) was adjusted using a standard bonferroni correction (Rice 1989). 
Mendelian inheritance of both Sasa-DAA-3UTR and Sasa-UBA-3UTR across the 30 
families was tested using x2 analysis. All tests were performed using SPSS ver12.0. 
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3.3 Results 
3.3.1 AGD histopathology scoring 
AGD histopathology scoring and MH genotyping was successful in 474 individuals. 
Some individuals were unable to be successfully scored for the severity of AGD due to 
an inadequate number of countable filaments. These individuals were removed from 
further analysis. Nineteen AGD induced mortalities (with visible gross lesions) were 
observed prior to day 19 post-inoculation. These individuals were also removed from 
further analysis. The percentage of gill filaments infected ranged from 0 to 85% across 
all individuals (Figure 3.1). The distribution of gill scores showed some skewness and 
kurtosis and was transformed using an arcsine square root transformation for all 
statistical analyses. Between families the mean percentage of infected filaments ranged 
from 21 to 40%. The number of individuals within each family varied between 13 and 
18 fish. 
Significant histopathology characteristic of AGD was observed within the gill sections, 
including epithelial oedema and hyperplasia and interlamellar vesicle formation. An 
infiltration of non-specific inflammatory cells including macrophages was typically 
observed within both the central venous sinus and on the boundaries of lesions. The 
presence of Neoparamoeba spp. was often observed within the margins of hyperplastic 
lesions. 
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Figure 3 .1. Frequency distribution (prior to transformation) of histopathology scores (% 
filaments infected) in 474 Atlantic salmon deriving from 30 full-sibling families. 
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3.3.2 MH polymorphism 
High variation at both the Sasa-DAA and Sasa-UBA loci was observed within our study. 
A total of seven Sasa-DAA-3UTR and ten Sasa-UBA-3UTR marker alleles were 
detected across the 30 families. Sasa-DAA-3UTR marker alleles were typically observed 
at 9-12 base pair.(bp) increments, while the Sasa-UBA-3UTR marker alleles were at 2bp 
increments. Marker allele nomenclature was assigned according to the size of each 
allele dete~ed during c~pillary electrophoresis. Allele frequencies across the 30 
families are presented within Table 3 .1. The Sasa-DAA locus was dominated by marker 
alleles 229 and 259, while the Sasa-UBA locus was dominated by allele 327. Mendelian 
inheritance for both the Sasa-DAA-3UTR and.Sasa-UBA-3UTR loci was observed 
across all families analysed (Appendix 2.1 and 2.2). 
3.3.3 Association between the MH and AGD severity 
The association between the presence and absence of Sasa-DAA-3UTR marker alleles 
and severity of AGD infection was tested by multiple regression analysis. All alleles at 
Sasa-DAA-3UTR locus had sufficient replication to be included within the analysis. The 
regression was generally a poor fit (R2 = 0.05), however, the overall relationship was, 
significant (F= 3.54, df= 7, 466, p<0.05). Only marker alleles Sasa-DAA-3UTR 239 and 
Sasa-DAA-3UTR 298 were found to be significantly associated with severity of 
infection (Table 3.2). However, following the individual analysis of these alleles, only 
Sasa-DAA-3UTR 239 remained significant (F= 7.52, df= 1, 471, p<0.05) after 
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Locus Marker allele (bp) Frequency No. of families 
Sasa-DAA-3UTR 207 0.164 14 
229 0.336 22 
239 0.086 9 
250 0.051 3 
259 0.252 21 
279 0.085 8 
298 0.025 3 
Sasa-UBA-3UTR 309 0.020 3 
313 0.115 12 
315 0.024 2 
317 0.112 9 
321 0.090 10 
323 0.012 1 
327 0.361 28 
329 0.018 2 
333 0.159 14 
335 0.090 11 
Table 3.1. Frequencies of Sasa-DAA-3UTR and Sasa-UBA-3UTR marker alleles within 
the 30 full-sibling families· of Atlantic salmon. 
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Sasa-DAA-3UTR alleles b (95% Cl) a (p) ANOVA 6 No. offish 
207 -0.36 (-2.51to1.78) 142 
229 1.35 (-0.85 to 3.55) 266 
239 -3.26 (-5.69 to -0.82)* 0.003* 82 
250 2.17 (-0.59 to 4.92) 47 
259. 0.93 (-1.18 to 3.04) 211 
279 1.57 (-0.89 to 4.03) 75 
298 6.85 (2.97 to 10. 73)* 0.034 24 
Table 3.2. a Regression coefficients (b) with 95% confidence intervals in brackets for all 
, single Sasa-DAA-3UTR marker alleles included within the multiple regression analysis, 
* denotes allele significance at p<0.05. b Individual ANOV A probabilities (p) of only 
Sasa-DAA-3UTR marker alleles significantly associated with severity of AGD infection 
determined within the multiple regression, * denotes significant difference at p<0.025 
following bonferroni correction. The number offish (No. offish) presenting at least one 
copy of that allele and therefore included within the analysis is also shown. 
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bonferroni correction for multiple tests. The negative regression coefficient (b= -3.26) 
for Sasa-DAA-3UTR 239 indicated that the presence of this allele was associated with a 
decrease in severity of infection and is graphically expressed in Figure 3.2. The mean , 
percentage gill filaments infected for individuals with the presence of marker allele 
Sasa-DAA-3UTR 239 was approximately 4.0% lower compared to individuals without 
this allele. Sasa-DAA-3UTR 239 was present in 82 fish and within 9 of the 30 families 
analysed. 
At the Sasa-UBA-3UTR locus three alleles had insufficient replication to be included 
within the· multiple regression analysis. These were Sasa-UBA-3UTR alleles 309, 323_ 
and 329. Analysis of the remaining Sasa-UBA-3UTR alleles indicated the regression 
was a poor fit (R2= 0.03) yet statistically significant (F= 2.14, df= 7,466, p<0.05). 
However, while the Sasa-UBA-3UTR alleles 321 and 327 both had regression 
coefficients significantly different from zero, neither allele remained significant 
following independent ANOV A verification. 
Analysis of variance was used to compare the severity of infection between fish 
heterozygous and homozygous for the Sasa-DAA-3 UTR and Sasa-UBA-3 UTR loci. In 
total, 101 fish were homozygous for the Sasa-DAA-3UTR locus and 90 fish were 
homozygous for the Sasa-UBA-3UTR locus. Only 24 fish were homozygous for both 
the Sasa-DAA-3UTR and Sasa-UBA-3UTR locus. No significant difference in the 
severity of infection was observed between heterozygotes and homozygotes for either 
the Sasa-DAA-3UTR (F= 0.51, df= 1,471, p>0.05) or the Sasa-UBA-3UTR locus (F= 
2.50, df= 1,471, p>0.05). 
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Figure 3.2. Mean% of gill filaments(± standard error) displaying AGD lesions for 
individuals with the presence and absence of marker allele Sasa-DAA-3 UTR 239. 
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The association between combined Sasa-DAA-3UTR and Sasa-UBA-3UTR marker 
alleles (genotypes) and severity of AGD infection was also investigated. A total of 20 
different Sasa-DAA-3UTR genotypes and 31 different Sasa-UBA-3UTR genotypes were 
observed within the sample material (Table 3.3). Genotype frequencies varied greatly, 
ranging from 0.004 up to 0.181. As a consequence only a small number of genotypes 
had adequate replication to be included within the regression analysis. At the Sasa-
DAA-3 UTR locus ten genotypes were represented by greater than 20 individuals and 
were therefore used as the predictors within the multiple regression (Table 3.4). The 
overall regression fit was low (R2= 0.06), however, statistically significant (F= 2.78, df 
= 10,463, p<0.05). Genotypes Sasa-DAA-3UTR 239-259 and 259-259 were both 
significantly associated with severity of infection. Both genotypes Sasa-DAA-3,UTR 
239-259 (F= 10.29, df= 1,471, p<0.05) and 259-259 (F= 6.86, df= 1,471, p<0.05) 
remained significant following independent analysis and bonferroni correction. The 
presence of Sqsa-DAA-3UTR genotypes 259-259 and 239-259 were associated with a 
decrease in disease severity by approximately 4.9 and 5.4%, respectively (Figure 3.3). 
At the Sasa-UBA-3UTR locus, only eight genotypes were represented by greater than 20 
individuals. These Sasa-UBA-3UTR genotypes included in the regression analysis were 
313-317, 333-335, 321-333, 321-327, 313-327, 317-3f.7, 327-327 and 327-333. The 
' regression fit for this locus was poor (R2= 0.02) and not statistically significant (F= 
1.36, df= 8,465, p>0.05). 
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Locus Genotype Frequency No. of families 
Sasa-DAA-3UTR 207-207 0.027 3 
207-229 0.116 8 
207-239 0.019 1 
207-259 0.074 7 
207-279 0.057 4 
207-298 0.006 1 
229-229 0.112 8 
229-239 0.046 4 
229-250 0.038 3 
229-259 0.181 13 
229-279 0.063 7 
229-298 0.004 1 
239-250 0.011 1 
239-259 0.057 6 
239-298 0.04 2 
250-250 0.002 . 1 
250-259 0.049 4 
259-259 0.059 6 
259-279 0.025 3 
279-279 0.013 2 
Sasa-DAA-3UTR 309-313 0.004 1 
309-327 0.023 3 
309-333 0.004 1 
309-335 0.008 1 
313-313 0.011 1 
Table 3.3. Continued over page 
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313-315 0.008 1 
313-317 0.042 3 
313-321 0.006 
313-323 0.015 
313-327 0.078 8 
313-333 0.027 4 
313-335 0.027 3 
315-321 0.017 1 
315-327 0.023 2 
317-317 0.011 1 
317-321 0.03 2 
317-327 0.08 7 
317-329 0.017 1 
317-335 0.034 4 
321-327 0.063 6 
321-333 0.044 5 
321-335 0.019 2 
323-327 0.008 1 
327-327 0.135 12 
327-329 0.006 1 
327-333 0.133 12 
327-335 0.036 7 
329-333 0.013 2 
333-333 0.027 1 
333-335 0.042 4 
335-335 0.006 
Table 3.3. Frequencies of Sasa-DAA-3UTR and Sasa-UBA-3UTR genotypes within the 
30 full-sibling families of Atlantic salmon 
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Sasa-DAA-3UTR genotypes b (95% Cl) a (p) ANOVA0 No. of fish 
207-229 -2.64 (-5.27 to -0.001) 55 
207-259 -2.64 (-5.70 to 0.43) 35 
207-279 -0.02 (-3.39 to 3.35) 27 
229-229 -0.17 (-2.84 to 2.48) 53 
229-239 -1.05 (-4.71to2.60) 22 
229-259 0.95 (-1.37 to 3.28) 86 
229-279 -0.06 (-3.25 to 3.24) 30 
239-259 -4.45 (-7.82 to -1.07)* 0.007* 27 
250-259 3.42 (-0.17 to 7.01) 23 
259-259 -3.72 (-7.05 to -0.39)* 0.011* 28 
Table 3.4. a Regression ~oefficients (b) with 95% confidence intervals in brackets for 
Sasa-DAA-3UTR genotypes included within the multiple regression analysis,* denotes 
genotype significance at p<0.05. b Individual ANOV A probabilities (p) of only Sasa-
DAA-3UTR genotypes significantly associated with severity of AGD infection 
determined within the multiple regression, * denotes significant difference at p<0.025 
following bonferroni correction. The number offish (No. offish) with each genotype is 
also shown. 
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Figure 3.3. Mean% of gill filaments(± standard error) displaying AGD lesions for 
individuals with the presence and absence of Sasa-UBA-3UTR genotypes 239-259 (A) 
and 259-259 (B). 
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3.4 Discussion 
To our knowledge this is the first study to undertake a molecular assessment of 
resistance to amoebic gill disease in Atlantic salmon. We examined the MH genes due 
to their high polymorphism, important immune function and previous associations with 
increased resistance to other diseases. The results demonstrate the overall effect of the 
Sasa-DAA and Sasa-UBA genes, as assessed by studying the embedded markers, on the 
severity of infection was small at the Sasa-DAA, yet .statistically significant. The 
presence of marker allele Sasa-DAA-3UTR 239 was significantly associated with a 
decrease in the severity of AGD infection. Individuals containing Sasa-DAA-3UTR 239 
had approximately 4.0% less gill filaments infected compared to individuals without 
this allele. Furthermore the presence of Sasa-DAA-3UTR genotypes 239-259 and 259-
259 were also associated with a decrease in disease severity. Individuals with these 
genotypes had approximately 5.4 and 4.9% less gill filaments infected compared to 
individuals without these genotypes, respectively. 
Although encouraging, the associations presented herein should only be viewed as 
suggestive at this time and require further research to verify their biological 
significance. The high number of alleles and genotypes observed at the MH (often at a 
low frequency) means finding a strong statistically significant association between 
alleles/genotypes and disease resistance in a small sample is difficult (Hill 1998). 
Furthermore high polymorphism of the MH also results in divergent sample sizes 
between groups of individuals with different alleles ·or genotypes. This was observed in 
our study and resulted in an unbalanced design, often with small sample sizes. 
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Consequently the statistical power to reliably detect differences in disease resistance 
was reduced. 
While a significant association between MH alleles or genotypes and AGD severity was 
identified within our study, individuals containing a copy of these alleles or genotypes 
appeared to demonstrate only a small decrease in the severity of infection compared to 
individuals without these alleles or genotypes. Preliminarily research has shown AGD 
resistance quantified through histopathological scoring has a moderate heritability 
(Taylor et al. 2007). It therefore seems possible that while reductions in gill scores of 4 
to 5% may be low in regard to the overall variation in resistance, it may actually 
account for a moderate proportion of the genetic variance. The variation in disease 
severity between the most resistant and susceptible families was 19%. It is also highly 
likely that AGD resistance is under polygenic control and thus additional non MH genes 
may also be contributing. A similar situation was observed for MD resistance within 
chickens following the initial association with the MHC B haplotype (Bacon 1987). 
Seven additional quantitative trait loci (QTL) were significantly associated with 
resistance each explaining 2-10% of the variation (Y onash et al. 1999). In rainbow 
trout, two QTL were found to be associated with resistance towards infectious 
pancreatic necrosis (Ozaki et al. 2001). 
Other associations between MH polymorphism and resistance to salmonid diseases 
including furunculosis (Langefors et al. 2001; Grimholt et al. 2003) infectious salmon 
anaemia (Grimholt et al. 2003) and infectious hematopoietic necrosis (Miller et al. 
2004) have been reported. Our findings, along with these previous studies, highlight the 
importance ofMH polymorphism in disease resistance. Although speculative, one may 
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hypothesise that the association between the Sasa-DAA-3UTR alleles/genotypes and 
reduced severity of infection was the result of an enhanced immune response triggered 
by a more effective presentation of exogenous derived peptide ligands by these MH 
class II molecules. Studies have indicated MH class rt cells are present within AGD 
affected lesions and show varying levels of expression (Morrison et al. 2006b ). The 
infiltration of leucocytes, with possible antigen presenting capacity, into the AGD 
affected regions observed within this and previous studies (Adams and Nowak 2004a) 
may provide further evidence of such an immune response. 
Our study could not exclude the possibility that the MH alleles associated with the 
lower severity of infection were actually in linkage disequilibrium with another locus 
that may be causing the observed associations. In humans, the MHC is a gene rich 
region spanning over 4Mb in length (Campbell and Trowsdale 1993; Newell et al. 
1996) with an MHC class III region encoding many cytokine and complement factors 
(Hauptmann and Bahram 2004). However, in Atlantic sahnon no such class III region 
has been identified and the only reported linkage between MH genes is between the 
Sasa-UBA and Sasa-TAP2B loci (Grimholt et al. 2002) and between the Sasa-DAA and 
Sasa-DAB loci (Stet et al. 2002). In rainbow trout a number of physical mapping studies 
have examined the genomic organisation of the MH class I region using large insert 
BAC or phage libraries (Shum et al. 2002; Phillips et al. 2003; Shiina et al. 2005). In 
general a number of loci associated with antigen processing and binding, such as the 
immunoproteasome subunits (PSMB), are closely linked to the Onmy-UBA locus (Shum 
et al. 2002; Phillips et al. 2003; Shiina et al. 2005). 
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In a previous study the marker allele Sasa-DAA-3UTR 239 was found to be linked to 
allele sequence Sasa-DAA *1001 (Wynne et al. 2007a). However, in contrast to 
European cultured populations of Atlantic salmon (Stet et al. 2002), not all Tasmanian 
Sasa-DAA-3UTR marker alleles are found to be associated with a single allele sequence. 
For instance, Sasa-DAA-3UTR 229 and Sasa-DAA-3UTR 298 were each found to be 
associated with two allele sequences (Wynne et al. 2007a). This suggests that not all 
variation at the Sasa-DAA locus was detected by using the 3' minisatellite marker 
within our study, and it is therefore possible that additional associations between these 
non detected alleles and the severity of infection may have been present. Furthermore, 
in the Tasmanian Atlantic salmon population, the link between specific Sasa-DAA and 
Sasa-DAB (MH class II beta chain) sequences remains complex. T~at is, in some cases 
multiple Sasa-DAB allele sequences appear to combine with a single Sasa-DAA allele 
sequence to produce diverse class II composite haplotypes (Wynne et al. 2007a). As a 
result, we were unable to determine the Sasa-DAA/Sasa-DAB composite haplotype by 
genotyping the 3' minisatellite marker and could not assess the possible association 
' . 
between Sasa-DAB polymorphism and AGD resistance. At present, no examination of 
the link between Sasa~.UBA-3UTR marker alleles and allele sequences has been 
undertaken within the Tasmanian Atlantic salmon population. Combining the Sasa-
DAA-3UTR marker analysis with allele specific Sasa-DAB PCR in order to resolve all 
alleles is a desirable future research direction. This type of analysis may allow more of 
the genetic effects of the MH on AGD resistance to be quantified. Unfortunately 
however, this was beyond the scope of the current study. 
The combined allele analysis aimed to identify Sasa-DAA-3UTR and Sasa-UBA-3UTR 
genotypes which were associated with severity of AGD infection. This approach has 
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been used successfully wit~ other studies to further examine the association of an 
allele or genotype with disease resistance (Grimholt et al. 2003). Our study found 
significant associations between the Sasa-DAA-3UTR genotypes 239-259 and 259-259 
and deceased disease severity. It must however be acknowledged that due to the high 
number of MH genotypes observed at the Sasa-DAA-3UTR and Sasa-UBA-3UTR loci, 
only a small number of genotypes had adequate replication to be included in the 
analysis. The Sasa-DAA-3UTR genotype 239-259 interestingly contained the same 
allele (Sasa-DAA-3UTR 239) that was identified as significant within the single allele 
analysis, thus strengthening this association. The Sasa-DAA-3UTR homozygote 
genotype 259-259 was also associated with a decrease in disease severity. Interestingly 
both these genotypes contained the Sasa-DAA-3 UTR 259 allele, which in the single 
allele analysis was not significantly associated with resistance. This uncertainty 
between the effects of Sasa-DAA-3UTR 259 in a heterozygote and homozygote form 
may highlight the limitation of treating alleles as an individual entity rather than a 
genotype within the single allele analysis. That is, when alleles associated with 
resistance and susceptibility are combined as a single heterozygote their effects could be 
diminished. However when present as homozygotes each allele may be more capable of 
displaying a significant effect because it is not restricted by the other allele. 
To conclude, the associations between MH alleles and AGD severity reported within 
this study should be viewed as preliminary fmdings only. A second study, aimed to 
verify the statistical and biological significance of the suggestive associations reported 
herein is required. Additional research is also currently underway in an attempt to 
elucidate additional genes that may affect AGD resistance. 
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Chapter 4: Transcriptome analyses of AGD affected Atlantic 
salmon reveals localised host gene suppression 
Published as: Wynne JW, O'Sullivan MG, Cook MT, Stone G, Nowak BF, Lovell DR, 
Elliott NG (2008) Transcriptome analyses of amoebic gill disease affected Atlantic 
salmon (Salmo salar) tissues reveal localised host gene suppression. Mar Biotechnol in 
press. 
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Abstract 
The transcriptome response of Atlantic salmon (Salmo salar) displaying advanced 
stages of amoebic gill disease (AGD) was investigated. Naive smolt were challenged 
with AGD for 19 days, at which time all fish were euthanised and their severity of 
infection quantified through histopathological scoring. Gene expression profiles were 
then compared between heavily infected and naive individuals using a 17K Atlantic 
salmon cDNA microarray with real-time quantitative RT-PCR (qPCR) verification. 
Expression profiles were examined in the gill, anterior kidney and liver. Twenty-seven 
transcripts were significantly differentially expressed within the gill, with 20 of these 
transcripts being ~own-regulated in the AGD affected individuals compared to naive 
individuals. In contrast, only nine transcripts were significantly differentially expressed 
within the anterior kidney, and five within the liver. Again the majority of these 
transcripts were down-regulated within the diseased individuals. A down-regulation of 
transcripts involved in apoptosis (procathepsin L, cathepsin H precursor and cystatin B) 
was observed in AGD affected Atlantic salmon. Four transcripts encoding genes with 
antioxidant properties were also down-regulated in AGD affected gill tissue according 
to qPCR analysis. The most up-regulated transcript within the gill was an unknown 
expressed sequence tag (EST) whose expression was 218 fold(± SE 66) higher within 
the AGD affected gill tissue. Our results suggest Atlantic salmon experiencing 
advanced stages of AGD demonstrate general down-regulation of gene expression, 
which is most pronounced within the gill. We propose that this general gene 
suppression is parasite mediated, thus allowing the parasite to withstand or ameliorate 
the host response. 
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4.1 Introduction 
AGD is the most important health issue affecting the culture of Atlantic salmon (Salmo 
salar) in Tasmania, Australia (Munday et al. 2001). This disease is caused by the 
protozoan Neoparamoeba perurans which, acting as the primary pathogen, infects the 
gills of marine cultured Atlantic salmon (Young et al. 2007). Fish infected with AGD 
often display lethargy, respiratory distress, rapid opercular movement, and ultimately, if 
not treated, geath (Munday et al. 1990). AGD affects species other than Atlantic 
salmon: cases have also been reported in rainbow trout (Oncor~ynchus mykiss) 
(Munday et al. 1990); turbot (Scophthalmus maximus) (Dykova et al. 1999); coho 
salmon (Oncorhynchus kisutch) (Kent et al. 1988); and seabass (Dicentrarchus labrax) 
(Dykova et al. 2000). 
AGD is characterised initially by attachment <;>f trophozoites to healthy gill epithelial 
tissue (Adams and Nowak 2003). Following attachment, localised host cell alterations 
are observed, including hypertrophy and desquamation of epithelial cells followed by 
hyperplasia and oedema (Adams and Nowak 2003). Hyperplasia and oedema: of the 
epithelial cells generally increase with disease progression, as does the formation of 
interlamellar vesicles (Adams and Nowak 2001; Adams and Nowak 2003). At later 
stages, moderate infiltration of leucocytes is observed within the central venous sinus 
adjacent to hyperplastic lesions and sometimes within the interlamellar vesicles (Adams 
and Nowak 2001; Adams and Nowak 2004a). In some cases, leucocytes are also found. 
in close association with amoeba within the hyperplastic tissue (Bridle et al. 2003). 
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Atlantic salmon infected with AGD demonstrate an up-regulation of the pro-
inflammatory cytokine interleukin- Ip (IL-1 p) within affected gill tissue (Bridle et al. 
2006a; Morrison et al. 2007). Recombinant IL-IP has been shown to induce expression 
of a number of genes within the rainbow trout macrophage cell line RTS-11 (Martin et 
al. 2007b), many of which are involved with the acute phase response. AGD affected 
Atlantic salmon however, do not display an up-regulation of genes encoding the acute 
phase proteins serum amyloid A or serum amyloid P-like pentraxin (Bridle et al. 
2006a). Furthermore the expression oftumor necrosis factor alpha (TNF- a.), interferon 
gamma (IFN-y) (Morrison et al. 2007) and inducible nitric oxide synthesis (iNOS) 
(Bridle et al. 2006a) appears unaffected by A9D in Atlantic salmon. These results 
suggest, while IL-1 p is up-regulated within AGD affected gill tissue its ability to induce 
an acute phase response is restricted. 
At present, the only successful treatment available for AGD is freshwater bathing 
(Parsons et al. 2001). Bathing for three hours in freshwater has been shown to reduce 
gill pathology and the number of attached trophozoites (Adams and Nowak 2004b ). 
Freshwater bathing, however, is not a viable long term solution due to the cost 
associated with this practice. Recent research has shown a significant genetic 
component of variability in AGD resistance or susceptibility within the Tasmanian 
Atlantic salmon population (Taylor et al. 2007). While a small proportion of this 
resistance may'be attributed to variation within the major histocompatibility (MH) class 
} 
II genes (Wynne et al. 2007b ), the molecular mechanisms controlling the majority of 
this resistance are yet to be elucidated. The identification of genes differentially 
expressed between AGD affected and naive individuals - at a time when considerable 
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variation in resistance is observed - may assist in identifying candidate genes associated 
with genetic resistance. 
DNA microarrays have become an important research tool for assessing transcriptional 
changes in a range of aquatic organisms, including microalgae (Lidie et al. 2005), 
crustaceans (Wang et al. 2006), molluscs (Jenny et al. 2007) and teleosts (von 
Schalburg et al. 2005b ). In particular, in salmonoids, a number of microarray platforms 
have been developed (Rise et al. 2004b; Krasnov et al. 2005; von Schalburg et al. 
2005b; Martin et al. 2007a). These platforms have been utilised to examine the response 
to such processes as stress (Krasnov et al. 2005), bacterial infection (Rise et al. 2004a; 
Ewart et al. 2005), maturation (von Schalburg et al. 2005a), vaccination (Purcell et al. 
2006) and cytokine stimulation (Martin et al. 2007a; Martin et al. 2007b). 
While previous studies have provided valuable insight into the early and intermediate 
gene expression response to AGD (Bridle et al. 2006a; Bridle et al. 2006b; Morrison et 
al. 2006a), analysis of the transcriptome at later stages of disease and in other organs is 
needed. The present study aimed to address that need by examining the transcriptome 
response in the gill, liver and anterior kidney of AGD affected Atlantic salmon at 19 
days post inoculation (DPI). 
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4.2 Materials and Methods 
4.2.1 Animals and disease challenge trial 
This study used individuals from an AGD challenge trial (Taylor et al. 2007) (Chapter 
3). Atlantic salmon smolts derived from 30 full-sibling families were sampled within 
the study. These families had never been selected for AGD resistance or any other 
production traits. Each family was initially represented by 18 individuals equally 
divided across three replicate 3000 L recirculating systems, equipped with primary and 
biological filtration, a heat exchanger and aeration. All individuals were initially 
maintained in freshwater and then acclimated to a salinity of 35 ppt and a temperature 
of l 6°C over a two week period. Following acclimation and just prior to challenge, two 
individuals were randomly selected from each tank and euthanised with 5 g L-1 Aqui-S 
(Aqui-S NZ Ltd, Lower Hutt, New Zealand). These individuals represented the nai'.ve 
samples within our ex~erimental design. Samples were dissected from the anterior 
kidney, liver and the first right gill hemibranch and stored in RNNater (Ambion, 
Austin, USA) at -80°C. The remaining gill cage was then dissected and fixed in 
seawater Davidson' s fixative for histology. 
Following acclimation, each tank was inoculated with 500 cells L-1 of Neoparamoeba 
spp. as described by Morrison et al. (2004). Individuals were monitored daily for AGD 
mortalities until 19 DPI when all individuals were euthanised with 5 g L-1 Aqui-S 
(Aqui-S NZ Ltd) and samples taken as described above. 
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4.2.2 Gill histopathology 
The second left anterior hemibranch of each individual was dissected, dehydrated, 
embedded in paraffin wax and sectioned at 5 µm. Sections were stained with 
haematoxylin and eosin and viewed with a light microscope (Zeiss, Oberkochen, West 
Germany) at 400X magnification. The severity of AGD infection was quantified for 
each individual by counting the percentage of gill filaments (primary lamellae) 
displaying hyperplastic lesions as previously described by Adams and Nowak (2004b ). 
All sections were also examined for the presence of Neoparamoeba spp. in order to 
diagnose clinical AGD. 
4.2.3 Microarray experimental design 
This study used a 16,950 feature Atlantic salmon cDNA microarray developed by the 
TRAITS.(Transcriptome Analysis of Important Traits in Salmon) and Salmon Genome 
Projects (Martin et al. 2007a) and was designed to follow MIAME guidelines (Brazma 
et al. 2001). Our study made direct comparisons between AGD affected and naive 
Atlantic salmon, in an attempt to idel).tify genes differentially expressed between these 
two states. 
For all three organs (gill, anterior kidney and liver), one naive individual (6 total) was 
directly compared with two AGD affected individuals (12 total) in two independent 
hybridisations. The naive individual was labelled with Cy3 for the first hybridisation 
and then Cy5 for the second hybridisation. Thus, dye-swap technical replicates were 
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performed for naive individuals only. This 1 :2 comparison was performed for all six 
naive and 12 AGD affected individuals, therefore utilising 12 arrays for each organ. No 
RNA samples were pooled and comparisons were performed on an individual tank 
basis. Furthermore, individuals examined in the microarray analysis were derived from 
six of the 30 full-sibling families. All hybridisations and protocols have been deposited 
into the ArrayExpress database (www.ebi.ac.uk/microarray-as/aer) and assigned the 
accession number E-MEXP-1286. 
4.2.4 RNA isolation 
Total RNA was isolated from approximately 100 mg of tissue using the RiboPure™ kit 
according to the map.ufacturer's protocol (Ambion). Following isolation, RNA was 
treated with rDNase I from the DNA:free™ kit (Ambion) to remove possible genomic 
DNA contamination. The ratio of absorbance at 260 nm and 280 nm was then 
quantified using a Beckman Coulter Du®530 spectrophotometer (Beckman Coulter, 
Fullerton, USA). Next, 2 µg of total RNA was denatured in 15 µl ofNorthernMax® 
Formaldehyde Load Dye (Ambion) and 20 µg mr1 ethidium bromide at 65°C for 15 
min. Samples were then run on a native T AE agarose gel and visualised under UV 
transillumination. 
4.2.5 Microarray hybridisation 
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Total RNA was quantified using the Qubit fluorescence quantification system as per the 
manufacturer's protocol (Invitrogen, Mount Waverly, Australia). Next, 3 µg of total 
RNA was reverse transcribed using Superscript II Reverse Transcriptase (Invitrogen) 
alld the 3DNA Array 350™ kit (Genisphere, Hatfield, USA) as per the manufacturer's 
protocol. cDNA synthesis was terminated by addition of3.5 µl of0.5 MNaOH/50 mM 
EDTA and incubation at 65°C for 15 min. Reactions were neutralised with 5 µl of 1 M 
tris-HCl (pH 7.5). Appropriate Cy3 and Cy5 reactions were then combined and purified 
using the QIAquick PCR purification kit (Qiagen, Doncaster, Australia) with one 
additional wash of 500 µl of 80% ethanol and cDNA was eluted in 30 µl of nuclease-
free water. 
All hybridisations ~ere performed with the Maui® hybridisation system (Bio Micro® 
Systems, Salt Lake City, USA) using the FL hybridisation mixing chambers 
(BioMicro® Systems). First, concentrated cDNA was combined with 2 µl LNA dT 
blocker (Genisphere) and 30 µl of2X formamide-based hybridisation buffer 
(Genisphere) and incubated at 80°C for 10 min and then at 49°C. Next, 50 µl of the 
cJ?NA hybridisation mix was applied to each pre-warmed microarray slide. The 
hybridisation was then performed for 15 hours at 49°C. Following hybridisation, the 
chambers were removed while submerged in 2X SSC/0.2% SDS at 49°C. Next, slides 
were washed once with 2X SSC/0.2% SDS at 49°C for 10 min, twice with 2X 
SSC/0.2% SDS at room temperature for 5 min, twice with 2X SSC at room temperature 
for 5 min, then twice with 0.2X SSC at room temperature for 5 min. All washes were 
performed with agitation. Slides were centrifuged dry at 51 Og for 5 min at 10°C. 
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The Cy3 and Cy5 cyanine capture reagents (Genisphere) were hybridised to the 
microarray slides by combining 2.5 µl of both the Cy3 and Cy5 capture reagents with 
20 µl nuclease free water and 25 µl of 2X formamide-based hybridisation buffer 
( Genisphere) and incubated at 80°C for 10 min and then at 49°C. Fifty micro litres of the 
cyanine hybridisation solution was then applied to the microarray slides and hybridised 
at 49°C for 2 hours. Following hybridisation, the chambers were removed in 2X 
I 
SSC/0.2% SDS at 49°C and slides then were washed and qried as described above. 
4.2.6 Image and data analysis 
Each slide was immediately scanned at a resolution of 5 µm with an Axon 4000B 
scanner (Axon Instruments, Union City, USA) using the software GenePix Pro ver3.0 
(Molecular Devices Corporation, ~unnyvale, USA). The Cy3 and Cy5 fluorphores 
where excited at 532 and 635 nm respectively. Power was consistently maintained at 
100% and the photo multiplier tube (PMT) balance was identical for all slides. PMT 
gain for the 532 nm channel was 574 and for the 635 nm channel was 663. GAL files 
were aligned automatically and fluorescence signal intensity data for the 532 and 635 
nm channels extracted. Results were saved as GenePix results (GPR) files. 
GPR files were read into the statistical software package R (ver2.3.l) and analysed with 
Limma (Smyth 2005). Prior to statistical analysis the data were normalised with the 
NormalizeWithinArrays function using the default print-tip loess method (Smyth and 
Speed 2003). The moderated t-test statistic, in conjunction with the 'holm' multiple 
testing adjustment, was used to detect differential expression between heavily infected 
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and naive individuals (Speed 2003). Background correction was performed on the data 
using the default method within Limma (Smyth 2005) . Filtering, however, was applied 
to remove all features with an average intensity< 97 (i.e., features where both channels 
had low intensity) - this resulted in approximately 20% of features being removed. 
The experimental design used was complex as it incorporated technical replication for 
the naive fish only: each naive fish was compared to two AGD affected individuals. 
The analysis of such a design is not straightforward and, depending on assumptions 
made, different analyses would be appropriate. A decision was made to fit three 
separate models to accommodate different scenarios~ each with a slightly different 
approach to the treatment of replication of naive individuals. Model 1 ignores technical 
replication ofnai've fish; model 2 incorporates correlation for replicates (utilis~s the 
duplicateCorrelation function (Smyth et al. 2005)); and model 3 uses an averages over 
fixed effects approach (treats the naive indivi~uals as a fixed effect - no assumption of 
same correlation for all spots and estimates the residual errors differently). 
For each model, transcripts were deemed to be differentially expressed if both replicate 
features had significant t-statistics (adjusted p<0.05). The mean adjusted p-value and 
fold-change were then calculated. In the case where the same transcripts were 
significant across multiple models, the mean adjusted p-value for lowest model number 
is presented within the Table (the fold-change was unaffected by the model). 
4.2.7 Transcript annotation 
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Sequences of differentially expressed transcripts were first subjected to Basic Local 
Alignment Search Tool (BLASTx) against the NCBI non-redundant protein databases 
in the program Blast2GO (Conesa et al. 2005). Sequences with E values <1x10-10 were 
deemed to be orthologous. If no significant homology was detected, the sequence was 
further analysed (using BLASTn) against the NCBI expressed sequence tag database 
( dbEST) in an attempt to identify Uni Gene sequence clusters 
(www.ncbi.nlm.nih.gov/ sites/ entrez?db=unigene ). Functional proteins associated with 
Uni Gene clusters were then used for annotation. In the case where rio proteins were 
associated with the UniGene clusters, the UniGene code and the annotation ''unknown~' 
was assigned. Where no significant BLAST or UniGene sequence was identified the 
transcript was designated "no BLAST hit." 
Identified transcripts were further annotated using Gene Ontology (GO) within the 
program Blast2GO (Conesa et al. 2005). When possible, the upper level parent GO term 
was assigned to transcripts for each of the following ontologies: cellular component, 
biological process and molecular function. Transcripts differentially expressed within 
the gill were then grouped based on these upper level GO terms for cellular component, 
biological process and molecular function. 
4.2.8 Real-time quantitative RT-PCR 
Two independent real-time quantita~ive RT-PCR (qPCR) experiments were conducted. 
The first aimed to verify the microarray results and the second aimed to compare the 
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expression of a sub-sample of genes between fish with differing severities of AGD 
infection. 
To substantiate the microarray results a selection of transcripts from the gill, anterior 
kidney and liver gene lists were selected for qPCR analysis. Eight transcripts in total 
were selected. The expression of the eight transcripts was compared between the six 
nai:ve and 12 AGD affected Atlantic salmon previously compared in the microarray 
analysis. The RNA was obtained from the previous extraction. 
The expression of a sub-sample of genes within the gill was also compared between fish 
displaying differing severities of AGD infection. These individuals represented the 
extremes of the severity distribution and were derived from a range of families. Eleven 
individuals with low AGD severity and 12 individuals with high AGD severity were 
chosen for analysis. The mean percentage of gill filaments infected with AGD lesions 
was 13.05 ± 0.77 and 58.97 ± 5.32 for the groups considered to have low and high 
disease severities, respectively. 
Primers were designed from the expressed sequence tags using PrimerExpress (Applied 
Biosystems). When the genomic organisation could be determined (through PCR with 
genomic DNA), primers that crossed exon-exonjunctions were designed. All primers 
used for the qPCR are shown in Table 4.1. The housekeeping gene beta (P)-actin was 
chosen as an endogenous control using the primers obtained from Bridle et al. (2006a). 
cDNA was generated from total RNA using Superscript III Reverse Transcriptase. 
Briefly, 2 µg of total RNA was quantified and reverse transcribed in a 20 µl reaction 
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TRAITS Identity Organ Amplicon Primer sequence (5'-3') 
clone ID size (bp) 
CK880278 UniGene-Ssa.25836 Gill 92 AATACCATCACTCATACCGCTT 
CCACTTTGCCACCTGTTATGT 
AM049499 Differentially regulated trout protein 1 Gill 105 AGCCTTTGCCAACACAACG 
CCGAAGAAAGGAAAGATGAAAGC 
EG648298 Glutathione S-transferase Gill, Liver 63 CGCTGTGGCGCTATGAGAA 
CACCACGATCTCCTTCCATTC 
EG647964 Glutathione peroxidase Gill 64 CCGGGAAATGGCTTTGA 
GCGTCCTTCCCATTCACAT 
CK877314 Lipase H Gill 90 CAGGCCTCTCTGCCGTTATG 
GTCTCAGAAGTTGGACTCCTCACA 
AM049784 Thioredoxin Gill 62 GCCACGCTGGAGGAGAAG 
CAGCGTCAGTGGCAGCATTA 
81468027 Procathepsin L Gill 68 TGGGCATGAACCACTTTGGT 
CTGCTTGTAGCCGTTCATCGT 
CK887101 NADP transhydrogenase Gill 60 CCATCGGTGGTGCAGACAT-
CCCAGCCGGAGTAGCTGTTA 
AJ424551 CCAAT/enhancer-binding protein 13 Anterior 71 CGGAGACGCAACACAAAGTG 
kidney CAGCTGCTCCACGCGTTT 
13-actin (endogenous control) All 113 TCTCTGGAGAAGAGCTAC 
CAAGACTCCATACCGAGGAA 
Table 4.1. List of transcripts chosen for microarray validation using real-time 
quantitative RT-PCR. The clone sequence ID used to design primers is indicated along 
with the identity of the most si~ficant BLAST result. The organ in which the 
transcript was examined is shown. PCR and cycling parameters were constant for all 
transcripts and are described within the text. The sense and anti-sense primer sequences 
are indicated along with amplicon size in base pairs (bp ). 
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containing 4 µl of 5X buffer, 200 nM of oligo dTc17), 0.5 roM of dNTPs, 5 mM of DTT, 
I 
40 units of RN aseOUT and 200 units of Superscript III reverse transcriptase. Following 
the addition ofRNA, oligo dT and dNTPs, the reaction was heated to 65°C for 5 min. 
The buffer, DTT, RNaseOUT and reverse transcriptase were then added and reactions 
were incubated at 50°C for 1 hour. Two units ofRNase H were finally added and 
reactions were incubated for 20 min at 37°C. 
All reactions were performed in triplicate in a total volume of 25 µl containing 12.5 µl 
of2X SensiMix (Quantac~, London, UK), 0.5 µl ofSYBR® Green I, 200 nM of forward 
and reverse primer, 5 µl of cDNA template (equivalent to 20 ng starting RNA) and 5 µl 
of water. Reactions were subjected to 95°C for 10 min, followed by 40 cycles of94°C 
for 20 sec, 56°C for 20 sec and 72°C for 20 sec using a Rotor-Gene™3000 real-time 
thermal cycler (Corbett Research, Mortlake, Australia). To verify amplification 
specificity, melt curves for each gene were examined from 72-95°C with a heating rate 
of 1 °C per 5 sec. In addition, amplicons were examined by agarose gel electrophoresis 
and also cloned into pGEM-T-easy (Promega, Annandale, Australia) and sequenced 
using T7 and Sp6 primers. To check for contaminating genomic DNA, a sub-sample of 
reverse transcription negative reaction was performed, where Superscript III Reverse 
Transcriptase (Invitrogen) was omitted from the reaction and PCR performed as above. 
4.2.9 qPCR data analysis 
Raw fluorescence data were obtained and analysed using the Rotor-Gene Analysis 
Software ver6.1 (Corbett Research). Thresholds were set manually above the point 
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where the fluorescence exceeds the background signal. The CT (cycle number at which 
the signal reaches the thresholds) were then calculated accordingly. Amplification 
efficiency (E) for each transcript was determined from a pooled cDNA sample serially 
diluted two-fold five times and calculated as E=l0(-1/S) where sis the slope of the 
standard curve of serial dilutions according to Pfaffl (2001). Differences in gene 
expression between AGD na'ive and affected Atlantic salmon were analysed using 
relative expression, with the software REST-XL (Pfaffl et al. 2002) according to the 
following equation: 
Ratio=(Etarget)ilCT[target( control-sample)]/ (Eref) ilCT[refl: control-sample)] 
P-actin served as the endogenous reference gene (ref). Na'ive Atlantic salmon were 
considered the control group for the microarray validation experiment. The fold-change 
therefore represents the expression change in AGD affected individuals relative to na'ive 
individuals. When gene expression was compared between individuals with high and 
low AGD severities, the high severity group was considered the control. In this 
experiment, the fold-change thus represents the expression change in low AGD severity 
individuals relative to high AGD severity individuals. The REST-XL software 
calculates the relative expression ratio of a target gene, while adjusting for differences 
in amplification efficiency. The mean ratio of each transcript is presented along with 
standard errors. 
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4.3 Results 
4.3.1 Challenge trial and gill histopathology 
The challenge trial was terminated at 19 DPI in an attempt to gain as much variation in 
the severity of infection as possible, without allowing the most susceptible individuals 
to succumb to AGD. The severity of infection, determined by histopathology scoring, 
ranged from 0 to 85% of gill filaments infected. Significant variation in the severity of 
infection was observed between the families as reported by Taylor et al. (2007) 
(Appendix 1.1). 
Histopathological .examination of AGD affected gill tissue confirmed pathology 
characteristic of AGD including epithelial hyperplasia, oedema and interlamellar vesicle 
formation (Figure 4.1 ). The presence of amoebae with the symbiont (parasome) was 
observed within the margins ofhyperplastic lesions. Histopathological examination of 
naive gill tissue found no pathology characteristic of AGD or of any other diseases. 
4.3.2 Microarray analysis -
Following analysis of gene expression profiles within the gill, 36 transcripts were 
significantly differentially expressed between AGD affected and naive individuals using 
the three statistical models (Table 4.2). These represented 29 down-regulated and seven 
up-regulated transcripts. Nine transcripts were significantly differentially expressed 
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Figure 4.1. Gross and histopathological examination of AGD affected and naive 
Atlantic salmon at 19 DPI. A: seawater Davidson's fixed AGD affected gill arch, 
multifocal mucoid lesions (L) are evident. B: histopathology of AGD affected gill 
tissue, interlamellar crypts (C), hyperplastic lamellar fusion (H) and the parasite 
Neoparamoeba spp. (A) are clearly visible. C: histology from gill of AGD naive 
Atlantic salmon representing normal gill morphology. D: histopathology of AGD 
affected Atlantic salmon, Neoparamoeba spp. (A) are associated with the margins of 
hyperplastic lesions. 
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Accession No I Clone ID Identity Align I(%) Fold-change pvalue Model Upper level GO terms 
CK880278 Unknown N/A 19.34 2.5435E-06 1,2,3 N/A 
UniGene-Ssa.25836 
AM049530 Differentially regulated trout protein 1 58 / 94% -4.20 1.0164E-05 1,2,3 Immune-relevant gene (Bayne et al. 2001) 
[Oncorhynchus mykiss] 
(AAG30030) 
AM049483 Differentially regulated trout protein 1 88/95% -4.08 2.3907E-05 1,2,3 Immune-relevant gene (Bayne et al. 2001) 
[Oncorhynchus mykiss] 
(AAG30030) 
C0472444 Unknown NIA 11.88 3.3783E-05 1,2,3 N/A 
UniGene-Ssa.26266 
AM049499 - 'Differentially regulated trout protein 1 88/97% -4.08 2.4468E-04 1,2,3 Immune-relevant gene (Bayne et al. 2001) 
[Oncorhynchus mykiss] 
(AAG30030) · 
gil_cgi_D1 E08_car_tra_sub_Op Differentially regulated trout protein 1 88/ 95% -3.78 0.0012 1,2,3, Immune-relevant gene (Bayne et al. 2001) 
[Oncorhynchus mykiss] 
(AAG30030) 
AM042205 PREDICTED: similar to es1 protein 186/74% -2.65 0.0012 1,2,3 G0:0005622 (1) intracellular 
[Danio rerio] 
(XP _693678) 
EG355156 Carcinoembryonic antigen-related cell 187 / 34% -3.16 0.0013 1,2,3 G0:0016020 (1) membrane; 
adhesion molecule 1 G0:0007155 (2) cell adhesion 
[Ganis lupus familiaris] 
(ABJ53204) 
CK891045 Unknown N/A -3.27 0.0016 1,2,3 N/A 
UniGene-Ssa.24730 
EG648298 Glutathione S-transferase 202 / 91% ~2.07 0.0023 1,2,3 G0:0005622 (1) intracellular; 
[Oncorhynchus nerka] G0:0044237 (2) cell metabolism; 
(BAA76974) G0:0016740 (3) transferase activity 
EG647964 Glutathione peroxidase 188 / 80% -2.00 0.0026 1,2,3 G0:0005622 (1) intracellular; 
[Danio rerio] G0:0042221 (2) response to chemical stimulus; 
(AA086703) G0:0016491 (3) oxidoreductase activity 
CK890208 Unnamed protein product 66/65% -3.31 0.0048 1,2 NIA 
[Tetraodon nigroviridis] 
CK885El23 
(CAG06489) 
Similar to villin 2 N/A -1.78 0.0056 1,2 G0:0016020 (1) membrane; 
UniGene-Ssa.22680 G0:0016043 (2) cell organization and biogenesis; 
G0:0005515 (3) protein binding 
Table 4.2. Continued over page 
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CK877314 Lipase member H 97157% 2.17 0.0059 1,2,3 G0·0005576 (1) extracellular region; 
[Dania rerio] G0:0044238 (2) primary metabolic process; 
(NP _001003499) G0:0016787 (3) hydrolase activity 
CK889792 PREDICTED: similar to es1 protein 196 / 76% -2.10 0.0064 1,2,3 G0:0005622 ( 1) intracellular 
[Damo rerio] 
EG649354t 
(XP _693678) 
Glutathione S-transferase 176 /96% -2.26 0.0065 1,2,3 G0:0005622 (1) intracellular; 
[Oncorhynchus nerka] G0:0044237 (2) cell metabolism; 
(BAA76974) G0:0016740 (3) transferase activity 
CK888444 Differentially regulated trout protein 1 88 / 95% -2.52 0.0067 1,2 Immune-relevant gene (Bayne et al. 2001) 
[Oncorhynchus mykiss] 
(AAG30030) 
CK878970 Dynein, cytoplasmic 1, heavy chain 1 149/ 85% 2.22 0.0081 1,2 G0:0005622 (1) intracellular; 
[Homo sapiens] G0:0044237 (2) cell metabolism; 
(EAW81764) G0:0016787 (3) hydrolase activity 
CK879849 Tryptase gamma 1 208/ 36% -1.97 0.0111 1,2,3 G0:0016020 ( 1) membrane; 
[Mus muscu/us] G0:0016787 (3) hydrolase activity 
(NP _036164) 
C0470395 Unknown N/A 7.08 0.0133 1,2 N/A 
UniGene-Ssa.35702 
AM049784 Thioredoxin 99/69% -1.50 0.0153 1,2 G0:0006118 (2) electron transport; 
[lctalurus punctatus] G0:0016491 (3) oxidoreductase activity 
(AAG00612) 
CK877639 Cystatin B 42/92% -1.71 0.0193 1,2 G0.0005622 (1) intracellular; 
[Oncorhynchus mykiss] G0:0050789 (2) regulation of biological process; 
(AAT98592) G0:0004857 (3) enzyme inhibitor activity 
CK884070 Glutathione peroxidase type 2 88/84% -1.89 0.0250 1,2 G0:0005622 (1) intracellular; 
[Oncorhynchus mykiss] G0:0042221 (2) response to chemical stimulus; 
(AAV32968) G0:0016491 (3) oxidoreductase activity 
81468027 Procathepsin L 174 / 98% -1.55 0.0277 1,2 G0:0005622 (1) intracellular; 
[Oncorhynchus mykiss] G0:0044237 (2) cell metabolism; 
(AAK69706) G0:0016787 (3) hydrolase activity 
CK895896 Cystatin B 98/61% -1.67 0.0323 1,2 G0:0005622 (1) intracellular; 
[Oncorhynchus mykiss] G0:0050789 (2) regulation of biological process; 
(AAT98592) G0:0004857 (3) enzyme inhibitor activity 
CK887577 Cathepsin H precursor 167 / 72% -1.62 0.0102 2 G0·0005622 ( 1) intracellular; 
[Fundulus heteroclitus] G0:0044237 (2) cell metabolism; 
(AA064473) G0:0016787 (3) hydrolase activity 
Table 4.2. Continued over page 
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AM042158 
CK898222 
CK885691 
DW590853+ 
CK880525+ 
CK884492+ 
CK875582+ 
DW591218+ 
CK879686 
CK878339 
Table 4.2. Legend over page 
C1q-like adipose specific protein 
[Danio rerio] 
(XP _689670) 
Argininosuccina~e synthetase 
[Dania rerio] 
(NP _001004603) 
Foxk2 protein 
[Dania rerio] 
AAl29152' 
No BLAST hit 
Unknown 
UniGene-Ssa.33252 
100/ 47% 
177 / 86% 
107 /64% 
N/A 
N/A 
Similar to mitogen-activated protein kinase N/A 
UniGene-Ssa. 709 
Unknown 
UniGene-Ssa.589 
N/A 
3.62 
-1.54 
-1.75 
-3.35 
-4.52 
-4.37 
-3.76 
0.0261 2 
0.0279 2 
0.0414 2 
0.0583 3 
0.0190 3 
0.0267 3 
0.0209 3 
G0:0016020 (1) membrane; 
G0:0002376 (2) immune system process 
G0:0005515 (3) protein binding 
G0:0005622 (1) intracellular; 
G0:0044237 (2) cell metabolism; 
G0:0016874 (3) ligase activity 
N/A 
N/A 
N/A 
G0:0050790 (2) regulation of catalytic activity; 
G0:0005515 (3) protein binding 
N/A 
Monoacylglycerol 0-acyltransferase 1 111 I 70% -4.43 0.0350 3 G0:0016020 ( 1) membrane; 
[Xenopus tropica/is] G0:0044237 (2) cell metabolism; 
(NP _001039202). G0:0016740 (3) transferase activity 
Glutathione S-transferase P 131/61% -2.30 0.0402 3 G0:0005622 (1) intracellular; 
[Cricetulus longicaudatus] G0·0044237 (2) cell metabolism; 
(P46424) G0:0016740 (3) transferase act1v1ty 
Myelin and lymphocyte protein 101/52% 3.41 0.0477 3 G0:0016020 (1) membrane; 
[Mus musculus] G0:0050789 (2) regulation of biological process; 
(NP 034892) G0:0005215 (3) transporter activity 
-,_ 
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Table 4.2. List of transcripts significantly differentially expressed within the gill of 
AGD affected Atlantic. salmon. Clone ID (accession number or TRAITS ID) is 
indicated, along with the identity of the most significant BLAST result, the accession 
number and the [species]. The number of aligned amino acids and similarity (%) 
between the transcript and its BLAST hit is shown for those transcripts with a 
significant (E<l x 10-10) BLASTx result. The fold-change and adjusted p value is also 
indicated. The model number in which the transcript.was significant (adjusted p<0.05) 
is displayed. :t indicates transcripts also significantly differentially expressed within the 
anterior kidney, t indicates transcripts also significantly differentially expressed within 
the liver. Gene Ontology (GO) terms represent (1) cellular component, (2) biological 
progress and (3) molecular function 
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within the anterior kidney of AGD affected salmon, with eight transcripts down-
regulated and one up-regulated (Table 4.3). A total of five transcripts were significantly 
differentially expressed within the liver of AGD affected salmon, with all but one 
transcript down-regulated (Table 4.4). 
BLAST analysis of the 36 transcripts from the gill list suggests that these sequences 
represent 27 unique transcripts, one of which had no significant sequence homology 
(designated no BLAST hit). Of the 26 identified transcripts, eight were recognised 
through UniGene clusters, however, six of these clusters had no functional protein 
assigned to them (transcripts were therefore designated unknown) (Table 4.5). The µiost 
significantly up-regulated transcript identified within the gill was the UniGene cluster 
Ssa.25836. One of most highly down-regulated transcripts in the gill was differentially 
regulated trout protein 1 (DRTPl). This gene was represented by five transcripts and 
showed a down-regulation between 2.52 and 4.20 fold within AGD affected gill. Other 
l 
significant transcripts represented by more than one clone were sequences displaying 
strong homology to glutathione S-transferase, glutathione peroxidase, a gene coding for 
\ 
esl protein and cystatin B. 
Of the nine transcripts differentially expressed within the anterior kidney, two had no 
significant sequence homology using BLAST and four had homology to non-annotated 
UniGene clusters. The only transcript significantly up-regulated appeared to be 
homologous to the CCAAT/enhancer-binding protein beta (C/EBP~). As observed in 
the gill, transcripts with homology to mitogen-activated protein kinase and 
monoacylglycerol 0-acyltransferase were also down-regulated. 
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Accession No I Clone ID Identity Align/(%) Fold-change pvalue Model Upper level GO terms 
AJ424551 CCAAT/enhancer-binding protein 13 71 /98% 2.39 0.0019 1,2 G0:0005622 (1) intracellular; 
[Oncorhynchus mykiss] G0:0006952 (2) defence response; 
. (AAN41660) G0:0003700 (3) transcription factor activity 
CK888465 Unknown N/A -2.70 0.0033 1,2,3 N/A 
UniGene-Ssa.2141 
CK880525t Unknown N/A. -6.09 0.0260 1,2 N/A 
UniGene-Ssa.33252 
DW591218i Monoacylglycerol 0-acyltransferase 1 111 /70% -5.92 0.0293 1,2 G0:0016020 (1) membrane; 
[Xenopus tropicalis] G0:0044237 (2) cell metabolism; 
CK884492i 
(NP _001039202) GO:Q016740 (3) transferase activity 
Similar to mitogen-activated protein kinase N/A -5.93 0.0324 1,2 G0:0050790 (2) regulation of catalytic activity; 
UniGene-Ssa.709 G0:0005515 (3) protein binding 
DW590853t No BLAST hit N/A -4.88 0.0422 1,2 N/A 
CK875582t Unknown N/A -5.35 0.0484 2 N/A 
UniGene-Ssa.589 
CK888829 Unknown N/A -3.42 0.0412 3 N/A 
UniGene-Ssa.31031 
CK887535 No BLAST hit N/A -2.52 0.0410 3 N/A 
Table 4). List of transcripts significantly differentially expressed within the anterior kidney of AGD affected Atlantic salmon. Clone ID 
(accession number or TRAITS ID) is indicated, along with the identity of the most significant BLAST result, the accession number and the 
[species]. The number of aligned amino acids and similarity (%) between the transcript and its BLAST hit is shown for those transcripts 
with a significant (E<l x 10-10) BLASTx result. The fold-change and adjusted p value is also indicated. The model number in which the 
transcript was significant (adjusted p<0.05) is displayed. t indicates transcript also significantly differentially expressed within the gill. Gene 
Ontolog)'.' (GO) terms represent (1) cellular component, (2) biological progress and (3) molecular function. 
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Accession No I Clone ID Top BLAST gene name Align/(%) Fold-change pvalue Model Upper level GO terms 
CK896995 No BLAST Hit N/A -2.98 0.0261 1,2 N/A 
BM413998 C1 q-like protein 104/ 57% -2.19 0.0351 1,2 G0:0016020 (1) membrane; 
[Dissostichus mawsom] G0:0002376 (2) immune system process 
(ABN45966) G0:0005515 (3) protein binding 
gil_cgi_E3H04_car_tra_sub_Op Translation initiation factor-3 subunit 5 43/95% 2.14 0.0268 1,2 G0:0006413 (2) translational initiation 
[Mus muscu/us] 
EG649354t 
(AAL38054) 
Glutathione S-transferase 176 /96% -1.75 0.0160 2 G0:0005622 (1) intracellular; 
[Oncorhynchus nerka] G0:0044237 (2) cell metabolism; 
(BAA76974) G0:0016740 (3) transferase activity 
CK896685 Uncharacterised protein C6orf58 193/ 86% -2.21 0.0288 2 N/A 
[Oncorhynchus mykiss] 
(Q5QT17) 
Table 4.4. List of transcripts significantly differentially expressed within the liver of AGD infected Atlantic salmon. Clone ID (accession 
number or TRAITS ID) is indicated, along with the identity of the most significant BLAST result, the accession number and the [species]. 
The number of aligned amino acids and similarity (%) between the transcript and its BLAST hit is shown for those transcripts with a 
significant (E<lxI0-10) BLASTx result. The fold-change and adjusted p value is also indicated. The model number in which the transcript 
was significant (adjusted p<0.05) is displayed. t indicates transcripts also significantly differentially expressed within the gill. Gene 
Ontology (GO) terms represent (1) cellular component, (2) biological progress and (3) molecular function. 
97 
Total BLAST hit Uni Gene No BLAST 
(<1x10-10) cluster hit 
Up-regulated Down-regulated 
Gill 7 20 26 8 
Anterior kidney 1 8 7 5 2 
Liver 1 4 4 0 1 
Table 4.5. The proportion of transcripts up and down-regulated within the gill, anterior 
kidney and liver. The number of transcripts with significant BLAST identities, UniGene 
clusters or no BLAST hits are summarised. 
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The liver showed the least number of differentially expressed transcripts between AOD 
affected and naive individuals. The degree of differential expression was also lower. 
BLACST analysis of the five significantly differential expressed transcripts indicated that 
they represent five unique genes with one no BLAST hit. Only a single transcript that 
showed high homology with translation initiation factor 3 subunit 5 was significantly 
up-regulated. As observed within the giil, a transcript with strong homology to 
, glutathione S-transferase was down-regulated. 
Grouping the gill differentially expressed transcripts by parental gene ontology terms 
suggests that the majority of informative transcripts assigned cell component terms 
served as intracellular (00:0005622) cell components (Figure 4.2). A smaller number 
of transcripts were associated with extracellular (00:0005615) and membrane 
(00:0016020) cell components. Grouping the informative transcripts' assigned 
biological processes resulted in a diverse range of parent terms: the most common 
processes being cell metabolism (00:0044237) and regulation ofbiologic~l process 
(00:0050789). Grouping parent terms of informative transcripts' assigned molecular 
functions indicates that the majority of these are involved in activities such as 
oxidoreductase (00:0016491), transferase (00:0016740) and hydrolase (00:0016787). 
v 
A large number of transcripts were also grouped by protein binding activities 
(00:0005155). 
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A 
B 
G0:0016020 Membrane 
G0:0005615 Extracellular 
space 
G0:0050789 Regulation 
of biological process 
G0:0002376 Immune 
system process 
G0:0044238 Primary 
metabolic process 
G0:0042221 Response to 
chemical stimulus 
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G0:0007155 Cell 
adhesion 
G0:0005622 Intracellular 
G0:0006118 Electron 
transport 
G0:0050790 Catalytic 
activity 
c 
G0:0004857 Enzyme 
inhibitor activity 
G0:0005215 Transporter 
activity 
G0:0005155 Protein 
binding 
G0:0016787 Hydrolase 
activity 
G0:0016740 Transferase 
activity 
G0:0016491 
Oxidoreductase activity 
Figure 4.2. Gene Ontology annotation of transcripts differentially expressed within the 
gill. Gene Ontology assignment was possible for 61 % of transcripts. A: frequency of 
parent terms from transcripts assigned cell component GO terms. B: frequency of parent 
terms from transcripts assigned biological process GO terms. C: frequency of parent 
terms from GO transcripts assigned molecular function child terms. 
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4.3 .3 qPCR verification of microarray results 
Nine transcripts identified from the microarray analysis were subjected to qPCR to 
further investigate their expression within our sample material (Figure 4.3). While 
NADP transhydrogenase was not identified as significantly differentially expressed 
. within the microarray experiment, its involvement in the thioredoxin and glutathione 
pathways justified its additional examination with qPCR. 
Melt analysis demonstrated single melt curves for all amplicons confirming 
amplification of a single product. Moreover, cloning and sequencing of qPCR products 
demonstrated that the transcript of interest was being amplified. As reported previously 
(Bridle et al. 2006b) expression of the endogenous control, ~-actin, did not appear to be 
influenced by AGD. No amplification was observed within any RT negative reactions. 
The fold-change(± standard errors) determined through microarray and qPCR analysis 
for all eight transcripts examined in the gill is depicted in Figure 4.3. The transcript 
showing homology to Lipase H showed disagreement according to qPCR and 
microarray analysis. It appears when measured with qPCR, this transcript is actually 
down-regulated in AGD affected individuals - rather than up-regulated - as indicated 
by the microarray analysis. This discrepancy may indicate cross-hybridisation effects on 
this feature. All other transcripts examined in the gill with qPCR showed agreement in 
terms of up and down-regulation. 
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Figure 4.3. Fold-change(± standard errors) values relative to naive and normalised to~-
actin of all transcripts verified in the gill by real-time quantitative RT-PCR (qPCR) in 
AGD affected Atlantic salmon. EST= expressed sequence tag UniGene-Ssa.25836, 
DRTP = differential regulated trout protein 1, LIP = lipase H, PCATH = procathepsin 
L, GST = glutathione S-transferase, GPX = glutathione peroxidase, TDX = thioredoxin, 
NADP = NADP transhydrogenase. Values between -1 and +1 indicate no differential 
express10n. 
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With the exception of Lipase H the only other transcript to show disagreement between 
qPCR and microarray analysis was glutathione S-transferase when examined in the 
liver. This transcript was found to be up-regulated by 1.07 (± SE 0.30) fold according to 
the qPCR analysis, however, it was down-regulated by-1.75 (±SE 0.02) in the 
microarray analysis. There were some discrepancies between the magnitude of the fold-
change between the microarray and qPCR results. For instance, C/EBPP within the 
anterior kidney of infected fish was up-regulated 2.39 (±SE 0.18) fold in the microarray 
analysis, but only 1.57 (±SE 0.45) fold up-regulated when examined with qPCR. The 
unknown EST (UniGene-Ssa.25836) was the most up-regulated transcript in regard to 
both the microarray and the qPCR results. Data from the microarray analysis suggest 
that this transcript was up-regulated 19.34 (±SE 3.04) fold, however closer examination 
with qPCR demonstrated this transcript was 218 (±SE 66) fold up-regulated in AGD 
affected gill tissue (Figure 4.3). The reason for these discrepancies is probably due to 
the greater dynamic range displayed by qPCR compared to microarrays. 
4.3.4 qPCR analysis offish with different levels of AGD severity 
The gill gene expression of four transcripts was also compared between fish showing 
high and low severities of AGD infection, as quantified through histopathological 
scoring. Compared to the heavily infected group, expression of the unknown EST 
(UniGene-Ssa.25836) showed a significant down-regulation within lower severity 
group (p<0.001). Fish with less severe cases of AGD showed a suppression of this 
transcript by 4.57 (± SE 0. 72) fold compared to fish with high disease severities. No 
104 
significant difference in expression between groups was observed for DRTP, 
thioredoxin or procathepsin L (p>0.05). 
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4.4 Discussion 
This study aimed to examine the transcriptome response to AGD at a time when 
considerable variation in the severity of infection was present between individuals. An 
unexpected finding was the general down-regulation of genes within the gill - and to a 
lesser extent within the anterior kidney and the liver - of AGD affected Atlantic 
salmon. This result is in contrast to the gill transcriptome response during the early 
stages of AGD infection (44 to 189 hours), where, at all time points, a greater number 
of genes were up-regulated than down-regulated (Morrison et al. 2006a). The late stages 
of AGD are typically characterised by extensive lesion formation on the gill, with 
numerous amoeba associated with the margins of these lesions (Adams and Nowak 
2003). Our study examined fish at 19 DPI, a time when advanced signs of AGD were 
present. The contrast between the transcriptome response reported in this and previous 
studies (Morrison et al. 2006a) possibly reflects the different time points ·examined. 
The present study demonstrated that once individuals become highly infected with 
AGD and thus approach the terminal stages of disease, a down-regulation of many 
genes occurs. We believe this gene ~uppression may be mediated by the parasite in an 
attempt to restrict the immune response and thus increase parasite survival. The fact that 
the most pronounced gene suppression was at the site of infection - the gill - rather than 
the liver or anterior kidney adds strength to this hypothesis. For instance, if the gene 
suppression was simply a consequence of the individual approaching death we would 
expect to see systemic gene suppression, rather than this demonstrated local response. 
Nevertheless, it must be conceded that the extreme level of parasitism would have 
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resulted in a extreme stress response which may have influenced the results obtained. 
Indeed if this stress response affected oxygen consumption the down-regrilation of gene 
expression may indeed be most pronounced in the gill compared to the anterior kidney 
and liver. Future transcriptome profiling experiments aimed at assessing the generally 
stress response in Atlantic salmon - especially in regard to respiratory stress - may 
provided valuable information concerning this hypothesis. 
Suppression of the immune response 'to AGD has also been reported in other studies. 
Indeed, Atlantic salmon have been shown to display decreased phagocyte function in 
the form of suppressed respiratory burst response during advanced stages of AGD 
(Gross et al. 2004b; Gross et al. 2005). Immunosuppression caused by both 
intracellular and ectoparasitism has been reported previously and is suggested as an 
important process contributing to the interaction and coevolution between parasites and 
their hosts (Yang and Cox-Foster 2005). Indeed, a general down-regulation in gene 
expression is observed within macrophages infected with Leishmania donovani (Ross), 
the causative agent of human leishmaniasis (Buates and Matlashewski 2001). Moreover, 
varroa mites are capable of causing immunosuppression in the honey,bee, Apis 
mellifera (L.) (Yang and Cox-Foster 2005). The tick/xodes scapularis (Say) is also 
capable of causing immunosuppression by releasing a cystatin within the parasite's 
saliva, which inhibits proliferation of cytotoxic T lymphocytes and decreases cathepsin 
L activity (Kotsyfakis et al. 2006). Two cathepsin transcripts (procathepsin L and 
cathepsin H precursor) were also down-regulated within our study. 
The gill is the primary and only site of infection by Neoparamoeba p'erurans and 
displays an extensive cellular response to the pathogen. While a large transcriptome 
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response was observed at the site of infection - albeit gene suppression - an interesting 
finding was the lack of differential expression within the imm_unologically important 
organs of the anterior kidney and liver. The anterior kidney is postulated as the major 
source of B lymphocyte development within teleosts and therefore plays a pivotal role 
within the immune response (Hansen and Zapata 1998). Likewise the liver also plays an 
important role within the immune response as it is the major source of acute phase 
proteins (Streetz et al. 2001). The lack oftranscriptome response observed in the 
anterior kidney and liver within the current study is in agreement with two previous 
studies which examined the differential expression of a selection of immune response 
genes within gill, liver and anterior kidney. It appears that the majority of 
transcriptional variation occurs-within the gills of both AGD affected Atlantic salmon 
(Bridle et al. 2006a) and rainbow trout (Bridle et al. 2006b) compared to the other 
organs. The fact that the liver and anterior kidney had considerably fewer differentially 
expressed genes highlights the localise~ nature of the host-pathogen interaction. 
The liver and anterior kidney had no significantly differentially expressed transcripts in 
common. The gill, however, had five transcripts in common with the anterior kidney 
and two transcripts in common with the liver. Although the degree to which these 
transcripts were differentially expressed varied between the organs, all but one 
transcript displayed the same direction of expression. That is, when down-regulated in 
the gill, the transcript was also down-regulated in the anterior kidney. For instance, a 
transcript with sequence homology to mitogen-:activated protein kinase was 
significantly down-regulated 5.93 fold within the anterior kidney and 4.37 fold within 
the gill. A similar situation was observed for Atlantic salmon infected with Aeromonas 
salmonicida Lehmann et Neumann (Ewart et al. 2005). This study found many of the 
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same genes were differentially expressed in the liver, spleen and anterior kidney 
following A. salmonicida challenge (Ewart et al. 2005). One interesting exception in the 
present study was the two different transcripts showing homology to the complement 
Clq-like protein. In the gill, a transcript representing the Clq-like protein was up-
regulated, while in the liver a different transcript representing Clq-like protein was 
down-regulated. A pair-wise sequence alignment of these two transcripts revealed 
· significant dissimilarity, suggesting they may represent different Clq loci. 
In order to maintain homeostasis in terms of constant cell numbers, a balance between 
physiological cell death and cellular proliferation must be achieved. Apoptosis plays an 
important role in maintaining this balance. Two transcripts capable of triggering 
apoptotic cell death - procathepsin L and cathepsin B precursor - were down-regulated 
within AGD affected tissue. Cathepsins are a family of proteases that reside within the 
lysosome. In response to certain stimuli, cathepsins are released into the cytoplasm and 
are capable of triggering apoptotic cell death (Chwi~ralski et al. 2006). Involved in the 
same pathway, cystatin B has a protective role by binding tightly to cathepsins L and H 
and preventing inappropriate proteolysis (Pol and Bjork 2001; Kopitar-Jerala 2006). 
Down-regulation of the cathepsin and cystatin B pathway may reduce apoptosis within 
the gill, which in turn, may promote the cellular proliferation in response to AGD. 
An interesting fmding from our study was the down-regulation of at least four genes 
with antioxidant properties. These were glutathione S-transferase, glutathione 
peroxidase, thioredoxin and NADP transhydrogenase. In general, such antioxidants 
function mainly to protect an organism from oxidative damage caused by reactive 
oxygen and nitrogen intermediates. In Atlantic salmon, genes of glutathione S-
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transferase family have been shown to be down-regulated in whole fish in response to 
the fungal disease saprolegniasis (Roberge et al. 2007) and within the head kidney of 
individuals infected withPiscirickettsia salmonis Fryer, Lannan, Giovannoni et Wood 
(Rise et al. 2004a). However, in contrast, a number of studies have also reported an up-
regulation of antioxidants in response to infection. Atlantic salmon infected with A. 
salmonicida display an up-regulation of glutathione peroxidase within the spleen and 
liver (Ewart et al. 2005). P. salmonis infected macrophages also show an up-regulation 
of antioxidants (Rise et al. 2004a). Down-regulation of antioxidant genes at the terminal 
stages of AGD may suggest fish are ·suffering oxidative stress. Such a physiological 
state combined with the high level of parasitism may be an important factor 
contributing to AGD induced death. 
Thioredoxin is a multifunctional protein: Along with thioredoxin reductase and NADPH 
this enzyme is capable of catalysing dithiol-disulfide oxidoreductions in what has been 
collectively termed the thioredoxin system (Arner and Holmgren 2000) . Due to its 
powerful redox potential, thioredoxin is also a strong intercellular antioxidant and when 
over expressed, protects the cell against oxidative stress. In addition, thioredoxin acts as 
a chemoattractant for monocytes, neutrophils and T-cells (Bertini et al. 1999). Within 
the gill tissue of AGD affected Atlantic salmon a decreased expression of both 
thioredoxin and NADP transhydrogenase was observed, suggesting this system has 
been compromised as either a result of host response or pathogen mediation. As 
thioredoxin is a chemoattractant, down-regulation of the thioredoxin system may 
prevent or at least restrict the infiltration of inflammatory cells within the gill. This may 
compromise the ability of individuals to mount an effective immune response against 
AGD. 
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Inflammation is generally characterised by a dramatic increase of acute phase proteins, 
collectively known as the acute phase response (Gabay and Kushner 1999). This 
response is stimulated initially by the pro-inflammatory cytokines (such as IL-1, 
interleukin-6 (IL-6), and TNFa), which leads to the translocation of two important 
transcription factors, NF-KB and CfEBPp). The latter then binds to the promoter 
regions on many acute phase proteins and in so doing increases the expression of these 
proteins within the plasma (Poli 1998). In mice C/EBPP is involved in the regulation of 
serum amyloid A, serum amyloid P and complement component C3 (Poli 1998). A 
number of other acute phase proteins (C-reactive protein), cytokines (IL-lp, IL-6, 
TNFa, interleukin-8, interleukin-12) as well as iNOS and lysozyme also contain the 
functional C/EBPP binding motif, and are thus believed to be regulated to some degree 
by C/EBPP (Agrawal et al. 2001). Recently, transfection of a r~inbow trout macrophage 
cell line with recombinant IL-1 p has demonstrated this cytokine will indeed induce 
expression of C/EBP within salmonid cells (Martin et al. 2007b ). C/EBPP must undergo 
sequential phosphorylation by mitogen-activated protein kinase and glycogen synthase 
kinase to acquire DNA binding ability (Tang et al. 2005; Kim et al. 2007). 
The up-regulation oflL-lP reported previously (Bridle et al. 2006a; Bridle et al. 2006b; 
Morrison et al. 2007) and the up-regulation of C/EBPP within the current study would 
suggest fish are attempting to mount an acute phase response to AGD. However, no 
such response is observed in our study, at least at the transcriptome level. Interestingly,. 
mitogen-activated protein kinase which is essential for C/EBPP binding activity was 
down-regulated in both the gill and anterior kidney of AGD affected Atlantic salmon. It 
therefore seems likely that while the expression of C/EBPP is increased, its activity as a 
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mediator of transcription is impaired. It may be possible that the pathogen itself is 
somehow capable of blocking the activity of mitogen-activated protein·kinase and in 
tum C/EBPp, which could severely compromise the host response. 
The most highly up-regulated transcript observed within AGD affected Atlantic salmon 
was localised to the gill, and displayed a fold-change of 19.34 (±SE 3.04) and 218 (± 
SE 66) following microarray and qPCR analysis, respectively. BLAST against the 
NCBI dbEST suggests this transcript belongs to the UniGene cluster Ssa.25836 which 
currently has no functional protein assigned. Compared to heavily infected individuals, 
fish displaying less severe cases of AGD display significantly lower expression of this 
transcript by 4.57 (±SE 0.72) fold. This result may suggest that the expression of this 
transcript is positively correlated to the severity of infection. Characterising this 
unknown EST was beyond.the scope of this study. However future research is 
undeiway to elucidate if it encodes a functional protein. 
In conclusion, this study profiled the transcriptome response in the gill, liver and 
anterior kidney at the advance stages of an acute AGD infection in Atlantic salmon. We 
reported a significant down-regulation of many transcripts within the gill, and to a lesser 
extent within the anterior kidney and the liver. We hypothesise that this gene 
suppression may be parasite mediated, and involved in a mechanism by which the 
I, 
amoeba avoids or withstands the host response. 
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Chapter 5: Transcriptome profiling AGD resistant Atlantic 
salmon 
Submitted as: Wynne JW, 0' Sullivan MG, Stone G, Cook MT, Nowak B, Lovell DR, 
Taylor R, Elliott NG (2008) Resistance to amoebic gill disease (AGD) is characterised 
by the transcriptional dysregulation of immune and cell cycle pathways. in preparation. 
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Abstract 
AGD is a parasite mediated proliferative gill disease capable of affecting a range of 
teleost hosts. While a moderate heritability for AGD resistance in Atlantic salmon has 
been reported previously, the mechanisms by which individuals resist the proliferative 
effects remain poorly understood. To gain more knowledge of this commercially 
important trait, we compared gill transcriptomes of two groups of Atlantic salmon, one 
designated putatively resistant, and one designated putatively susceptible to AGD. 
Utilising a 17k Atlantic salmon cDNA microarray we identified 196 transcripts that 
were differentially expressed between the two groups. Expression of 11 transcripts was 
further examined with real-time quantitative RT-PCR (qPCR) in the AGD resistant and 
susceptible animals, as well as non-infected naive fish. Gene expression determined by 
qPCR was in strong agreement with the microarray analysis. A large number of 
differentially expressed genes were involved in immune and cell cycle responses. 
Resistant individuals displayed significantly higher expression of genes involved in 
adaptive immunity and negative regulation of the cell cycle. In contrast, AGD 
susceptible individuals showed higher expression of acute phase proteins and positive 
regulators of the cell cycle. Combined with the gill histopathology, our results suggest 
AGD resistance is acquired rather than innately present, and that this resistance is for 
the most part associated with the dysregulation of immune and cell cycle pathways. 
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5.1 Introduction 
Many pathological conditions in vertebrates result in cell proliferation and changes in 
cellular architecture. Sometimes such conditions are initiated by a pathogen, as is the 
case with the parasite mediated proliferative condition: amoebic gill disease (AGD). 
Proposed to be caused by the protozoan Neoparamoeba perurans (Young et al. 2007; 
I 
Young et al. 2008c ), AGD affects cultured teleost species including Atlantic salmon 
(Salmo salar) (Adams and Nowak 2001; Young et al. 2008c), rainbow trout 
(Oncorhynchus mykiss) (Munday et al. 1990); turbot (Scophthalmus maximus) (Dykova 
et al. 1999); coho salmon (Oncorhynchus kisutch) (Kent et al. 1988); and seabass 
(Dicentrarchus labrax) (Dykova et al. 2000). Following initial infection, AGD causes 
" 
extensive alterations in gill morphology: severe epithelial hyperplasia, hypertrophy, 
oedema and interlamellar vesicle formation (Adams and Nowak 2001). At present, the 
only successful treatment for fish affected by AGD is freshwater bathing (Parsons et al. 
2001). However, as fish are continuously being re-infected, bathing needs to be 
repeated up to 12 times in a production cycle. Due to the high fmancial cost associated 
with this practice, bathing is not considered a viable long-term management solution. 
Previous studies have suggested moderate heritability for AGD resistance within 
Atlantic salmon (Taylor et al. 2007). Enhancing this genetic resistance through selective 
breeding has become a major research focus. While improvements are possible using 
traditional phenotype-based selection, the use of marker-assisted selection (MAS) is 
preferable. MAS is most appropriate for traits in which the phenotype is difficult or 
expensive to measure, such as disease resistance. To facilitate a MAS program, genes 
(or their correlated markers) associated with resistance need to be identified. Such an 
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undertaking is complicated by the fact that disease resistance - as a trait - is often 
complex and usually under polygenic control. For example, resistance to the parasite 
Gyrodactylus safaris in Atlantic salmon is associated with multiple genomic regions, 
presumably spread over a number of genes (Gilbey et al. 2006). A similar situation is 
observed for the loci controlling resistance to Ceratomyxa shasta in rainbow trout 
(Nichols et al. :2003). 
Mechanisms controlling AGD resistance in Atlantic salmon remain poorly understood. 
Studies have demonstrated that some Atlantic salmon previously infected with AGD 
will develop resistance upon subsequent re-infection and that this resistance is 
associated with the presence of anti-Neoparamoeba spp. antibodies (Vincent et al. 
2006). Furthermore, a significant association between AGD resistance and allelic 
variation within the major histocompatibility (MH) class II alpha (Sasa-DAA) chain has 
also been described (Wynne et al. 2007b ). Despite these encouraging associations, the 
- main molecular mechanisms controlling AGD resistance are yet to be identified. 
Host response to AGD has been studied extensively. At the transcriptome level, Atlantic 
salmon infected with AGD show up-regulation of the pro-inflammatory cytokine 
interleukin-Ip (IL-1 p) within the gill tissue (Bridle et al. 2006a; Morrison et al. 2007), 
and the transcription factor CCAAT/enhancer binding protein p (C/EBPP) within the 
anterior kidney (Wynne et al. 2008). While suggestive of an acute phase response 
(APR), previous studies have reported either no, or only modest inductions of acute 
phase proteins following AGD infection (Bridle et al. 2006a; Bridle et al. 2006b; 
Morrison et al. 2006a; Wynne et al. 2008; Young et al. 2008a). Furthermore, upon first 
infection by AGD Atlantic salmon demonstrate a localised host immunosuppression 
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(Wynne et al. 2008), including down-regulation of genes involved in the MH class I and 
class II pathways (Young et al. 2008a). More recently, it has become apparent that 
genes involved in apoptosis and cellular proliferation pathways may have an important 
role in the host response to AGD, at least upon first infection (Morrison et al. 2006a; 
Wynne et al. 2008) 
DNA microarrays are an important tool for investigating transcriptional changes within 
many aquatic organisms. In salmonids, microarrays have been used to examine 
responses to stress (K.rasnov et al. 2005), bacterial infection (Rise et al. 2004a; Ewart et 
al. 2005), maturation (von Schalburg et al. 2005a), vaccination (Purcell et al. 2006) and 
cytokine stimulation (Martin et al. 2007a; Martin et al. 2007b). Microarrays have also 
become popular for identifying genes associated with disease resistance (Liu et al. 
2001; Diez-Tasc6n et al. 2005). The present study has used a recently developed 
Atlantic salmon cDNA microarray (Martin et al. 2007a) to compare the transcriptome 
response of AGD resistant and AGD susceptible Atlantic salmon following natural 
infection. 
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5.2 Materials and Methods 
5.2.1 Field AGD challenge 
On 17 August 2006 a total of2375 PIT (passive integrated transponder) tagged Atlantic 
salmon smolts from half-sibling families were stocked into a single (lOxlOm) sea-cage 
located within a commercial Atlantic salmon farm in Southern Tasmania. These fish 
were allowed to become naturally infected with AGD until 26 September 2006. The 
entire population was then scored for severity of AGD using the standard industry 
scoring method, which estimates the number of visible gross lesions on the gill surface 
(Powell et al. 2000). A score between 0 and 5 is then assigned to each individual, where 
0 represents no visible lesions and 5 represents heavily infected gills. Following 
s-coring, all fish were bathed in freshwater using standard industry protocols. After 
bathing, fish were again allowed to become naturally infected with AGD to a severe 
commercial score ( 10% of the cage population scoring over gill score 5) until 6 
December 2006 when the gill scoring and bathing process was repeated. Following the 
second bathing, the remaining 1822 fish were allowed to become re-infected for the 
third time and their severity of AGD infection scored after 50 days. The fish, however, 
. _) 
were not bathed and were allowed to become more severely infected with AGD and 
eventually succumb to the disease. The trial was then terminated on 16 March 2007 
when the total mortality had reached 57% and significant variation in the severity of 
infection was still present on survivors. 
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Upon termination all surviving individuals were scored for AGD severity and a sample 
of28 fish was selected for further analysis. These animals consisted of 14 individuals 
with either few or no gross signs of AGD (industry gill score of 0) and 14 individuals 
with severe gross signs of AGD (industry gill score of 4 or 5). From here on, these 
individuals are considered "resistant" and "susceptible", respectively. However, it must 
be acknowledged that, by surviving until trial termination, all individuals have 
demonstrated some degree of resistance. The 28 individuals were derived from over 14 
random half-sibling families. Only one of the faptllies was represented by over two fish. 
The family origin of some individuals (7 in total) was not known as these individuals 
had not been selected for pedigree analysis by the Tasmanian Atlantic salmon selective 
breeding program. Fish were euthanised with 5 g L.1 Aqui-S (Aqui-S NZ Ltd, Lower 
Hutt, New Zealand) and tissue samples dissected from the first right anterior gill 
hemibranch and stored in RNAlater (Ambion, Austin, USA) at room temperature for 24 
hours then -80°C until used. The first and second left anterior gill hemibranch was also 
dissected and fixed in seawater Davidson's fixative for 48 hours, then 70% ethanol until 
- ' 
processed. All animal procedures were approved by the University of Tasmania Animal 
Ethics Committee under the guidelines of the Australian Code of Practice. 
5.2.2 RNA isolation 
Approximately 100 mg of gill tissue was homogenised in TRI-reagent (Ambion) using a 
Quicklyse tissue homogeniser (Qiagen, Doncaster, Australia). Total RNA was then 
isolated using the RiboPure™ kit according to the manufacturer's protocol (Ambion). 
Following isolation, RNA was treated with rDNase I from the DNA:free™ kit 
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(Ambion). The quantity and quality of total RNA was estimated by examining the 
260:280 nm absorbance ratio (Nanodrop Technologies, Delaware USA) and visualisi?g 
2 µg of total RNA on a native 2% agarose gel. RNA was denatured in 15 µl of 
NorthernMax® Formaldehyde Load Dye (Ambion) and 20 µg m1·1 ethidium bromide at 
(j5°C for 15 min prior to gel electrophoresis. 
5.2.3 Microarray experimental design 
This study used a 16,950 feature (so-called "17k") Atlantic salmon cDNA microarray 
developed by the TRAITS (Transcriptome Analysis of Important Traits in Salmon) and 
Salmon Genome Projects (Martin et al. 2007a). The study was designed to follow 
MIAME guidelines (BraZilla et al. 2001). The experiment aimed to compare the gill 
gene expression profile between AGD resistant and AGD susceptible Atlantic salmon to 
identify genes differential expressed between these two states. The microarray 
experimental design consisted of direct comparisons between single resistant and single 
susceptible fish. No sample pooling was conducted within this microarray study. A total 
of 14 single fish comparisons were made, each with a dye-swap replicate. Therefore a 
total of 28 microarray hybridisations were conducted. The individual comparisons 
between resistant and susceptible fish were randomised, as was the order of slide 
processing. All hybridisations and protocols have been deposited into the ArrayExpress 
database and assigned the accession number E-MEXP-1396. 
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5.2.4 Microarray processing 
Total RNA was quantified using the Qubit fluorescence quantification system as per the 
manufacturer's protocol (Invitrogen, Mount Waverly, Australia). Next, 5 µg of total 
RNA was reverse transcribed using Superscript II reverse transcriptase (Invitrogen) and 
the 3DNA Array 350™ kit (Genisphere, Hatfield, USA) as per the manufacturer's 
protocol. cDNA synthesis was terminated by the addition of 3.5 µl of 0.5 M NaOH/50 
mM EDT A and incubation at 65°C for 15 min. Reactions were neutralised with 5 µl of 
1 M tris-HCl (pH 7.5). Appropriate Cy3 and Cy5 reactions were then combined and 
purified using the QIAquick PCR purification kit (Qiagen) with one additional wash of 
500 µl of 80% ethanol. cDNA was eluted in 30 µl of nuclease-free water. 
All hybridisations were performed with the Maui® hybridisation system (BioMicro ® 
Systems, Salt Lake City, USA) usiiig the FL hybridisation mixing chambers 
(BioMicro® Systems). First, concentrated cDNA was combined with 2 µl LNA dT 
blocker (Genisphere) and 30 µl of2X formamide-based hybridisation buffer 
(Genisphere) and incubated at 80°C for 10 min and then at 49°C until loaded onto the 
slide. Second, 50 µl of the cDNA hybridisation mix was applied to each pre-warmed 
microarray slide. The hybridisation was then performed for 15 hours at 49°C. Following 
hybridisation, the chambers were removed while submerged in 2X SSC/0.1 % SDS at 
49°C: Third, slides were washed once with 2X SSC/0.1 % SDS at 49°C for 10 min, twice 
with 2X SSC/0.1 % SDS at room temperature for 5 min, twice with 2X SSC at room 
temperature for 5 min, then twice with O.lX SSC at room temperature for 5 min. Slides 
were centrifuged dry at 51 Og for 5 min at room temperature. 
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The Cy3 and Cy5 cyanine capture reagents (Genisphere) were hybridised to the 
microarray slides ~y combining 2.5 µl of both the Cy3 and Cy5 capture reagents with 
20 µl nuclease free water and 25 µl of 2X formamide-based hybridisation buffer 
(Genisphere), incubating at 80°C for 10 min, and then at 49°C until loaded on the slide. 
Fifty micro litres of the cyanine hybridisation solution was then applied to the 
microarray slides and hybridised at 49°C for 4 hours. Following hybridisation, the 
chambers were removed in 2X SSC/0.1 % SDS at 49°C and slides were washed and 
dried as described above. 
5.2.5 Microarray scanning and image processing 
All slides were scanned using an Axon 4000B (Axon Instruments, Union City, USA) 
with the software GenePix Pro ver3.0 (Molecular Devices Corporation, Sunnyvale, 
USA). The Cy3 and Cy5 fluorophores were excited at 532 and 635 nm respectively. 
The photo multiplier tube (PMT) balance was determined empirically through a series 
of preview scans on the first eight slides. The PMT gain for the 532 nm channel was 
500 and for the 635 nm channel was 710. Laser power was maintained at 100% and, 
along with the PMT balance, remained constant for all slides. GAL files were aligned 
automatically and checked by eye. Intensity data for the 532 and 635 nm channels were 
extracted and saved as GenePix results files. 
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5.2.6 Statistical analysis of microarray data 
GPR files were read into the statistical software package R ( ver2.3 .1) and analysed with 
Limma (Smyth 2005). Prior to statistical analysis, data were normalised with the 
NormalizeWithinArrays function using the default print-tip loess method (Smyth and 
Speed 2003). The moderated t-test statistic was computed for each feature and was used 
to detect differential expression between AGD resistant and susceptible Atlantic 
salmon. When a two group comparison is conducted this t-test is equivalent to an 
analysis of variance (ANOVA). The moderated t-statistic was chosen over an ordinary 
t-statistic because it moderates the standard errors across genes and increases the 
degrees of freedom and thus reliability of an,alysis (Smyth 2004) The false discovery ' 
rate (FDR) was controlled by a Bonferroni-type FDR approach previously described by 
Benjamini and Hochberg (1995). Only transcripts which had a significant t-statistic with 
FDR <0.05 (Benjamini and Hochberg 1995) and were greater than 2-fold differentially 
expressed were considered statistically significant within our study. The mean fold-
change is present for each transcript deemed significant within our study. 
5.2.7 Transcript annotation 
Sequences of differentially expressed transcripts-were first subjected to Basic Local 
Alignment Search Tool (BLAST) against the NCBI non-redundant protein database in 
the program Blast2GO (Conesa et al. 2005). Sequences with E values <1x10-10 were 
considered ho~ologous. If no significant homology was detected the sequence was 
further analysed (using BLASTn) against the NCBI expressed sequence tag database 
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( dbEST) in an attempt to identify Uni Gene sequence clusters 
(www.ncbi.nlm.nih.gov/sites/entrez?db=unigene). Functional proteins associated with 
Uni Gene clusters were then used for annotation. In the case where no proteins were 
associated with the Uni Gene clusters, the Uni Gene code is presented. When no 
significant BLAST or UniGene cluster was identified the transcript was designated 
''unknown.'' 
5.2.8 Real-time quantitative RT-PCR 
A selection of genes was chosen for real-time quantitative RT-PCR (qPCR) to verify 
the microarray results. These genes were selected based on their involvement in the 
immune and cell cycle pathways. The remaining RNA samples from the microarray 
analysis (see above) were utilised for qPCR assays: No samples were pooled and assays 
were run on individual fish (14 resistant and 14 susceptible). In addition, six non-
.infected na'ive smolts were also included within the qPCR analysis (again not pooled). 
These individuals were obtained from a laboratory based seawater tank system, and 
were presumed to represent non-diseased gene expression levels for salmon maintained 
in seawater. The inclusion of non-infected naive samples in the qPCR analysis allow as 
to determine if certain genes were actually differential expressed in the resistant fish or 
simple a result of the differences in disease/physiological condition compared to the 
susceptible animals. 
Primers were designed from EST sequences using PrimerExpress (Applied 
Biosystems). Primer sequences for IL-lp, C/EBPP and the unknown EST, UniGene-
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Ssa.25836, were obtained from previous studies (Haugland et al. 2005; Wynne et al. 
2008). All primers used for the qPCR are shown in Table 5.1. The housekeeping genes 
~-actin and elongation factor IA8 (EF As) were chosen as the endogenous controls using 
the primers obtained from Haugland et al. (2005) and Olsvik et al. (2005) respectively. 
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TRAITS clone I Identity Primer sequence (5'-3') 
reference 
CCCTCCCCACTGACCAG 
CK897380 lmmunoglobulin light chain precursor (lg) GGTCCTTTAGGGTGGCCTC 
GATGAGCAGGGCAACTACCT 
EG649443 MHC class II invariant chain-like protein 2 (MH le) GCATCCACACACCAGCAA 
TCACCAGTGGCGCAGTT 
CK894671 p13 cyclin dependent kinase inhibitor(CDKI) CAGTGTGTCGGTCTGCGATA 
CGGAACTGTATAATGACGATGAG 
DW588077 CDC14 cell division qycle 14 homolog a (CDC14) TCAGGGCTCGCAGTTTATC 
CCAACCGCTACAGACCAAAT 
AM042284 Serum amyloid A (SAA) GGTCCTTCAGTTTGGCTAGTAAC 
CCGGCGCCTTAAAGATG 
AM042158 C1q-like adipose specific protein (C1q) CAAGCATGTCTTCACCAACAC 
TCCATCTGACAAATGCGTTT 
AM049496 C type lectin receptor A (CTL) CCATTCGCTGACCTGGTT 
TGAACTACACCGAAGACTGCTTA 
CK889753 Cyclin 81 (CYC8) CCTCGTTCACCTTCACAACAT 
CGGAGACGCAACACAAAGTG 
(Wynne et al. 2008) CCAAT/enhancer binding protein 13 (C/E8P) CAGCTGCTCCACGCGTTT 
AATACCATCACTCATACCGCTT 
(Wynne et al. 2008) UniGene-Ssa.25836 (EST) CCACTTTGCCACCTGTTATGT 
GCTGGAGAGTGTGTGGAAGA 
'(Haugland et al. 2005) lnterleukin-113 (IL-18) TGCTTCCCTCCTGCTCGTAG 
CCAGTCCTGCTCACTGAGGC 
(Haugland et al. 2005) 13-actin GGTCTCAAACATGATCTGGGTCA 
TGCCCCTCCAGGATGTCTAC 
(Olsvik et al. 2005) Elongation factor IAs CACGGCCCACAGGTACTG 
Table 5.1. List of transcripts chosen for microarray validation using real-time 
quantitative RT-PCR. The clone sequence ID used to design primers is indicated along 
with the identity of the most significant BLAST result. In the case where primer 
sequences were obtained from previous studies, the appropriate reference is cited. PCR 
and cycling parameters were constant for all transcripts and are described within the 
text. The sense and anti-sense primer sequences are also presented. 
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cDNA was generated from total RNA using Superscript III reverse transcriptase 
(Invitrogen). Briefly, 2 µg of total RNA was quantified and reverse transcribed in a 20 
µl reaction containing 4 µl of 5X buffer, 200 nM of oligo dT(l7), 0.5 mM dNTPs, 5 mM 
DTT, 40 units RN.aseOUT and 200 units of Superscript III reverse transcriptase. 
Following the addition ofRNA,.oligo dT and dNTPs, the reactions were heated to 65°C 
for 5 min. The buffer, DTT, RNaseOUT and reverse transcriptase were then added and 
reactions were incubated at 50°C for 1 hour. Two units of RN ase H were finally added 
and reactions were incubated for 20 min at 37°C. The cDNA was then diluted to 4 ng 
(starting RNA) µl -I with nuclease free water. 
All reactions were performed in triplicate in a total volume of 25 µl containing 12.5 µl 
of2X SensiMix (Quantace, London, UK), 0.5 µl ofSYBR® Green I, 200 nM of forward 
and reverse primer, 5 µl of cDNA template cind 5 µl of water. Reactions were subjected 
to 95°C for 10 min, followed by 40 cycles of 94°C for 20 sec, 56°C for 20 sec and 72°C 
for 20 sec using a Rotor-Gene™3000 real-time thermal cycler (Corbett Research, 
Mortlake, Australia). To verify amplification specificity, melt curves for each gene were 
examined from 72-95°C with a heating rate of 1°C per 5 sec. In addition, amplicons 
were examined by agarose gel electrophoresis and also cloned into PGEM-T-easy 
(Promega, Annandale, Australia) and sequenced using T7 and Sp6 primers. 
5.2.9 qPCR data analysis 
Raw fluorescence data were obtained and analysed using the Rotor-Gene Analysis 
Software ver6.l (Corbett Research). Thresholds were determined manually and CT 
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(cycle number at which the signal reaches the thresholds) calculated accordingly. 
Amplification efficiency (E) for each transcript was determined from a pooled cDNA 
sample (including the 14 AGD resistant and 14 AGD susceptible samples) serially 
diluted two-fold five times and calculated as E=l0(-1/S) where sis the slope of the 
standard curve of serial dilutions according to Pfaffl (2001). Differences in gene 
expression between AGD resistant and susceptible Atlantic salmon were analysed using 
relative expression, with the software REST-XL (Pfaffl et al. 2002) according to.the 
following equation. 
Ratio = (Etarget)~CT[target(control-sample)]/(Eref)~CT[ref(control-sample)] 
~-actin and EF Aa served as the endogenous reference genes. For the purpose of 
verifying the microarray results, the susceptible Atlantic salmon were considered the 
control sample. When the comparisons between na'ive and AGD resistant and 
susceptible were performed, the na'ive samples were considered the control. The 
analysis using different reference genes was performed independently. The REST-XL 
software calculates the relative expression ratio of a target gene, while adjusting for 
differences in amplification efficiency. Standard errors represent the variation between 
the individual fish within each group (i.e. between the 14 resistant fish or 14 susceptible 
fish). 
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5.3 Results 
5.3.1 AGD histopathology 
Histopathology of gill sections from the 14 AGD resistant and 14 AGD susceptible 
individuals revealed significant differences in the severity o~ infection (Figure 5.1 ). 
Inspection of the susceptible fish revealed substantial pathology including extensive 
lamella fusion; hyperplasia and hypertrophy of the epithelial cells; oedema; and 
interlamellar vesicle formation. In contrast, the resistant individuals showed very minor 
AGD pathology with only a few small lesions (two or three fused lamellae) observed 
microscopically. Nevertheless, the fact that all AGD resistant fish displayed some 
degree of pathology suggests resistance is associated with tolerance to the parasite, 
rather than absolute resistance. A moderate infiltration of inflammatory cells 
morphologically identified_ as neutrophils and monocytes/macrophages was observed 
within the lesions and within the adjacent central venous sinus of susceptible and 
resistant fish. The presence of amoebae with the symbiont (parasome) was observed 
within all AGD susceptible individuals and within some AGD resistant fish. 
The mean gross gill scores for the 14 fish designated resistant and the 14 designated 
susceptible for the four different gill scoring events are illustrated in Figure 5.2. Both 
the resistant and susceptible groups showed considerable signs of AGD pathology 
during the early stages of the trial. It was not until the third gill scoring event that the 
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Figure 5 .1. Gross pathology and histopathology of AGD resistant and susceptible 
Atlantic salmon. A: Gross presentation of seawater Davidson's fixed gill section 
obtained from an Atlantic salmon resistant (gross gill score 0) to AGD. B: Gross 
presentation of seawater Davidson's fixed gill section obtained from an Atlantic salmon 
susceptible (gross gill score 5) to AGD. Extensive multifocal mucoid lesions are clearly 
visible. C: histology from the gill of an AGD resistant Atlantic salmon displaying 
normal gill morphology. D: histopathology of an Atlantic salmon susceptible to AGD. 
Extensive hyperplastic lamellar fusion is clearly visible. 
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Figure 5.2. Mean gross gill score history± standard error of the 28 analysed Atlantic 
salmon designated either AGD resistant (n = 14) or AGD susceptible (n = 14). Gross 
gill scoring was completed at four time points, with the final time point representing 
trial termination. Vertical dashed lines indicate freshwater bathing events. All fish were 
assumed to return to a gill score of 0 following bathing. 
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resistant individuals showed considerable improvement in resistance. The greatest 
difference in gross gill score between the two groups was observed at trial termination 
when all resistant fish had a gross gill score of 0, while all the susceptible fish had a 
gross gill score of 5. 
5.3.2 Microarray gene expression profiles, comparison between AGD resistant vs. 
susceptible Atlantic salmon 
) 
In total, 196 transcripts were deemed to be significantly differentially expressed 
between AGD resistant and AGD susceptible Atlantic salmon (Figure 5.3). One 
hundred and four transcripts, termed up-regulated, appeared to have significantly higher 
expression in the AGD resistant individuals compared to AGD susceptible individuals. 
Ninety-two transcripts, termed down-regulated, had significantly lower expression in 
the AGD resistant individuals compared to the AGD susceptible individuals (Table 5.2). 
BLAST analysis of the 104 up-regulated sequences found 70 with positive identities; 34 
had no BLAST hit or belonged to a non-annotated Uni Gene cluster. BLAST analysis of 
the 92 down-regulated transcript sequences, found 65 positive identities; 27 had either 
no BLAST hit or represented a non-annotated UniGene cluster. All transcripts with 
1· 
positive identities that were significantly up- or down-regulated in the resistant fish are 
listed in Table 5.3 and Table 5.4, respectively. Transcripts with e.ither no BLAST hit or 
homology to a non-annotated UniGene cluster are presented within Appendix 3.1 and 
, 
3.2. 
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Figure 5.3. Volcano plot of normalised microarray data produced from 28 
4 
hybridisations. The mean of each replicate feature is presented. The x-axis represents 
the log2 of the fold-change between AGD resistant and susceptible Atlantic salmon. The 
y-axis corresponds to the log odds which represents the odds (or probability) that a 
certain gene is differential expressed. A log odds value of 0 represents a 50% chance 
that the gene is differential expressed. The greater the log odds value the greater the 
probability the gene is truly differentially expressed and not a false positive. The 
vertical lines represent the two-fold change (log2) threshold utilised in this study. 
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BLAST hit no BLAST hit 
6LASTx BLASTn non annotated unknown 
(UniGene) Uni Gene 
Up-regulated 55 15 26 8 
Down-regulated 52 13 23 4 
Table 5.2. The number of transcripts significantly up- and down-regulated in the AGD 
resistant individuals is summarised. Transcripts were identified through either BLASTx 
of the NCBI non-redundant protein database or BLASTn of the NCBI EST database 
· (annotated UniGene clusters). The number of transcripts which had no BLAST hit or 
belonged to a non-annotated UniGene clusters is also presented. 
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Functional 
class Clone ID 
Electron transport 
C0472279 
AM402919 
DW591439 
Immune and stimulus response 
Cell cycle 
CK894662 
CK897380 
CK885361 
AM041756 
AJ425406 
EG649443 
C0471779 
EG355307 
CK880837 
CK881973 
DW588549 
CK892925 
CK893291 
var_imm_IGB09_abe_tra_sub_Op 
CK894671 
DW588093 
ova_oyr _ 03B05_gal_sal_std_ 5p 
Signal transduction and communication 
CK884106 
Table 5.3. Continued over page 
Identity 
Cytochrome P4501A 
Cytochrome P450 1A1 
Cytochrome b 
Guanylate binding protein 4 
lmmunoglobulin light chain precursor 
Matrix Gia protein 
Bactericidal permeability-increasing protein 
Invariant chain INVX 
MHC class II invariant chain-like protein 2 
Bactericidal permeability-increasing protein 
Granzymek 
lmmunoglobulin light chain precursor 
lmmunoglobulin light chain 
lmmunoglobulin light chain 
Barrier to autointegration factor 1 
C1q subcomponent, gamma polypeptide 
CDS a 
p13 cyclin dependent kinase inhibitor 
Septin 5 
Sjogrens syndrome scleroderma autoantigen 1 
CC chemokine SCYA112 
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Fold· 
Accession pValue change Biological process GO 
Ssa.31314 1.381E-11 2.79 G0:0006118: electron transport 
092110 1.32E-13 2.60 G0:0006118: electron transport 
YP_001122912 6.30E-09 2.36 G0:0006118: electron transport 
AAM44075 9.47E-11 2.46 G0:0006955: immune response 
AAD38362 5.74E-07 2.45 G0:0006955: immune response 
AA064980 1.24E-12 2.39 G0:0009607: response to stimulus 
BAB91243 4.70E-13 2.27 G0:0006955: immune response 
AAL58577 3.95E-12 2.22 G0:0006955: immune response 
AAL91669 1.91E-12 2.18 G0:0006955: immune response 
BAB91243 3.07E-13 2.14 G0:0006955: immune response 
AAQ54830. 5.98E-09 2.13 G0:0006955: immune response 
AAG18372 2.05E-05 2.12 G0:0006955: immune response 
BAD16718 6.81E-06 2.11 G0:0006955: immune response 
AAK97642 2.42E-09 2.11 G0:00~6955: immune response 
NP_446083 7.73E-04 2.09 G0:0009607: response to stimulus 
EDL80826 7.82E-12 2.05 G0:0006955: immune response 
AAW33876 5.11E-09 2.04 G0:0006955: immune response 
CAC12808 1.94E-11 2.26 G0:0007049: cell cycle 
AAH94347 1.66E-12 2.21 G0:0007049: cell cycle 
NP_001033617 9.78E-11 2.03 G0:0007049: cell cycle 
AAT52146 9.52E-16 3.66 G0:0007165: signal transduction 
CK877670 Mitogen-activated protein kinase kinase kinase 6 isoform 3 Ssa.709 4.95E-14 3.00 G0:0007165: signal transduction 
CK879697 PREDICTED: similar to A-kinase anchoring protein XP_699814 8.20E-14 2.95 G0·0007165: signal transduct1on 
AJ424476 Arrestin domain containing 2 NP_956233 1.28E-08 2.29 G0:0007165: signal transduction 
DW588069 DIX domain containing 1 NP_878304 2.37E-12 2.27 G0·0007154: cell communication 
DW589803 Proteolipid protein 2 XP _001507488 2.29E-11 2.19 G0.0007165: signal transduction 
CK897432 Mitogen-activated protein kinase kinase kinase 6 isoform 3 Ssa.709 1.30E-13 2.19 G0:0007165: signal transduction 
CK897499 Mitogen-activated protein kinase kinase kina~e 6 isoform 3 Ssa.709 2.78E-10 2.03 G0:0007165: signal transduction 
CK897571 hydroxysteroid 11-beta dehydrogenase BAC76709 1.45E-10 2.03 G0:0007154: cell communication 
AJ424335 Mitogen-activated protein kinase kinase kinase 6 isoform 3 Ssa.709 6.25E-09 2.01 G0:0007165: signal transduction 
Cellular process 
C0469753 Spondin 1a CAM56280 5.27E-11 2.25 G0.0007155: cell adhesion 
CK884207 Collagen a-f!(I) chain precursor 093484 8.97E-10 2.24 G0:0001501: skeletal development 
CK896922 Growth arrest and DNA-damage-inducible J3 NP_056490 6.70E-12 2.23 G0:0008219: cell death 
EG649361 Collagen a-2(1) chain BAB79230 4.49E-10 2.21 G0:0001501: skeletal development 
EG649013 Collagen a-3(1) BAB55662 4.55E-10 2.2 G0:0008283: cell proliferation 
DW592221 Collagen a-2(1) chain BAB79230 1.44E-08 2.17 G0:0001501: skeletal development 
CK885060 Collagen precursor (XVI) Ssa.34037 3.38E-10 2.13 G0:0007155: cell adhesion 
CN181319 Collagen precursor (XVI) Ssa.30921 4.21E-10 2.12 G0:0007155: cell adhesion 
CK885437 Echinoderm microtubule associated protein like 2 NP _001025406 3.07E-10 2.1 G0:0016043: cellular organization 
DW591808 Collagen a-4(1V) Ssa.34688 3.50E-10 2 07 G0:0048468: cell development 
DW589811 Heat shock 70kda protein 9b (mortalin-2) AAI02335 1.60E-12 2.06 G0:0016043: cellular organization 
CK873772 Collagen a-1(1) BAA33380 2.06E-10 2 05 G0:0001501: skeletal development 
gil_cgi_E4E12_car_tra_sub_Op Collagen a-2(Vlll) Ssa.24648 2.38E-07 2.05 G0:0007155: cell adhesion 
CK885676 TSC22 domain family, member 3 isoform 2 NP_004080 5.75E-11 204 G0:0008219: cell death 
EG355157 Collagen a-2(Vlll) Ssa.24648 1.54E-07 2.03 G0:0007155: cell adhesion 
AJ424854 Collagen a-3(1) BAB55662 5.59E-10 2.03 G0:0008283: cell proliferation 
EG648912 Collagen a-1(1) BAA33380 1.89E-11 2.02 G0:0001501 : skeletal development 
AJ424291 Collagen a-1(XV) 1soform 2 Ssa 32837 1.92E-14 2.01 G0:0007155: cell adhesion 
CK884893 PREDICTED: similar to collagen a-2(1X) XP _001498143 2.16E-08 2.01 G0:0001501: skeletal development 
Cellular metabolism 
Table 5.3. Continued over page 
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C0472136 Sulfotransferase isoforrn 2 AA064984 1.02E-09 3.07 G0:0044237: cellular metabolism 
EG647995 Creatine kinase, muscle EAW57337 1.14E-12 2.33 G0:0044237: cellular metabolism 
DW588077 CDC14 cell division cycle 14 homolog a NP_956473 9.09E-11 2.19 G0:0044237: cellular metabohsm 
EG647833 H1 histone family, member X NP _001080265 1.31E-12 2.18 G0:0044237: cellular metabolism 
DW588390 Creatine kinase, muscle EAW57337 7.26E-11 2.18 G0:0044237:.cellular metabolism 
CK883781 Ubiquitin CAG04600 7.01E-12 2.17 G0:0044237: cellular metabolism 
CK885560 protein tyrosine phosphatase NP_001013058 1.37E-08 2.14 G0:0044237: cellular metabolism 
CK880071 Creatine kinase, brain NP_775329 4.14E-12 2.07 G0:0044237: cellular metabolism 
CK894889 Dual adaptor of phosphotyrosine and 3-phosphoinositides EAX06111 4.37E-08 2.01 G0:0044237: cellular metabolism 
Other metabolism 
EG355006 Apolipoprotein D precursor Ssa.29386 2.18E-12 2.48 G0:0006629: hpid metabolic process 
CK885772 Sulfotransferase 1 isoform 3 ABJ98761 1.13E-11 2.29 G0:0006805: xenobiotic metabolism 
Transport 
CK874017 Epithelial calcium channel AAP12529 1.85E-09 2.33 G0:0006816: calcium ion transport 
AM042393 Prosaposin isoform 8 Ssa.6260 6.24E-08 2.25 G0:0006810: transport 
CK885326 RAB32, member RAS oncogene family NP_958489 1.98E-09 2.07 G0:000681 O: transport 
No GO assigned 
CK876833 Keratocan ABG72686 4.03E-15 2.49 N/A 
CK879811 Novel protein containing a SEA domain CAM14120 6.86E-14 2.49 N/A 
BM414353 FAM83F protein AAH31099 9.37E-11 2.08 N/A 
CK873807 T-cell immunoglobulin and mucin domain containing 4 Ssa.5164 6.65E-12 2.07 N/A 
CK897241 Neuroblastoma, suppression oftumorigenicity 1 NP_996980 2.05E-09 2.05 N/A 
CK879753 VHSV-induced protein AAM18475 3.66E-10 2.05 N/A 
C0470982 Anhydrase Ssa.5502 4.74E-12 2.01 N/A 
Table 5.3. Legend over page 
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Table 5.3. Transcripts with BLAST identities that were significantly up-regulated in 
AGD resistant compared to AGD susceptible Atlantic salmon are presented. Clone ID 
(accession number or TRAITS ID) is indicated, along with the identity of the most 
significant BLAST result, the accession number of that BLAST hit, and the high level 
Gene Ontology biological process term when available. The fold-change and adjusted p 
value are also indicated. 
) -
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Functional 
class Clone ID 
Electron transport 
CK892524 
CK882754 
81468047 
AM412213 
Stress response 
CK890160 
CK885807 
81468144 
CK880657 
AJ424875 
CK878109 
lmmune/defense response 
AM042158 
AM042078 
CK896920 
AM042338 
AM049678 
CK889507 
AM049496 
gil_cgi_D1 E08_car_tra_sub_Op 
AM041713 
AM049499 
AM049530 
AM049476 
AM049895 
AM049483 
Table 5.4. Continued over page 
Identity 
Aldo-keto reductase 
Cytochrome c oxidase subunit IV isoform 2 precursor 
Cytochrome P450, family 2, subfamily J, polypeptide 24 
Cytochrome c oXJdase subunit 1 
Heat shock 60 kD protein 1 
Heat shock 60 kD protein 1 
NADH dehydrogenase (ubiquinone) 
lsocitrate dehydrogenase 2 (NADP+) 
Heat shock protein 60 
Heat shock 60 kD protein 1 
C1q-like adipose specific protein 
C1q-like adipose specific protein 
C1q-like protein 
Natterin-like protein 
C type lectin receptor A 
Transferrin 
C type lectin receptor A 
Differentially regulated trout protein 1 
Arachidonate 5-lipoxygenase 
Differentially regulated trout protein 1 
Differentially regulated trout protein 1 
C type lectin receptor A 
C type lectin receptor A 
Differentially regulated trout protein 1 
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Fold-
Accession pValue change Biological process GO 
CAl20762 2.875E-16 -2.73 G0:0006118: electron transport 
AAF79934 6.702E-18 - 2.48 G0.0006118: electron transport 
NP _001076518 1.450E-12 - 2.45 G0:0006118: electron transport 
A8G37914 1.932E-09 -2.26 G0:0006118: electron transport 
NP_851847 8.778E-20 -2.70 G0:0006950: stress response 
NP_851847 3.099E-15 -2.38 G0:0006950: stress response 
Ssa.5559 1.267E-10 - 2.16 G0:0006950: stress response 
Ssa.5190 5.643E-14 -2.14 G0:0006950: stress response 
A8H88213 4.534E-08 -2.14 G0:0006950: stress response 
NP_851847 3.311E-15 -2.06 G0:0006950: stress response 
AAM73701 1.85E-13 -6.88 G0:0006955: immune response 
AAM73701 1.75E-13' -6.55 G0:0006955: immune response 
A8N45966 3.09E-08 -5.17 G0:0006955: immune response 
Q5CZR5 9.77E-15 -4.06 G0:0009405: pathogenesis 
Ssa.851 1.28E-15 -3.83 G0:0006955: immune response 
8AA84102 4.40E-09 -3.69 G0:0006952: defense response 
AAT77220 4.56E-18 -3.65 G0:0006955: immune response 
AAG30030 1.04E-14 -3.37 G0:0006955: immune response 
Ssa.7568 5.55E-13 -3.36 G0:0006952: defense response 
AAG30030 5.99E-13 -3.18 G0:0006955: immune response 
AAG30030 2.38E-12 -3.17 G0:0006955: immune response 
AAT77220 7.03E-18 -3.15 G0:0006955: immune response 
AAT77220 5.47E-15 -3.14 G0:0006955: immune response 
AAG30030 3.89E-15 -3.02 G0:0006955: immune response 
AM049472 C type lectin receptor 8 AAT77221 1.79E-07 -2.87 G0:0006955: immune response 
AM042284 Serum amyloid A CAM12347 4.79E-10 -2.5 G0:0006952: defense response 
Cell cycle 
CK889994 Karyopherin a2 NP _001002335 9.457E-16 -2.16 G0:0007049: cell cycle 
CK889753 Cyclin 81 A8154407 2.798E-14 -2.08 G0:0007049: cell cycle 
CK890958 Cyclin 81 A8154407 5.150E-15 -2.06 G0:0007049: cell cycle 
Transcription factors 
G0:0045449: regulation of 
8M414000 General transcription factor 118 CAM14348 7.352E-09 -3.20 transcription 
G0·0045449: regulation of 
CK897622 Interferon regulatory factor 6 isoform 1 Ssa.33979 3.315E-14 - 3.13 transcription 
G0:0045449: regulation of 
CK892065 CCAAT/enhancer binding protein 13 A8D84407 8.715E-08 - 2.14 transcription 
Signal transduction 
var_imm_IGA01_abe_tra_sub_Op lnterleukin-113 AAT36642 2.005E-15 -5.54 G0:0007165: signal transduction 
AY617117 lnterleukin-113 AAT36642 1.203E-15 - 5.49 G0:0007165: signal transduction 
AY617117 lnterleukin-113 AAT36642 6.039E-15 - 5.21 G0:0007165: signal transduction 
AY617117 lnterleukin-113 AAT36642 1.085E-14 -4.52 G0:0007165: signal transduction 
kid_cki_A2C12_car_tra_sub_Op Turner-associated calcium signal transducer NP_998340 2.840E-15 -2.70 G0:0007165: signal transduction 
EG647772 Mitogen-activated protein kinase kinase kinase 6 isoform 3 Ssa.709 2.860E-09 -2.28 G0:0007165: signal transduction 
CK885687 N-myc and STAT interactor Ssa.1929 3.178E-16 -2.12 G0:0007165: signal transduction 
Cellular process 
CK885737 Fibroblast growth factor-binding protein Ssa.25939 3.24E-14 -5.73 G0.0008283: cell proliferation 
CK892779 Intestinal mucin-like protein P98089 5.91E-12 -5.26 G0:0006928: cell migration 
8M414013 Myosin, heavy polypeptide 9, non-muscle NP_990808 4.19E-08 -3.56 G0·0016043: cellular organization 
8M414061 Calpain 1, isoform CRA_a EDM12549 6.52E-12 -2.41 G0:0008283: cell proliferation 
CK895032 Desmoglein 113 NP_859010 4.06E-12 -2~22 G0:0007155: cell adhesion 
CK888161 Cystathionase isoform 2 Ssa.31931 1.78E-19 -2.17 G0:0008283: cell proliferation 
CK888789 Cystathionase NP_997769 2.37E-16 -2.13 G0:0008283: cell proliferation 
Cell metabolism 
Table 5.4. Continued over page 
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CK885733 Cytidine deaminase NP_991242 1.79E-16 -6.75 G0.0044237: cellular metabolism 
DW589192 Glutamate decarboxylase-like 1 NP _001039075 , 7.75E-11 -4.54 G0:0044237: cellular metabolism 
CK891048 Ribonucleotide reductase m2 polypeptide AAH75746 7.51E-17 -2.57 G0.0044237: cellular metabolism 
CK879648 Squalene monooxygenase Ssa.33937 3 94E-13 -2.54 G0:0044237: cellular metabolism 
BM413697 ribonucleaselangiogenin inhibitor Ssa.30974 1.87E-12 -2.38 G0:0044237: cellular metabolism 
CK890886 Ribonucleotide reductase m2 polypeptide NP_571525 2.33E-17 -2.34 G0:0044237: cellular metabolism 
DW591384 Tubulin,a2 AAQ91280 9.18E-18 -2.34 G0:0044237: cellular metabolism 
CK892811 Carbonyl reductase 1 NP_919387 1.23E-12 -2.12 G0:0044237: cellular metabolism 
AM042370 Ribonucleotide reductase m2 polypeptide AAH75746 8.46E-11 -2.11 G0:0044237: cellular metabolism 
Other metabolism 
G0:0006629: lipid metabolic 
C0471940 lsopentenyl-diphosphate delta isomerase 2 NP _001011323 3.67E-15 -2.49 process 
G0:0005975: carbohydrate 
EG355381 Aldose reductase AAA31157 1.38E-13 -2.38 metabolism 
G0:0006629: lipid metabolic 
CK875291 lsopentenyl-diphosphate delta isomerase EDL86437 4.09E-13 -2.35 process 
Transport and development 
DW589322 Type I keratin SB CAC45059 2.234E-13 -2.98 G0:0048731: system development 
EG647609 ATP-binding cassette, sub-family F (GCN20), member 2 NP_958472 2.921E-13 -2.02 G0:0006810: transport 
No GO assigned 
BM414515 Tumor differentially expressed 2 NP_956021 2.620E-18 -3.54 NIA 
BM414518 ORF1 of novel LINE-like retrotransposon Ssa.15073 1.847E-10 -2.31 NIA 
CK884079 ACyLtransferase-like family member Ssa.22612 7.163E-16 -2.29 NIA 
CK897877 Cysteine and histidine-rich domain-zinc-binding protein 1 NP_956633 3.002E-11 -2.25 NIA 
CK885188 Arginine-rich, mutated in early stage tumors EAW65138 2.233E-17 -2.21 NIA 
Table 5.4. Legend over page 
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Table 5.4. Transcripts with BLAST identities that were significantly down-regulated in 
AGD resistant compared to AGD susceptible Atlantic salmon are presented. Clone ID 
(accession number or TRAITS ID) is indicated, along with the identity of the most 
significant BLAST result, the accession number of that BLAST hit, and the high level 
Gene Ontology biological process term when available. The fold-change and adjusted p 
value are also indicated. , 
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A moderate redundancy was observed within the lists of genes differentially expressed. 
This provides some degree of internal validation for the microarray results. 
Furthermore, in most cases, the degree of differential expression between different 
transcripts representing the same gene was very similar. For instance, the fold-change of 
four transcripts representing differentially regulated trout protein 1 (DRTPl) ranged 
from 3.02 to 3.37 down-regulated in the AGD resistant Atlantic salmon. Removing 
redundancy reduced the number of significantly up- and down-regulated transcripts 
with known identities to 55 and 49, respectively. 
Grouping non-redundant informative transcripts based on high-level biological process 
gene ontology terms suggested the majority of transcripts differentially expressed were 
involved in the immune response (00:0006955) and cellular metabolism 
(<;10:0044237) (Figure 5.4). Some gene ontology terms, such as cell cycle 
(00:0007049), signal transduction (00:0007155) and cellular metabolism 
(00:0044237) were almost equally represented in both up- and down-regulated gene 
lists. However, other gene ontology terms showed large frequency differences between 
the up- and down-regulated groups. For instance, all transcripts assigned the terms, 
"stress response" (G0:0006950), "defence response" (00:0006952) and "regulation of 
transcription" (00:0045449) were down-regulated in the resistant individuals, while 
transcripts assigned the terms "skeletal development" (G0:0001501), "response to 
stimulus" (00:0009607) and "cell communication" (00:0007154) were only up-
regulated in the resistant individuals. Transcripts involved in cell adhesion 
(00:0007155) and immune response (00:0006955) were also more frequent in the up-
regulated list. 
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GO 0048731 system development 
G0.0048468 cell development 
G0·0045449 regulation of transcnpt1on 
G0.0044237 cellular metabolism 
GO 0016043 cellular orgamzat1on 
G0·0009607 response to stimulus 
GO 0009405. pathogenesis 
GO 0008283 cell proliferation 
GO 0008219. cell death 
GO 0007165 signal transduct1on 
GO 0007155 cell adhesion 
GO 0007154 cell communication 
GO 0007049 cell cycle 
G0.0006955 immune response 
GO 0006952 defense response 
GO 0006950 stress response 
GO 0006928 cell m1grat1on 
GO 0006816 calcium ion transport 
GO 0006810. transport 
GO 0006805 xenob1ollc metabolism 
G0·0006629 lipid metabolic process 
G0.0006118 electron transport 
G0.0005975 carbohydrate metabolism 
GO 0001501 skeletal development 
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Figure 5.4. The proportion of informative transcripts (redundancy removed) assigned 
high level biological process Gene Ontology terms that were significantly up- and 
down-regulated in AGD resistant compared to AGD susceptible Atlantic salmon are 
presented. A total of 48 (87%) up-regulated informative transcripts and 44 (89%) down-
regulated informative transcripts could be assigned biological process Gene Ontology 
terms. 
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A number of transcripts with strong homology to genes involved in cell cycle and 
cellular proliferation were differentially expressed between AGD resistant and AGD 
susceptible fish. Resistant individuals showed increased expression of the cyclin 
dependent kinase inhibitor pl3, septin 5, growth arrest and DNA-damage-inducible P 
(GADDp), CDC14 cell division cycle 14 homolog A and mortalin-2 (70 kD HSP). 
Resistant individuals showed decreased expression of cyclin B, fibroblast growth 
factor-binding protein and N-myc STAT interactor. The resistant fish were also found 
to have an up-regulation of many transcripts resembling various types of collagen. Two 
transcripts resembling putative tumor suppress9rs (TSC-22 (TFGP stimulated clone-22) 
and neuroblastoma, suppression oftumorigenicity 1) were also up-regulated in the 
resistant fish, while a transcript with homology to tumor differentially expressed 2 was 
down-regulated. 
The acute phase response genes serum amyloid A (SAA), C-type lectin receptor A, C-
type lectin receptor B, Clq complement component, DRTPl and transferrin were all 
down-regulated within the gill of AGD resistant fish. Three transcription factors were 
down-regulated in the AGD resistant fish: interferon regulatory factor 6 isoform 1, 
general transcription factor lib, and C/EBPp. The pro-inflammatory cytokine IL-1 p was 
significantly down-regulated in the resistant fish. The resistant fish demonstrated lower 
expression of stress related genes, namely transcripts encoding the heat shock 60kD 
protein. 
In contrast, the AGD resistant individuals appeared to have higher expression of 
transcripts involved in adaptive immunity: immunoglobulin light chain (lg), MHC class 
II invariant chain (MH le), CDS and a transcript known as T -cell immunoglobulin and 
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mucin domain containing 4. Two transcripts known as bactericidal permeability-
increasing protein were also up-regulated in the resistant fish. 
5.3.3 qPCR of AGD resistant vs. susceptible Atlantic salmon 
Eleven transcripts identified as significantly up- or down-regulated within the 
microarray analysis were further examined with qPCR. Melt curve and sequencing 
analysis of amplicons indicated the single product" of interest was amplified in all cases. 
The expression of the reference genes ~-actin or EF AB did not appear to be influenced 
byAGD. 
Typically, the fold-change of transcripts examined with qPCR was in agreement with 
the fold-change determined through the microarray analysis (Pearson correlation = 0.96, 
p<0.001; Figure 5.5)~ Some minor discrepancies were observed in the magnitude of the 
differential expression, with the microarray slightly underestimating the differential 
expression compared to qPCR. 
In addition to verifying the microarray results, the genes selected for qPCR allowed us 
to confirm the expression of genes involved in two distinct processes: the acute phase 
response and the cell cycle response. The only gene not involved in these pathways (at 
least to OU}' knowledge) but analysed with qPCR, was th~ unknown EST, UniGene-
Ssa.25836. At present, the function of this gene has not been determined, however, our 
previous research has found it to be significantly up-regulated during AGD infection 
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Figure 5.5. Correlation between the fold-change determined through microarray and 
real-time quantitative RT-PCR (qPCR) analysis of 10 transcripts is presented. Due to 
showing such a large differential expression according to both the microarray and qPCR 
analysis the unknown EST Uni Gene Ssa.25836 was not included within this figure. 
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(Wynne et al. 2008). The fold-change of each transcript examined with qPCR is shown 
in Table 5.5. 
5.3.4 qPCR of AGD resistant and susceptible vs. naive Atlantic salmon 
Inclusion of samples from naive seawater-ma~tained fish in the qPCR analysis allowed 
us to examine what could be considered the "normal" expression levels of these 11 
genes. For some transcripts, the expression in both the AGD resistant and susceptible 
Atlantic salmon was higher compared to the naive individuals (Figure 5.6). An example 
of such was the expression of the immune gene lg, which was up-regulated by 
approximately 5.1 and 2.4 fold in the AGD resistant and susceptible individuals 
compared to naive, respectively. Another adaptive immune related gene, MH le, 
showed a similar pattern. 
Most transcripts involved in the acute phase response showed significantly higher 
expression in the AGD susceptible individuals compared to the naive controls, with the 
exception of SAA. This transcript demonstrated decreased expression in both the AGD 
resistant and susceptible individuals relative to naive. The resistant individuals 
generally demonstrated a small decrease in expression of the acute phase proteins Clq, 
C-type lectin receptor A (CTL) and IL-1~ relative to the naive samples. As reported 
previously (Wynne et al. 2008) the expression of C/EBP~, and the unknown EST, 
UniGene-Ssa.25836, were both up-regulated in AGD resistant and susceptible fish 
compared to the naive fish. 
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Clone ID Identity Fold-change normalised Fold-change normalised 
to j3-actin (± SE) to EFAe (±SE) 
CK897380 lmmunoglobulin light chain precursor 2.83 (2.43) 2.16 (3.09) 
EG649443 MHC class II invariant chain-like protein 2 3.13 (3.41) 2.94 (0.33) 
CK894671 p13 cyclin dependent kinase inhibitor 2.34 (0.60) 2.04 (0.20) 
DW588077 CDC14 cell division cycle 14 homolog a 1.53 (1.25) 1.12 (0.24) 
CK889753 Cyclin 81 -2.79 (0.71) - 2.61 (1.07) 
N/A lnterleukin-1~ - 8.31 (3.01) - 8.50 (2.48) 
CK892065 CCAAT/enhancer binding protein~ - 2.40 (0. 78) -2.19 (0.77) 
AM042284 Serum amyloid A - 2.97 (2.76) - 3.16 (2.23) 
AM042158 C1q-like adipose specific protein - 11.33 (18.80) -10.07 (16.48) 
AM049496 C type lectin - 4.28 (1.67) - 3.54 ( 1.65) 
CK880278 UniGene-Ssa.25836 - 70.05 (517.76) -61.81 (134.26) 
Table 5.5. The fold-changes of a sub-sample of transcripts determined by real-time 
quantitative RT-PCR (qPCR) normalised to either beta actin or elongation factor 1A8 
are presented. Negative fold-changes represent transcripts down-regulated in AGD 
resistant compared to AGD susceptible Atlantic salmon, while positive fold-changes 
represent transcripts up-regulated in AGD resistant compared to AGD susceptible 
Atlantic salmon. The standard errors (SE) represent the variation between individuals 
within the resistant group compared to individuals within the susceptible group. 
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Figure 5.6. The fold-change of a sub-sample of transcripts determined by real-time 
quantitative RT-PCR (qPCR) of AGD resistant (n=14) and susceptible (n=l4) Atlantic 
salmon compared to naive Atlantic salmon and normalised to elongation factor 1 A8 . 
See Table 1 for acronym descriptions for transcripts. Standard errors represent the 
variation within the resistant group and within the susceptible group compared to naive 
Atlantic salmon smolt. Note, scale change on y-axis in part A and part B. 
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The transcripts involved in cell cycle control also showed differential expression in the 
AGD affected individuals relative to naive samples, albeit to a lesser degree than the 
acute phase proteins. Cyclin B showed decreased expression in both AGD resistant and 
susceptible Atlantic salmon relative to the naive individuals. In contrast, compared t? 
naive fish, the cyclin dependent kinase inhibitorp13 (CDK.I) showed a small up-
regulation in the resistant individuals and a down-regulation in the susceptible 
individuals. 
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5.4 Discussion 
Colonisation of the gill by Neoparamoeba perurans causes extensive morphological 
alterations of the gill structure (Adams and Nowak 2001). Although the mechanisms by 
which the parasite induces such a cellular response remain unclear, some individuals 
demonstrate a remarkable ability to resist these mechanisms (Taylor et al. 2007). The 
current study suggests that resistance to AGD is acquired following multiple infection 
events rather than being innately present. The molecular mechanisms influencing the 
ability of certain animals to acquire this resistance is a logical avenue worth exploring. 
The ability of Atlantic salmon to develop an adaptive immune response against AGD 
has been the subject of multiple studies (Findlay and Munday 1998; Gross et al. 2004b; 
Vincent et al. 2006). While the ability of Atlantic salmon to develop anti-
Neoparamoeba spp. antibodies appears unequivocal (Gross et al. 2004a), their 
functional relevance to AGD resistance has only recently been demonstrated (Vincent et 
al. 2006). The results obtained in our study- namely the up-regulation of certain 
adaptive immune related genes - support the hypothesis that AGD resistance may be 
associated with an adaptive immune response. Indeed, the up-regulation of transcripts 
resembling genes such as MH class II invariant chain-like protein and immunoglobulin 
light chain in the AGD resistant individuals may be an indicator of enhanced antigen 
presentation and immunoglobulin production within these animals. 
Acting as an MH class II chaperone, the class II associated invariant chain stabilises and 
promotes the exit of MH class II molecules from the endoplasmic reticulum to the 
endosomal pathway where non-self peptides can be bound (Lotteau et al. 1990). Mice 
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deficient in the expression ofMHC class II invariant chain generally demonstrate lower 
cell surface expression ofMHC class II (Viville et al. 1993). In addition to its role in 
antigen presentation, MH class II invariant chain can also stimulate B cell maturation 
(Matza et al. 2003). In our study both the AGD resistant and susceptible Atlantic 
salmon showed higher expression of the MH class II invariant chain-like protein 
compared to naive animals, although the expression in the susceptible individuals was 
only slightly greater than that of the naive individuals. As a result of inc~eased invariant 
chain expression, resistant individuals may have a superior ability to present 
Neoparamoeba derived antigens and stimulate B cell maturation, which would be 
expected to contribute to an enhanced immun~ response. 
Rehi.tive to both susceptible and non-infected naive animals, immunoglobulin light 
chain was up-regulated in the resistant fish. Furthermore, expression in susceptible fish 
was also slightly higher than that in naive animals. This result is in contrast to the 
expression of various transcripts resembling immunoglobulin -heavy chains, which upon 
first infection are down-regulated in AGD infected salmon (Young et al. 2008a). The 
increased expression of immunoglobulin in the AGD resistant animals could at ieast be 
partly a function of enhanced B cell maturation and subsequent immunoglobulin 
production. The up-regulation of CDS and granzyme Kin the resistant fish may also 
suggest a movement of cytotoxic T lymphocytes into the gills of AGD resistant fish. 
' 
Therefore, it is possible that the resistant fish are displaying both a humoral and cellular 
adaptive immune response to AGD. Further research concentrating on comparing the 
different cell types between the gills of AGD resistant and susceptible Atlantic salmon 
is required. 
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The acute phase response (APR) is central to the innate imnnu1:e system. In response to 
tissue injury or infection a dramatic increase or decrease of certain plasma proteins -
known as the acute phase proteins (APP)-will occur (Gabay and Kushner 1999). The 
I 
APR is initially stimulated by pro-inflammatory cytokines (IL-1, IL-6 and tumor 
necrosis factor alpha) which lead to the translocation of the transcription factors NF-KP 
and C/EBPp. Following sequential phosphorylation, the transcription factor C/EBPP is 
-
capable of binding to the promoter and in turn inducing the expression of many APP 
(Tang et al. 2005; Kim et al. 2007). Previous research in rainbow trout cells has 
demonstrated that stimulation with recombinant IL-1 p will increase the expression of 
C/EBP and certain other APP (Martin et al. 2007b ). The current study demonstrated 
higher expression oflL-lP and C/EBPP within those animals susceptible to AGD. 
Over-expression of the APP serum amyloid A, Clq complement component, DRTPl, 
transferrin and C-type lectin receptors A and B was also observed in the AGD 
susceptible animals compared to the resistant animals. 
In an earlier study we have reported that, upon first infection, Atlantic salmon 
demonstrate little or no APR to AGD relative to naive individuals (Wynne et al. 2008). 
The over-expression of genes encoding APP within the susceptible animals was 
therefore unexpected. It seems likely that the up-regulation of APR genes in the 
susceptible individuals may, to some extent, provide increased protection to AGD 
which allowed the individuals to survive until the trial termination, despite displaying 
significant pathology. The ability of an AGD affected animal to progress from this 
APR to an adaptive or acquired immune response, like that seen in the resistant 
individuals, may ultimately determine whether that individual will develop resistance to 
AGD. 
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Although AGD is a parasitic disease, it also has many hallmarks of a proliferative 
condition. Fish displaying advanced stages of AGD demonstrate considerable cellular 
proliferation within the gill. In addition to the dysregulation of immune related genes, 
the micro array analysis revealed a range of transcripts involved in the regulation of the 
cell cycle were also differentially expressed between AGD resistant and AGD 
susceptible Atlantic salmon. The commitment of cells to re-enter the cell cycle is 
controlled by a range of positive and negative factors. Positive factors, such as cyclins 
and their specific cyclin-dependent kinases (CDK), stimulate cell cycle progression 
(Malumbres and Barbacid 2001). Negative factors, such as cyclin-dependent kinase 
inhibitors (CDKI) and tumor suppressor loci, act to induce cell cycle arre~t. The 
microarray study demonstrated over-expression of two transcripts with high homology 
to cyclin B in the individuals susceptible to AGD compared to the resistant fish. 
However, closer examination with qPCR revealed that, when compared to non-infected 
naive animals, cyclin B expression was actually down-regulated in the resistant animals 
and furthermore showed little difference in expression in the susceptible fish. Although 
somewhat speculative, this down-regulation of cyclin B may in fact be mediated by the 
CDC14 homolog A phosphatase and the growth arrest and DNA-damage (GADD) 
proteins, which are both important antagonists of the cyclin B-CDKl complex (Kipreos 
2004; G~o et al. 2005) and were found to be more highly expressed in the AGD 
resistant Atlantic salmon. GADD has previously been reported to be down-regulated in 
AGD affected Atlantic salmon (Morns.on et al. 2006a). The suppression of cyclin B, 
through CDC14 and GADD, may be an important mechanism by which the resistant 
animals can limit the cellular proliferation associated with AGD. 
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Cell cycle arrest can also be induced through the up-regulation oftumor suppressor loci. 
Previous research has demonstrated that the tumor suppressor p53 is down-regulated in 
AGD affected Atlantic salmon (Morrison et al. 2006a). The current study demonstrates 
that three putative tumor suppressor loci, p13 CDKI (also known as CDKN2X), TSC-22 
(TFG~ stimulated clone-22) and neuroblastoma, suppression oftumorigenicity 1, were 
up-regulated in the AGD resistant Atlantic salmon compared to susceptible fish. 
Relative to non-infected naive Atlantic salmon, p13 CDKI was up-regulated in the 
resistant fish while it was down-regulated in susceptible fish. The p13 gene shares 
strong similarity with other members of the mammalian CDKN2 family of tumor 
suppressor loci, namely, CDKN2A (p16) and CDKN2B (p15) (Kazianis et al. 1999) and 
regulates the cell cycle progression by binding and inactivating CDK4 and CDK6. The 
higher expression oftumor suppressor loci in the AGD resistant animals is a likely 
mechanism responsible for limiting the cellular proliferation in resp~nse to the 
infection. 
B~ definition the resistant animals generally displayed few or no AGD lesions on the 
gill surface. In contrast, the susceptible individuals had a large number of lesions 
covering almost the entire gill surface. This means comparing resistant with susceptible 
animals was in fact aJso comparing lesioned with non-lesioned gill material. Lesion 
restricted expression of certain genes has been reported previously for AGD affected 
Atlantic salmon (Morrison et al. 2006a; Morrison et al. 2007; Young et al. 2008a). We 
therefore expected that some of the differentially expressed transcripts were simply 
caused by the different cell types present within a lesion rather than 
resistance/susceptibility per se. To further investigate this ~ituation we included naive 
individuals in the qPCR analysis. The expression of IL-1~ and Clq in the resistant fish 
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was almost identical to that of the naive. In contrast, the susceptible fish had 
considerably higher expression of IL-1 ~ and C 1 q compared to the naive individuals. 
This result suggests the up-regulation oflL-1~ and Clq is probably a consequence of 
infection, rather than a down-regulation in the resistant animals. Conversely, the 
expression of immunoglobulin light chain was highest in the resistant animals compared 
to naive, suggesting the expression of this transcript is indeed associated with 
resistance. 
lh conclusion, we report that the ability of Atlantic salmon to resist the effects of AGD 
is associated with dysregulation of genes involved in the cell cycle and the adaptive 
immune response. This study provides preliminary insights into what appears to be 
acquisition ofresistance to AGD. The challenge remains to fully elucidate the role that 
the adaptive immune response plays in this. Finally, the future identification of 
quantitative trait loci associated with these pathways may provide valuable insight into 
the host genetic influences controlling AGD resistance. This will facilitate a more 
effective exploitation of AGD resistance as a commercial selective breeding trait. 
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Chapter 6: Further investigation of the unknown transcript 
CK880278 
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Abstract 
Two previous transcriptome profiling experiments have identified one unknown 
transcript (accession number CK880278) which shows particularly high differential 
expression between naive and amoebic gill disease (AGD) affected Atlantic salmon. 
This chapter describes a study conducted to further investigate this transcript in an 
attempt to elucidate its possible function. Briefly, 3' and 5' rapid amplification of 
cDNA ends was performed to obtain the full length 675bp m.RNA sequence. Next, by 
means of semi-quantitative reverse transcription PCR, I examined the expression 
distribution in different organs of a naive Atlantic salmon smolt. Expression was 
observed in all organs examined, although highest in the anterior kidney and ~owest in 
the muscle and skin. In situ hybridisation of digoxigenin labelled RNA probe on gill 
sections from naive Atlantic salmon demonstrated that expression ~f this transcript is 
isolated to epithelial pavement cells within the gill. In contrast, in situ hybridisation on 
gill sections derived from AGD affected Atlantic salmon demonstrated high expression 
of this transcript in almost all proliferating cells within the AGD lesion. Despite 
obtaining the full length sequence the identity of this transcript could not be determined 
by the use of the basic local alignment search tool (BLAST). Three open reading frames 
were predicted, which ranged in size between 41 amino acids (aa) and 11 laa. In an 
attempt to identify the correct open reading frame, recombinant proteins for two of the 
three hypothetical protein sequences were generated. These proteins will be used ~ a 
later study to develop polyclonal antibodies for western blot analysis of Atlantic salmon 
crude lysate. In conclusion, this study describes the full length m.RNA sequence and 
expression characteristics of a transcript previously shown to be highly induced in AGD 
affected Atlantic salmon. Further research is required to determine which open reading 
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frame encodes the actual protein and what functional relevance this protein has on 
AGD. Completing this additional research was beyond the time constraints of my 
candidature. 
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6.1 Introduction 
AGD is a parasite mediated proliferative disease capable of affecting a range of ~ultured 
I 
teleosts (Munday et al. 2001 ). Caused by the protozoan Neoparamoeba perurans 
(Young et al. 2007; Young et al. 2008c), individuals affected by AGD display extensive 
hyperplasia of the gill epithelium (Adams and Nowak 2001; Young et al. 2008c):. The 
cellular proliferation in the gill is associated with a down-regulation of genes involved 
in apoptosis (Chapter 4), cell cycle inhibitors (Chapter 5) and tumor suppressor loci 
' ' 
(Morrison et al. 2006a). Genes involved in the major histocompatibility (MH) class I 
and class II pathways are also down-regulated within the lesions of AGD affected 
Atlantic salmon (Young et al. 2008a). The lll-echanism by which the amoebae are 
capable of mediating the cellular alterations associated with AGD remains unclear. 
Previous transcriptome profiling experiments have identified one transcript that displays 
significant up-regulation in response to AGD in both laboratory based challengettrials 
(Chapter 4) and natural AGD infections (Chapter 5). Compared to naive Atlantiq 
salmon, individuals infected by AGD demonstrated an up-regulation of this transcript 
by over 180-fold. In addition, individuals with higher disease severity display hi~her 
I 
expression of this transcript compared to individuals with low disease severity (Chapter 
4). Due to its considerable up-regulation, I hypothesise that this gene may have an 
I 
important role in AGD pathogenesis and is thus worthy of further investigation. I 
Unfortunately the identity of this transcript remains unknown. Interrogation of 
nucleotide collections such as databases maintained by the National Centre of 
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Biotechnology and Information (NCBI) reveal no homology to any known sequence. 
The clone was originally derived from an anterior kidney cDNA library produced by the 
Salmon Genome Project (SGP) (Adzhubei et al. 2007). It was subsequently included on 
the newly developed Transcriptome Analysis of Commercially Important Traits 
(TRAITS)/SGP cDNA microarray (Martin et al. 2007a). 
Determining the identity of a nucleotide sequence with no sequence homology to any 
previously reported sequence is difficult. Some of the major steps to achieve this 
objective are illustrated in Figure 6.1. The first step is to obtain the full length mRNA 
sequence, often undertaken using 3' and 5' rapid amplification of cDNA ends (RACE). 
BLAST may then be used to search for regions oflocal similarity between the queries 
sequences within various databases. If no sequence homology can be detected using 
BLAST, the next most important step is to determine ifthe nucleotide sequence actually 
encodes a functional protein. 
To determine if a particular sequence encodes a functional protein the open reading 
frame/s must first be identified through computational prediction. The hypothetical 
protein sequences are then used to develop recombinant proteins in either prokaryotic 
(most commonly in Escherichia coli) or eukaryotic cell lines. Despite certain post 
transcriptional modifications (especially in the prokaryote system) and engineered 
fusion tags, these recombinant proteins should imitate the actual functional protein as 
closely as possible. The recombinant proteins can then be used to immunise rabbits for 
the production of polyclonal antibody sera. These antibodies are subsequently used for 
western blot analysis against cell lysate derived from an organ or cell culture that is 
known to expresses this protein. 
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EST sequence 
Antibody production 
Expression stimulation 
Western blot analysis 
Knockout studies Protein stimulation 
\ .-1-ln-fe_r_f_u_n_ct-io_n__, 
Figure 6.1. Flow diagram of steps involved in the characterisation of the unknown EST 
CK880278. *represents steps completed in this study. The chapter sections describing 
each stage are indicated in parenthesis. 
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Although determining if the sequence encodes an actual protein is important, it provides 
little information regarding the possible function of the gene. For this pmpose it may be 
appropriate to examine the mRNA expression distribution in organs and cells and how 
this is affected by different stimuli (e.g. lipopolysaccharide ). This may help identify 
possible roles of the gene. 
To further elucidate the potential role functional studies are required. Silencing the gene 
expression through RNA interference (RNAi) is one such approach. Following the 
knockout or at least knockdown of expression the biological and transcriptional 
responses are assessed. The dysregulation of biological and transcriptional responses 
may provide some indication of the role of the gene. Another strategy is to use the 
recombinant protein to stimulate cell lines derived from the species under investigation. 
When combined with transcriptome profiling this strategy may prove useful to identify 
dysregulation of genes and pathways in response to the uncharacterised protein. This 
approach has been previously used to study the transcriptome response in salmonid cells 
to stimulation with both interleukin-Ip (IL-1 p) (Martin et al. 2007b) and interferons 
(Martin et al. 2007a). Despite the use of these strategies described above, it must be 
conceded that in many cases the role of a protein can ·simply not be determined with 
current molecular procedures. 
The present study describes the first steps taken to characterise the unknown transcript 
(accession number CK880278) previously identified through microarray experiments. 
More specifically, I first obtained the full length sequence and then examined its 
expression in the different tissues, including AGD affected gill tissue. Next, 
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recombinant proteins were generated against the predicted open reading frames and will 
be used to produce polyclonal antibodies for western blot analysis. Unfortunately due to 
time restraints, the full series of experiments required to assign a possible function to 
this gene could not be completed. This chapter is presented in a step-by-step structure 
where each experiment is presented and discussed in sequential order. The direction. of 
future research is considered at the conclusion of this .sequence. 
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6.2 Isolation of full length mRNA sequence 
6.2.1 Materials and Methods 
The full length mRNA sequence was obtained using 3' and 5' RACE. All gene specific 
primer sequences used in RACE were designed based on the EST sequence CK880278. 
To achieve 3' RACE 1 µg of total RNA from the gill of a single AGD affected Atlantic 
salmon was quantified with a Qubit fluorometer (Invitrogen, Mount Waverly, Australia) 
and reverse transcribed using superscript III reverse transcriptase (Invitrogen) and a 
custom oligo dT. This oligo, designated Race-dT, contains an adapter sequence on the 
5' end (Table 6.1). Reverse transcription was performed following the manufacturer's 
protocol (Invitrogen) with the additional RNase H digestion for 20 min at 37°C. The 
first round amplification was performed in a total volume of 50 µl containing 5 µl of 
1 OX buffer, 2.5 mM of MgClz, 500 µM of dNTPs, 400 µM of the gene specific forward 
primer (EST03G 12-20F), 400 µM of adapter reverse primer (Adapt-dT, Table 6.1), 2 
units of AmpliTaq-Gold (Applied Biosystems, Foster City, USA) and approximately 50 
ng (starting RNA) of template. Reactions were subjected to 10 min at 95°C followed by 
37 touchdown cycles of 95°C for 1min,60°C decreasing in 1°C increments every 2 
cycles for 1 min with an additional 5 cycles at 44°C,' 72°C for 3 min and a final 
elongation step of72°C for 7 min. Cycling was performed in an Eppendorfthermal 
cycler (Eppendorf, Hamburg, Germany). Resulting product was diluted 1:20 in water 
and subjected to a second round amplification using the gene specific primer, 
EST03G12-50F (Table 6.1), and the Adapt-dT primer. Reactions were performed in a 
total volume of 50 µl as above, however standard cycling of 9 5°C for 10 min, 3 5 cycles 
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Primer name 
Race-dT 
Adapt-dT 
EST03G12-9F 
EST03G12-20F 
EST03G12-50F 
EST03G12-37 4R 
EST03G 12-324R 
EST03G12-615R 
ORF111-F 
ORF111-R 
ORF71-F 
ORF71-R 
ORF41-F 
ORF41-R 
BACT-F 
BACT-R 
Primer sequence 5'- 3' 
CTGGAGATCGATGCGGCCGCTTTTTTTTTTTTTTTTT 
CTGGAGATCGATGCGGCCGC 
AGAACACCTGATTACTACAACCTTCA 
CCAGGACAATACCATCACTCATAC 
ACAAACAACTCCCAGAAAAACTG 
CCTACATTGATTACATTGTTGAATTCG 
GTAGCACTTTTTCACTTATCTGAGATG 
ACCTACATTGATTACATTGTTGAATTC 
CACCGAACACCTGATTACTACAACCTTCAA 
CTATGGTGATGCTGGGTGC 
CACCGATTGTGCTTCAACTGTCGTC 
TTAAGCGGTATGAGTGATGGTATT 
CACCGCTCTCTGTGACCTCATCGAA 
TCACTTTCTACTTGGAAGCCAGT 
TCTCTGGAGAAGAGCTAC 
TTAGAAGCATTTGCGGAG 
Table 6.1. Primers utilised in this study. The primer name and sequence is indicated. 
Nucleotides underlined represent bases required for Gateway directional cloning 
(Invitrogen). 
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of 95°C for 1 min, 55°C for 1 min and 72°C for 3 min and a final elongation step of 
72°C for 7 min was used. Resulting PCR product was visualised on agarose gel and 
then directly sequenced using the primer EST03G 12-50F (Table 6.1) and Adapt-dT 
with the Applied Biosystems BigDye Terminator Kit (Applied Biosystems) as per the 
manufacturer's protocol. Sequences were obtained using the ABI 3100 capillary 
sequencer (Applied Biosystems). 
To achieve 5' RACE the GeneRacer kit (Invitrogen) was used. Following quantification 
(Qubit fluorometer; Invitrogen), 2 µg of total RNA was dephosphorylated, decapped 
and 5'oligos ligated exactly as stipulated by the manufacturer's protocol. RNA was then 
reverse transcribed using superscript III (Invitrogen) as per the manufacturer's protocol. 
The first round amplification conditions were identical to the 3' RACE first round 
conditions (including the touchdown cycling). The gene specific reverse EST03G12-
374R primer (Table 6.1) and the commercial forward GeneRacer 5' primer were used. 
Resulting PCR product was diluted 1 :20 in water and a second round nested 
amplification was performed using the same PCR conditions as the first round. The 
gene specific reverse primer, EST03G12-324R (Table 6.1), and the commercial forward 
GeneRacer Nested 5' primer was used for the second round amplification. PCR product 
was cloned into pGEM-T easy (Promega, Annandale, Australia) following the 
manufacturer's protocol and six clones were sequenced using the T7 and Sp6 primers 
with the Applied Biosystems BigDye Terminator Kit (Applied Biosystems) and ABI 
3100 capillary sequencer (Applied Biosystems). 
Full length sequences were amplified using the primers EST03G12-9F and EST03Gl2-
615R. PCR was performed in a 50µ1 reaction containing 5µ1 of lOX buffer, 2 mM of 
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MgCh, 500 µM of dNTPs, 400 µM of the gene specific forward primer (EST-9F), 400 
µM ofreverse primer (EST-615R), 1µ1 of PfuUltra II Fusion HS DNA polymerase 
(Stratagene, La Jolla, USA). Reactions were first subjected to 2 min at 95°C and then 35 
cycles of 1 min at 95°C, 1 rilin at 56°C and 2 min at 72°C. A final extension step at 
72°C for 3 min was then used. PCR product was purified using the Qiagen MinElute 
system (Qiagen) as per the manufacturer's protocol. Six microliters of PCR product was 
A tailed to facilitate TA cloning. Brefily 6 µl of PCR product was incubated with 1 µl of 
lOX buffer, 10 µM of dATP, and- 5 units of Taq polymerase (Finnzyme, Espoo, 
Finland) at 70°C for 30 min. The PCR product was then cloned and 19 clones 
sequenced as described above. 
2.2 Results and Discussion 
The 3' RACE resulted in only the addition of poly (A) tail. However, the 5' RACE 
extended the sequence by 245bp to produce a maximum full length sequence of 675bp 
(not including the poly A) (Figure 6.2). Sequences derived from the six RACE clones 
showed some minor nucleotide variation. This variation was for the most part 
concentrated to base pairs 7-10 and a string of A bases at position 135-146. Considering 
a non-proof reading Taq polymerase was used for this RACE reaction it is likely some 
of these nucleotide variations were caused by Taq errors, especially at position 135-146. 
Primers to amplify the full length sequence were designed based on the conserved 
regions of these RACE clones. 
Amplification, cloning and sequencing of 19 full length clones demonstrated that two 
sequence variants (not including single nucleotide polymorphisms) were obtained when 
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Clonel ACG CGG G-- --A GAA CAC CTG ATT ACT ACA ACC TTC AAG CGC GCC ATC GCA TCG S4] 
Clone2 S4] 
Clone3 .G- S4] 
Clone4 . G- A .. S4] 
Clones . -A CT . S4] 
Clone6 . GA CT • S4] 
CK880278 S4] 
Clonel AGG AAG AAC ACA CAG ACA CAG CAA TGG ATT GTG CTT CAA CTG TCG TCA CTT CAC [108] 
Clone2 [108] 
Clone3 [108] 
Clone4 [108] 
Clones [108] 
Clone6 [108] 
CK880278 [108] 
Clonel ATA CCA ACA GCA AAA ACG ACT GCA ATA AAA AAA AA- -TG TGT TGC CCC ATG TCC [162] 
Clone2 [162] 
Clone3 [162] 
Clone4 •. A - [162] 
Clones .. A A .. [162] 
Clone6 [162] 
CK880278 [162] 
Clonel TAC TGA ATC AGG CAA AAA CAT ATC AGG TCA AAA CAT ATC AGG CCA AAA CAT ATC [216] 
Clone2 [216] 
Clone3 [216] 
Clone4 [216] 
Clones [216] 
Clone6 [216] 
CK880278 [216] 
Clonel AGG CCA AAA CAT ATC AGG CAG TGT GGG CGG AAG TAT TTC CAT TGG CAA CCA GGA [270] 
Clone2 [270] 
Clone3 [270] 
Clone4 [270] 
Clones [270] 
Clone6 [270] 
CK880278 [270] 
Clonel CAA TAC CAT CAC TCA TAC CGC TTA ACA AAC GAC TCC CAG AAA AAC TGT CGC ACC [324] 
Clone2 [324] 
Clone3 . G. A •. [324] 
Clone4 A •. [324] 
Clones A •. [324] 
Clone6 A .. [324] 
CK8B0278 A •. [324] 
Clonel CAG CAT CAC CAT AGC CAA CAT AAC AGG TGG CAA AGT GGG TCT CTA CTA CAA GGC [378] 
Clone2 [378] 
Clone3 [378] 
Clone4 [378'] 
Clones [378] 
Clone6 [378] 
CK880278 [378] 
Clonel AGA GAA GAT GGC TCT CTG TGA CCT CAT CGA AGG AAG TCA ACT CAG GAA GGG cc [431] 
Clone2 [431] 
Clone3 [431] 
Clone4 ... [431] 
Clones [431] 
Clone6 [431] 
CK880278 [431] 
Figure 6.2 Sequence alignment of six clones produced from 5 'RACE of the EST 
CK880278. The 5' region of the EST CK880278 is also shown. Dots indicate sequence 
identities to Clone 1 and dashes indicate gaps within the alignment. 
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using these primers. Seventeen of these clones were almost identical to the EST 
CK880278 at their 3' region (Figure 6.3). Two clones showed considerable nucleotide 
divergence to both the other 17 clones and the EST CK880278. Considering the . 
sequences derived from the 17 clones were almost identical to the 5' region of the EST 
CK880278 it seems most likely these clones represent the actual full length transcript of 
this EST. Given the sequence divergence of clones 7 and 19, these clones probably 
reflect non-specific amplification rather than a variant allele. Future research using 
southern blots will be required to confirm the presence of a single locus. 
The mRNA sequence contained a polyadenylation site and some putative AU-rich 
translation inhibitor elements. BLASTx analysis of the full length sequences against 
the non-redundant (nr) protein database maintained by the NCBI revealed only weak 
sequ~nce homology. The most significant BLASTx hit was to the hypothetical protein 
BURPS 171Ob_1.103 from the bacteria Burkholderia pseudomallei (E = 0.007). 
BLASTn against the NCBI nr nucleotide collection revealed no homology to any 
·sequence. However BLASTn against the NCBI EST database revealed significant 
homology (E = 0) to a number of Atlantic salmon EST sequences, almost all of which 
were assigned to the non-annotated UniGene cluster Ssa.25836. Interrogation of the 
tissue expression distribution of the 71 sequences comprising the UniGene cluster 
Ssa.25836 revealed this transcript is most highly expressed in the thymus, thyroid and 
anterior kidney of Atlantic salmon. The lack of significant BLAST results may suggest 
this transcript is either unique to Atlantic salmon, or more likely, shows extensive 
divergence to its ancestral ortholog. 
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Despite the lack of significant BLAST hits it is interesting to note that there is an EST 
sequence from Salvalinus fontinalis that is 94% similar and larger in size than 
CK880278 and when this sequence is analysed with BLAST it has a hit to a growth 
factor independent zinc finger protein (Gfi-1). The significance of this alignment is 
relatively low E = 5xlo-s compared to the threshold employed in the previous chapters 
and therefore makes the annotation more uncertain. 
172 
Clonel AGA ACA CCT GAT TAC TAC AAC CTT CAA GCG CGC CAT CGC ATC GAG GAA GAA CAC ACA GAC ACA GCA ATG GAT TGT GCT TCA ACT [ 84] 
Clone2 . . . . . . . . . . .. . . . . .. . .. . . . . .. . . . . .. . . . . .. . . . . .. . . . . .. . . . . .. . . . . .. ... . .. . .. . .. . .. . . . . . . [ 84] 
Clone3 . . . . . . . . . . . . . .. . .. . . . . . . . . . . .. . . . ... . .. . . . . .. . . . . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . . . [ 84] 
Clones . . . . . . .. . . . . . .. . .. . . . . . . . .. . . . . .. . . . . . . . . . ... . .. . . . . . . . .. . .. . . . . .. . .. . .. . .. . .. . . . . .. [ 84] 
Clone6 . . . .. . . .. . . . . . . ... . .. . . . . .. . .. . .. . .. . . . . .. . .. . . . . .. . .. . .. . .. . .. . .. . .. . .. . .. . . . . .. . . . [ 84] 
Clones . . . . . . . . . . . . . .. . .. . . . . . . . . . . . . . .. . .. . . . . .. . .. . . . . .. . . . ... . .. . . . . .. . .. . . . . .. . .. . . . . .. [ 84] 
Clone9 . . . . . . . . . . .. . . . . .. . . . . .. ... . .. . . . . .. . . . . .. . .. . . . . .. . . . . .. . . . . .. . .. . . . . .. . .. . .. . . . . .. [ 84] 
ClonelO . . . . . . . . . . . . . . . . . . . .. . . . . .. . . . . .. ... . . . . .. . .. . .. . . . . .. . .. . .. . . . . .. . .. . . . . .. . .. . .. . . . [ 84] 
Clonell . . . . . . . . . .. . . .. . .. . . . . . . . . . . .. . . . . .. . . . . .. ... . .. . .. . . . . .. . .. . . . . .. . .. . . . . .. . .. . . . . .. [ 84] 
Clonel2 . . . . . . . . . . .. . . . . .. . . . . .. ... . .. . . . . .. . . . . .. . .. . . . . .. . . . . .. . .. . . . . .. . .. . . . . .. . .. . . . . .. [ 84] 
Clone13 . . . . . . . . . . .. . . . . .. . .. . .. . .. . . . . .. . .. . . . . . . ... . . . . .. . .. . .. . .. . .. . .. . . . . .. . .. . . . . .. . . . [ 84] 
Clonel4 . . . .. . . . . .. . . .. . .. . . . . . . . . . . .. . . . . .. . . . . .. ... . .. . . . . .. . .. . .. . . . . .. . .. . . . . .. . .. . . . . .. [ 84] 
ClonelS . . . . . . . .. . . . . . . . .. . .. . . . ... . . . . .. . .. . . . . .. . .. . . . . . . . .. . .. . . . . .. . .. . .. . .. . .. . .. . .. . . . [ 84] 
Clonel6 . . . . . . . .. . . . . . . . .. . . . ... . .. . .. . .. . . . . .. . .. . . . . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . ... . . . [ 84] 
ClonelB .. . ... .. . . . . . .. . .. . . . . .. . .. . . . . . . . . . . . . . .. . .. . . . . .. . .. . . . . .. . .. . . . . .. . .. . . . . .. . .. [ 84] 
Clone4 . . . . . . . . . . .. . . . ... . .. . .. . .. . . . . .. . .. . . . . .. . .. . . . . . . . .. . .. . . . . .. . .. . .. . .. . .. . .. . . . . .. [ 84] 
Clonel7 .. . . . . . . . .. . . .. . .. . . . . . . . . . . .. . . . ... . .. . .. . .. . .. . . . . .. . .. . .. . . . . .. . .. . . . . . . . . . . . . . .. [ 84] 
Clonel9 . .. . . . . . . .. . . . . . . . . .. . . . .. GT .• . .. . .C T .. . c. . . . . .. ..G ... . .. . .. . .. -- --- -TA ATG .GA G.G GT . [ 84] 
Clone? . . . . . . .. . .. . . . . . .. . . . . . . •. GT .• . .. . .C T .. . c. . . . . . . . .G ... . .. . . . . .. .-- -CA .TA ATG .GA G.G GT . [ 84] 
CK880278 --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- [ 84] 
Clonel GTC GTC ACT TCA CAT ACC AAC AGC AAA AAC GAC TGC AAT AAA AAA AAA TGT GTT GCC CCA TGT CCT ACT GAA TCA GGC AAA AAC (168] 
Clone2 .. . ... . . . .. . . .. . .. . .. . .. . .. . .. . . . . .. . . . . .. . .. . . . . .. . .. . .. . .. . .. . .. . . . . .. . .. . .. . . . . . . (168] 
Clone3 . .. ... . . . . .. . . . . .. . .. . . . . .. . .. . . . . .. . . . . .. . .. . . . . . . . .. . .. . .. . .. . .. . .. . .. . .. . . . . .. . . . [168] 
Clones . .. . . . . . . .. . . .. . .. . . . . .. . . . . .. . .. ... . .. . .. . .. . . . . .. . . . . .. . .. . .. . .. . .. . . . . . . . .. . .. . . . [168] 
Clone6 . . . . . . . . . .. . . .. . . . . .. . . . . .. . . . . . . ... . .. . . . . .. . .. . . . . . . . .. . .. . .. . .. . .. . .. . .. . . . . .. . .. [168] 
Clones . . . .. . . . . . .. . . . . .. . .. . . . ... . .. . . . . .. . .. . .. . .. . . . . .. . .. . .. . .. . .. . .. . . . . .. . .. . . . . .. . . . [168] 
Clone9 . . . . .. . .. . . . . . . . .. . .. . . . ... . .. . .. . .. . .. . .. . .. . . . . .. . .. . .. . .. . . . . .. . .. . . . . .. . .. . . . . .. (168] 
ClonelO . . . . .. . . . . . . . . . . .. . . . . . . . . . . .. . . . ... . .. . .. . .. . .. . .. . . . . .. . .. . . . . .. . .. . . . . . . . . . . . . . .. (168] 
Clonell . . . ... . . . . .. . . . . .. . .. . .. . .. . . . . .. . .. . . . . .. . .. . . . . . . . .. . .. . . . . .. . .. . . . . .. . . . . . . . .. . . . (168] 
Clonel2 . . . . . . . . . . . . . .. . .. . . . . . . . . . . .. . . . ... . . . . .. . .. . . . . .. . . . . .. . .. . . . . .. . .. . . . . .. . .. . . . . .. [168] 
Clonel3 .. . . . . . . . . . . . .. . .. . . . . . . . . . . .. . . . ... . .. . .. . .. . .. . .. . . . . .. . .. . . . . .. . .. . . . . .. . .. . . . . .. [168] 
Clonel4 . .. . . . . . . .. . . .. . .. . . . . . . . . . . . . . .. ... . . . . .. . .. . . . . .. . . . . .. . .. . . . . .. . .. . .. . .. . . . . . . . .. [168] 
ClonelS . . . . . . . .. .. . . . . . .. . .. . . . ... . . . . .. . .. . . . . . . . .. . . . .. . . .. . .. . .. . .. . .. . .. . . . . .. . .. . . . . . . [168] 
Clonel6 . . . . . . . . . .. . . .. . .. . . . . . . . . . . .. . . . ... . . . . .. . .. . . . . .. . .. . .. . .. . . . . .. . .. . . . . . . . . . . . . . .. [168] 
Clonel8 . . . .. . . . . .. . . .. . .. . . . . . . ... . .. . . . . .. . . . . .. . .. . . . . .. . . . . .. . .. . . . . . . . . . . .. . .. . . . . .. . . . [168] 
Clone4 . . . . . . . . . . . . ... . .. . . . . .. . . . . .. . .. . . . . . . . .. . . . . .. . .. . .. . .. . . . . .. . .. . . . . . . . . . . . . . . . (168] 
Clonel7 .. . . . . . . . . . . . .. . .. . . . . .. . .. . . . . . . ... . .. . . . . . . . . . . . . . .. . .. . . . . .. . .. . .. . .. . .. . .. . .. . . . (168] 
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Clone9 . . . . . . . . . . .. . . . ... . .. . .. . .. . .. . .. . .. . . . . .. ... --- --- --- --- --- --- --- --- --- --- --- --- --- [672] 
ClonelO . . . ... . . . . .. . . . . .. . . . . .. . .. . . . . . . . . . . . . . . . . . . --- --- --- --- --- --- --- --- --- --- --- --- --- [672] 
Clonell ... . . . . . . . .. . . . . .. . .. . . . ... . .. . .. . .. . .. . .. . .. --- --- --- --- --- --- --- --- --- --- --- --- --- [672] 
Clone12 . .. . . . . . . . .. . . . . .. . .. . . . . .. . . . . .. ... . .. . .. . .. --- --- --- --- --- --- --- --- --- --- --- --- --- [672] 
Clone13 . .. ... . .. .. . . . . . .. . .. . . . . .. . . . . .. . .. . . . . . . . .. --- --- --- --- --- --- --- --- --- --- --- --- --- [672] 
Clone14 . . . . . . . . . . . . . .. . .. . . . . . . . . . . . . . . . ... . .. . . . . .. --- --- --- --- --- --- --- --- --- --- --- --- --- [672] 
ClonelS . . . .. . . .. . . . . . . . .. . .. . . . ... . .. . .. . .. . .. . . . . .. --- --- --- --- --- --- --- --- --- --- --- --- --- [672] 
Clone16 . . . . .. . . . . . . . .. ... . .. . .. . .. . . . . .. . .. . . . . .. . .. --- --- --- --- --- --- --- --- --- --- --- --- --- [672] 
ClonelS . . . ... . . . . . . . .. . .. . . . . .. . .. . . . . .. . .. . . . . .. . .. --- --- --- --- --- --- --- --- --- --- --- --- --- [672] 
Clone4 . . . . . . . . . .. . ..• T .• A •. . . . ... . .. . .. . .. . .. . . . . . . --- --- --- --- --- --- --- --- --- --- --- --- --- [672] 
Clone17 . . . ... . . . .. . •.• T •• A .. . .. . .. . . . . .. . .. . . . . .. . .. --- --- --- --- --- --- --- --- --- --- --- --- --- [672] 
Clone19 G.T G.G A.G CTA GCC AAG A .• GGA G.G .TC TGG G.G G .• • AG .AC GGG GTG GAT CAC AAC CCC AAA AAG TAA CGC CAC CAG GAA [672] 
Clone? G.T G.G A.G CTA GCC AAG A .. GGA G.G .TC TGG G.G G .. • AG .AC GGG GTG GAT CAC AAC CCC AAA AAG TAA CGC CAC CAG GAA [672] 
CKSS027S •.. . . . . . . . . . . . . . . . . . . . . . ... . .. . . . . .. . . . . .. •.. TTT TGA CAA AAA AAT AAA TGG TAC CAA ACT G-- --- --- [672] 
Figure 6.3. Continued over page 
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Clonel --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- [7S6] 
Clone2 --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- [7S6] 
Clone3 --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- [7S6] 
Clones --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- [7S6] 
Clone6 --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- [7S6] 
Clones --- --- --- -~- --- --- --- --- --- --- --- --- --- --- -~- --- --- --- --- --- --- --- --- --- --- --- --- --- [7S6] 
Clone9 --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- [7S6] 
ClonelO --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- [7S6] 
Clonell --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- [7S?J 
Clone12 --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- [7S6] 
Clone13 --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- [7S6] 
Clonel4 --- --- --- --- --- --- --- --- --- --- ---·--- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- [7S6] 
ClonelS --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- [7S6] 
Clone16 --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- [7S6] 
Clone18 --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- [7S6] 
Clone4 --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- [7S6] 
Clone17 --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- [7S6] 
Clone19 ACC TCC TGT ATC TTA ACA CCC TTT ATT AAT CAC AGA TTA AAC TAC ATA CAA ATT ATT GAT TAA AAA TAA AGA TAA GTG AAA TAG [7S6] 
Clone? ACC TCC TGT ATC TTA ACA CCC TTT ATT AAT CAC AGA TTA AAC TAC ATA CAA ATT ATT GAT TAA AAA TAA AGA TAA GTG AAA TAG [7S6] 
CK880278 --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- [7S6] 
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Figure 6.3. Sequence alignment of 19 full length clones of the EST CK880278. The 5' region of the EST CK880278 is also shown. Dots 
indicate sequence identities to Clonel and dashes indicate gaps within the alignment. 
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6.3 Protein prediction 
6.3.1 Materials and Methods 
ORF Finder (www.ncbi.nlm.nih.gov/gorD was used to predict the open reading frame/s 
of the full length transcript. Primers were then designed - based on the full length 
sequence - to amplify each of the predicted hypothetical proteins (Figure 6.4). The 
PROSITE 
1 ACGCGGGGAC TAGAACACCTitGATTACTA'CA'"'.ll.CCTTCAAGC GCGCCATCGC ATCGAGGAAG 
ORFlll-F 
61 AAcAcAcAGA cAcAGcAATG oA:i'tGlfGc'f'F:l'cKAtTG"fct;T""'cAcTTcAcAT AccAAcAGcA 
ORF71 - F 
121 AAAACGACTG CAATAAAAAA AAATGTGTTG CCCCATGTCC TACTGAATCA GGCAAAAACA 
181 TATCAGGTCA AAACATATCA GGCCAAAACA TATCAGGCCA AAACATATCA GGCAGTGTGG 
2 41 GCGGAAGTAT TTCCATTGGC AACCAGGAcr-x1J.'.Ac"c.Alfci(u~eJii.AccG"c'i' ,TSCAAACGA 
ORF71 - R 
301 CTCCCAGAAA AACTGTCGCA CCC:!\GCJl:TC' CC"'ATAGCCAA CATAACAGGT GGCAAAGTGG 
ORFl ll - R 
361 GTCTCTACTA CAAGGCAGAG AAGATG~C~£r(itftg,i~ru;&~:~ATCG~GGA AGTCAACTCA 
ORF41 - F 
421 GGAAGGGCCA CTCCATTCTC ATCCTGGAAA ACACCTTTAA GAAGACCCCT CTTCCTCCTC 
481 TATGTC~t~lfoC~~QJ\.1tGT~AG'.AAAGTG~C AATACATACA GATTAAACTA CATACAAATT 
ORF41-R 
541 ATTGATTAAA AATAAAGAGA GAATACATCT CAGATAAGTG AAAAAGTGCT ACAAGATATA 
601 CTTTGATTGT ATGGTCGAAT TCAACAATGT AATCAATGTA GGTTTTTGAC AAAAAAATAA 
661 ATGGTACCAA ACTGAAAAAA AAAAAAAAAA A 
Figure 6.4. Full length mRNA nucleotide sequence of the unknown EST CK880278. 
Sequence obtained by 5' RACE is underlined. Primer sequences used to amplify the 
predicted open reading frames are indicated by grey shading. 
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database (Falquet et al. 2002) was used to search for motifs and patterns within each of 
the hypothetical protein sequences. 
6.3.2 Results and Discussion 
Three potential open reading frames were predicted in the forward orientation (Figure 
6.5). These predicted protein sequences were 1 llaa, 71aa and 41aa in length. The 1 llaa 
sequence contained no start codon, while both the 71 and 41 aa sequences contained 
start and stop codons. BLASTp analysis of each open reading frame against the NCBI 
nr protein database revealed no significant homology, likewise a conserved domain 
(CD) BLAST search also suggested no CDs were present within the predicted protein 
sequences. 
The short length of all predicted hypothetical protein sequences'- with one containing 
no start codon - raised some concern regarding whether the actual full length mRNA 
sequence had been obtained through RACE. To address this concern, I repeated the 
5' RACE, this time using the SMART™ RACE kit (Clontech Laboratories, Mountain 
View, USA) as per the manufacturer's protocol. The full length sequence obtained from 
this kit (data not shown) was identical to the sequence obtain using the GeneRacer kit 
(Figure 6.2). I therefore concluded that the full length mRNA is indeed a 675bp 
fragment. 
A number of phosphorylation and glycosylation sites were predicted across the 
hypothetical protein sequences (Figure 6.5). The 71aa hypothetical protein also 
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Figure 6.5 A 
ACG CGG GGA CTA GAA CAC CTG ATT ACT ACA ACC TTC AAG CGC GCC ATC GCA TCG AGG AAG 60 
T R G L E H L r T T tr F aj R A r A Is R aj 20 
AAC ACA CAG ACA CAG CAA TGG ATT GTG CTT CAA CTG TCG TCA CTT CAC ATA CCA ACA GCA 120 
N T Q T Q Q W I V L Q L S S L H I P ~ 40 
AAA ACG ACT GCA ATA AAA AAA AAT GTG TTG CCC CAT GTC CTA CTG AAT CAG GCA AAA ACA 180 
[El T T A I K K N V L P H V L L N Q A K T 60 
TAT CAG GTC AAA ACA TAT CAG GCC AAA ACA TAT CAG GCC AAA ACA TAT CAG GCA GTG TGG 240 
Y Q V K T Y Q A K T Y Q A K T Y Q A V W 80 
GCG GAA GTA TTT CCA TTG GCA ACC AGG ACA ATA CCA TCA CTC ATA CCG CTT AAC AAA CGA 300 
A E V F P L A T R T I P S L I P L N K R 10 0 
CTC CCA GAA AAA CTG TCG CAC CCA GCA TCA CCA TAG 336 
L P E K L S H P A S P * 111 
CCAACATAACAGGTGGCAAAGTGGGTCTCTACTACAAGGCAGAGAAGATGGCTCTCTGTGACCTCATCGAAGGAAGTCA 415 
ACTCAGGAAGGGCCACTCCATTCTCATCCTGGAAAACACCTTTAAGAAGACCCCTCTTCCTCCTCTATGTCACTGGCTT 494 
CCAAGTAGAAAGTGACAATACATACAGATTAAACTACATACAAATTATTGATTAAAAATAAAGAGAGAATACATCTCAG 573 
ATAAGTGAAAAAGTGCTACAAGATATACTTTGATTGTATGGTCGAATTCAACAATGTAATCAATGTAGGTTTTTGACAA 652 
AAAAATAAATGGTACCAAACTG (A)n 675 
Figure 6.5 B 
ACGCGGGGACTAGAACACCTGATTACTACAACCTTCAAGCGCGCCATCGCATCGAGGAAGAACACACAGACACAGCA 77 
ATG GAT TGT GCT TCA ACT GTC GTC ACT TCA CAT ACC AAC AGC AAA AAC GAC TGC AAT AAA 137 
M o c A s T v v T s H T N Is K N tj c N K 20 
AAA AAA TGT GTT GCC CCA TGT CCT ACT GAA TCA GGC AAA AAC ATA TCA GGT CAA AAC ATA 197 
K K c v A P c P T E Is G aj N r s G N r 40 
TCA GGC CAA AAC ATA TCA GGC CAA AAC ATA TCA GGC AGT GTG GGC GGA AGT ATT TCC ATT 257 
G Q N I S G Q N I S G S V G G S I S 60 
GGC AAC CAG GAC AAT ACC ATC ACT CAT ACC GCT TAA 293 
G N Q D N T I T H T A * 71 
CAAACGACTCCCAGAAAAACTGTCGCACCCAGCATCACCATAGCCAACATAACAGGTGGCAAAGTGGGTCTCTACTACA 372 
AGGCAGAGAAGATGGCTCTCTGTGACCTCATCGAAGGAAGTCAACTCAGGAAGGGCCACTCCATTCTCATCCTGGAAAA 451 
CACCTTTAAGAAGACCCCTCTTCCTCCTCTATGTCACTGGCTTCCAAGTAGAAAGTGACAATACATACAGATTAAACTA 530 
CATACAAATTATTGATTAAAAATAAAGAGAGAATACATCTCAGATAAGTGAAAAAGTGCTACAAGATATACTTTGATTG 609 
TATGGTCGAATTCAACAATGTAATCAATGTAGGTTTTTGACAAAAAAATAAATGGTACCAAACTG(A)n 675 
Figure 6.5. Continued over page 
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Figure 6.5 C 
ACGCGGGGACTAGAACACCTGATTACTACAACCTTCAAGCGCGCCATCGCATCGAGGAAGAACACACAGACACAGCAAT 79 
GGATTGTGCTTCAACTGTCGTCACTTCACATACCAACAGCAAAAACGACTGCAATAAAAAAAAATGTGTTGCCCCATGT 158 
CCTACTGAATCAGGCAAAAACATATCAGGTCAAAACATATCAGGCCAAAACATATCAGGCCAAAACATATCAGGCAGTG 237 
TGGGCGGAAGTATTTCCATTGGCAACCAGGACAATACCATCACTCATACCGCTTAACAAACGACTCCCAGAAAAACTGT 316 
CGCACCCAGCATCACCATAGCCAACATAACAGGTGGCAAAGTGGGTCTCTACTACAAGGCAGAGAAG 383 
ATG GCT CTC TGT GAC CTC ATC GAA GGA AGT CAA CTC AGG AAG GGC CAC TCC ATT CTC ATC 443 
M A L C D L I E G S Q L R K G H S I L I 20 
CTG GAA AAC ACC TTT AAG AAG ACC CCT CTT CCT CCT CTA TGT CAC TGG CTT CCA AGT AGA 503 
L E N IT F aj K T p L p p L c H w L p ~ 40 
AAG TGA 509 
[] * 41 
CAATACATACAGATTAAACTACATACAAATTATTGATTAAAAATAAAGAGAGAATACATCTCAGATAAGTGAAAAAGTG 588 
CTACAAGATATACTTTGATTGTATGGTCGAATTCAACAATGTAATCAATGTAGGTTTTTGACAAAAAAATAAATGGTAC 667 
CAAACTG (A) n 
Figure 6.5. Full length cDNA sequence of the unknown transcript. The predicted open 
reading frames representing the 11 laa (A), 71aa (B) and 4laa (C) sequences are 
indicated. Predicted phosphorylation sites are represented by boxes. Predicted 
glycosylation sites are underlined. Six consecutive N-myristoylation sites are shown in 
shaded grey text. The polyadenylation site is indicated by bold text. 
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contained six consecutive N-myristoylation sites. These sites were isolated to a 
pentapeptide repeat region located at the c-terminus of the- sequence. Despite these 
predictions, the motifs are generally too non-specific to provide any clue regarding the 
function of these hypothetical proteins. 
6.4 Organ expression distribution 
6.4.1 Materials and Methods 
Semi-quantitative reverse transcription PCR (RT-PCR) was conducted to- examine the 
expression of the transcript in different organs. Organ samples were dissected from the 
gill, brain, skin, anterior kidney, muscle, liver, heart, intestine and spleen of a single 
naive Atlantic salmon smolt. Samples were stored in RNAlater (Ambion, Austin, USA) 
at -80°C following dissection. For each sample approximately 100 mg of tissue was 
homogenised in TRI-reagent (Ambion) using a Quicklyse tissue homogeniser (Qiagen, 
Doncaster, Australia). Total RNA was then isolated using the RiboPure™ kit according 
to the manufacturer's protocol (Ambion). Following isolation, RNA was treated with 
rDNase I from the DNA:free ™kit (Ambion). The quantity and quality of total RNA 
was estimated by examining the 260:280 nm absorbance ratio (Nanodrop Technologies, 
Delaware, USA). 
A total of 500 ng of RNA was reverse transcribed using superscript III reverse 
transcriptase in a 20 µl reaction as per the manufacturer's protocol (lnvitrogen). The 
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resulting cDNA was diluted to 10 ng (starting RNA) µl -I with nuclease free water. The 
unknown transcript was amplified using the primers ORFl 11-F and ORFl 11-R (Table 
6.1). The housekeeping gene ~-actin was also amplified using the primers BACT-F and 
BACT-R (Table 6.1 ). PCR parameters were identical for both ~-actin and the unknown 
transcript. Reactions were performed in 50 µl containing 5 µl of 1 OX buffer, 2.5 mM 
MgCh, 500 µM of dNTPs, 400 nM of forward and reverse primer, 2 units of AmpliTaq-, 
Gold (Applied Biosystems) and 50 ng of cDNA template. Amplification was conducted 
in an Eppendorf thermal cycler (Eppendorf) using the following cycling profile: 10 min 
at 95°C, 30 cycles of 1 min at 94°C, 1 min at 56°C and 2 min at 72°C. Amplicons were 
electrophoresed on 2% TAE (Tris-acetate-EDTA) agarose gel containing lX SYBR 
Safe™ DNA gel stain (Invitrogen) and visualised on a Safe Imager™ Blue-Light 
transilluminator (Invitrogen). 
6.4.2 Results and Discussion 
Semi-quantitative RT-PCR was conducted to compare the expression oflhe unknown 
transcript in different organs of naive Atlantic salmon smolt. This analysis revealed that 
the expression was evident although variable between all organs. The highest 
expression was observed in the anterior kidney (Figure 6.6), however moderate 
expression was also observed in the spleen, gill and heart. The lowest expression was 
observed in the muscle and skin. 
Since this transcript was originally derived from an anterior kidney cDNA library 
(Adzhubei et al. 2007), it was not surprising it should demonstrate high expression in 
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figure 6.6. Expression of the unknown transcript (EST) assessed by semi-quantitative 
RT-PCR in various tissues derived from a single naive Atlantic salmon smolt. The 
expression of P-actin is shown to confirm equal loading. No template controls (NT_C) 
are also presented. 
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this organ. It is however interesting that while expression is highest in the anterior 
kidney in naive animals, no differential expression is observed in this organ when 
individuals are infected by AGD (Chapter 4). Differential expression is restricted to the 
site of infection, the gill (Chapter 4). The expression profile of the 74 EST sequences 
comprising the Uni Gene cluster Ssa.25836 demonstrated that expression is highest in 
the thymus, thyroid and anterior kidney. This result is in agreement with my 
experimental results described above. 
6.5 Cellular expression distribution 
6.5.1 Materials and Methods 
In situ hybridisation was used to examine the expression of the unknown EST in the 
gills of naive and AGD affected Atlantic salmon. RNA probes were generated using in 
vitro transcription with digoxigenin (DIG) labelled UTP (Roche Applied Science, 
Penzberg, Germany). Briefly, a 216bp fragment was amplified using the primers 
ORF71-F and ORF71-R (Table 6.1) and parameters described above. PCR products 
were cloned into pGEM-T easy (Promega)· and plasmid was isolated from a single 
colony- grown overnight - using the Quick Lyse Miniprep kit (Qiagen). Orientation 
was confirmed by sequencing with T7 and Sp6 primers and the Applied Biosystems 
BigDye Terminator Kit (Applied Biosystems). Plasmid was quantified (Nanodrop 
Technologies) and 3.15 µg were linearised with either 50 units of Ncol or Spel (New 
England Biolabs, Ipswich, USA) at 37°C for 17 hours. Linearised plasmid was purified 
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using phenol:chloroform extraction and ethanol precipitation. "Run off' transcripts 
were produced using the DIG RNA labelling in vitro transcription kit (Roche Applied 
Science) exactly as per the manufacturer's protocol. Anti-sense probe was generated 
using the Ncol digested template and the Sp6 RNA polymerase. Sense probe (negative 
control) was generated using the Spel digested template and T7 RNA polymerase. RNA 
probes were quantified using the Qubit fluorometer (Invitrogen) and diluted to 5 ng µr 1 
in nuclease free water. 
Two AGD affected and two muve Atlantic salmon smolts were obtained from 
laboratory tank systems at the University of Tasmania. The second left anterior 
hemibranch was dissected and fixed for 15 hours at 4 °C in phosphate buffered saline 
(PBS; pH 7.4) containing 4% paraformaldehyde. Tissues were dehydrated with graded 
ethanol, cleared in xylene and embedded in paraffin wax. Seven micrometer sections 
were cut and m.ounted on Poly-Prep™ slides (Sigma-Aldrich, St Louis, USA). Sections 
were de-waxed in xylene, rehydrated in graded ethanol (100%-70%) and washed twice 
in diethylpyrocarbonate (DEPC)-treated water for 5 min. Slides were incubated twice 
for 10 min in DEPC-treated PBS (pH 7.4) and then twice for 10 min in DEPC-treated 
PBS (pH 7.4) containing 100 mM glycine. Sections were incubated for 15 min in 
DEPC-treated PBS (pH 7.4) containing 0.1 % Triton X-100 (Sigma-Aldrich). Sections 
were washed twice for 5 min each in DEPC-treated PBS (pH 7.4) and then 
permeabilised with 5 µg ml-1 Proteinase K (New England Biolabs) in DEPC-treated TE 
(10 mM Tris, 1 mM EDTA, pH 8.0) for 30 min at 37°C. Sections were pos~-fixed for 5 
min at 4°C with DEPC-treated PBS (pH 7.4) containing 4% paraformaldehyde. Slides 
were again washed twice (5 min each) with DEPC-treated PBS (pH 7.4) and then 
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acetylated twice with 0.1 M triethanolamine (Sigma-Aldrich) cont~ining 0.25% acetate 
anhydride (Sigma-Aldrich) for 5 min each. 
Next, sections were pre-hybridised with a solution. of 50% HiDi (deionised formamide; 
Applied Biosystems) and 4X SSC at 37°C for approximately 30 min. Pre-hybridisation 
solution was removed and sections were overlayed with 60 µl of denatured (80°C for 10 
min) hybridisation solution containing 40% HiDi (Applied Biosystems), 4X SSC, lX 
Denhardt's solution (Sigma-Aldrich), 10 mg mr1 yeast tRNA (Sigma-Aldrich), 10 mM 
DTT (Invitrogen), 10% dextran sulfate (Sigma-Aldrich), 10 mg mr1 fish sperm DNA 
(Roche Applied Science) and 25 ng of sense (control) or anti-sense probe. 
Hybridisations were performed at 42°C for 15 hours. Coverslips were removed and 
sections were washed twice in 2X SSC for 15 min at room temperature, twice in lX 
SSC for 15 min at 42°C and finally twice in 0.5X SSC for 15 min at 52°C. 
Unbound RNA probe was digested with 20 µg mr1 RNase A (New England Biolabs) in 
NTE buffer (500 mM NaCl, 10 mM Tris, 1 mM EDTA, pH 8.0) for 30 min at 37°C. 
Following digestion, sections were washed twice in O.lX SSC for 30 min each. 
- Sections were washed twice in buffer 1 (100 mM Tris, 150 mM NaCl, pH 7.5) for 10 
min each and then blocked in buffer 1 containing 0.1 % Triton X-100 (Sigma-Aldrich) 
and 2% sheep serum (Sigma-Aldrich) for 50 min. Blocking solution was removed and 
sections were incubated for 2 hours in buffer 1 containing 0.1 % Triton X-100 (Sigma-
Aldrich), 1 % sheep serum (Sigma-Aldrich) and a 1: 1000 dilution of anti-DIG alkaline 
phosphatase antibody (Roche Applied Science). Sections were washed twice for 10 min 
in buffer 1 and then incubated in buffer 2 (100 mM Tris, 100 mM NaCl, 50 mM MgClz, 
pH 9.5) for 10 min. Sections were in~ubated in BCIP/NBT solution (Sigma-Aldrich) for 
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15 hours. Colour development was stopped by rinsing slides in TE (pH 8.0). Sections 
were counter-stained for 5 min with nuclear fast red (Sigma-Aldrich) and washed twice 
in water. Sections were dehydrated through graded ethanol (70-100%),'cleared in 
xylene and mounted. 
6.5.2 Results and Discussion 
In situ hybridisation of the gill of naive Atlantic salmon suggested expression is 
restricted to the epithelial pavement cells within the gill (Figure 6. 7 A). In contrast, the 
gill of AGD affected Atlantic salmon displayed highest expression within the 
proliferating cells of the lesion (Figure 6.7B, 6.7D). Hybridisation with sense control 
probe revealed little or no staining (Figure 6.7C). 
Staining of the epithelial pavement cells in the naive animals resembled the results 
obtained from previous studies which examined the location of chloride cells in naive _ 
Atlantic salmon gills (Adams and Nowak 2003). However, unlike the latter study, the 
number of cells expressing this unknown transcript increased considerably in the AGD 
lesion. In contrast, large hyperplastic lesions showed a relatively low number of 
chloride positive cells (Adams and Nowak 2003). Previous research has shown that 
almost all cells in a hyperplastic AGD lesion express proliferating cell nuclear antigen 
(PCNA) (Morrison et al. 2006a). Likewise, my study found all proliferating cells with 
the AGD lesion were expressing the unknown transcript. The num~er of cells 
expressing immune genes such as MH class II (Morrison et al. 2006b) and 
immunoglobulin (Gross 2007) are variable in AGD lesions and are not expressed in all 
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Figure 6. 7. In situ hybridisation of naive and AGD affected gill tissue. In naive Atlantic 
salmon staining appears to be isolated to the epithelial pavement cells of primary 
lamellae (A), indicated by arrow. In the AGD affected gill tissue extensive staining was 
observed throughout the lesions (B). Little or no staining was observed when the sense 
control probe was hybridised to AGD affected gill tissue (C) indicated by arrow. 
Almost all proliferating cells within the AGD lesion appeared to express this transcript 
(D). 
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proliferating cells. Although somewhat speculative, the fact that the cellular expression 
of the unknown transcript more closely resembling that of PCNA may suggest this 
transcript is involved in cell proliferation pathways. 
Given the in situ hybridisation, results it also seems plausible that the significant up-
regulation of this transcript may be an artefact caused by the cell proliferation within the 
AGD lesion. For instance, if this transcript is constitutively expressed in naive epithelial 
pavement cells which then undergo proliferation upon AGD infection, the expression 
would appear to increase simply because there are more cells expressing this transcript 
in the infected compared to non-infected gill material. Under this hypothesis the 
transcript may represent a housekeeping gene which is specific to epithelial pavement 
cells. 
6.6 Recombinant protein expression 
6.6.1 Materials and Methods 
Recombinant proteins were produced for the three predicted open reading frames (open 
reading frame 41, 71 and 111 ). From a single Atlantic salmon the three open reading 
frames were amplified using the primers ORFl 11-F and ORFl 11-R for the 11 laa open 
reading frame, ORF71-F and ORF71-R for the 71aa open reading frame, and ORF41-F 
and ORF-41-R for the 41aa open reading frame (Table 6.1). PCR parameters are 
described within section 6.4 Organ expression distribution. Amplicons were purified 
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with the QIA Quick PCR Purification kit (Qiagen) and cloned into pENTR-D-TOPO 
(Invitrogen) as per the manufacturer's instructions. Plasmid was isolated from a single 
colony- grown overnight - using the Quick Lyse Miniprep kit (Qiagen). Constructs 
were sequenced with M13F and M13R primers and the Applied Biosystems BigDye 
Terminator Kit (Applied Biosystems) to confirm orientation. An LR Clonase™ 
recombination reaction was then performed between the pENTR-D-TOPO construct 
and the expression vector pDEST-17 (Invitrogen) as per the manufacturer's 
instructions. Expression plasmids were isolated from successful recombinants using the 
Quick Lyse Miniprep kit (Qiagen) and sequenced with T7 and gene specific reverse 
(ORFl 11-R, ORF71-R, ORF41-R) primers. 
Protein expression was optimised by the Protein Production Unit at Monash University. 
This optimisation consisted of testing a range of different E. coli strains for protein 
expression. All constructs were transformed into the appropriate cell line and 
transformants were selected on Luria-Bertani (LB) agar containing 100 µg ml-1 
ampicillin (Sigma-Aldrich). Single colonies were picked and grown in autoinduction 
media (Novagen, Darmstadt) with ampicillin for 24 hours at 20°C. Cultures were then 
lysed with Popculture (Novagen) and lysonase (Novagen). The lysed cells were applied 
to a vacuum filter membrane which separates soluble (flow-through) with insoluble 
(bound to membrane) proteins. The membrane bound insoluble fraction was then 
solubilised through the addition of 4% SDS and eluted under vacuum. 
Proteins were separated on a 4-15% BIS-Tris gel (Invitrogen) and transferred to a 
nitrocellulose membrane (Bio-Rad, Hercules, USA) overnight. The membrane was 
washed twice for 5 min each with TBS (Tris buffered saline) containing 0.1 % tween 
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(Sigma-Aldrich). Western blot analysis was then performed using the Westembreeze 
chromogenic immunodetection kit and 1: 1 OOO dilution of monoclonal anti-penta HIS 
antibody (Qiagen) exactly as per the manufacture's protocol (Invitrogen). 
6.6.2 Results and Discussion 
The expression of recombinant proteins representing the three predicted open reading 
frames was conducted using E. coli (Figure 6.8). Successful expression was achieved 
for the 11 laa and 71aa proteins. No expression of the 41aa could be detected with any 
cell line tested. Interestingly, western blot analysis of the cells transformed with the 
41aa construct did suggest a HIS tag protein of approximately 90 kDa in size was 
expressed. This however was significantly larger than the predicted 7 kDa size. Further 
optimisation will be required to express the 41 aa recombinant protein. Both the 111 aa 
and 71aa recombinant proteins were successfully detected using western blot analysis 
with an anti-HIS antibody. 
The 71aa recombinant proteins were expressed highest in the Rosetta-gami B (DE3) cell 
line while the 11 laa recombinant protein was most highly expressed in the BL21 (DE3) 
RP cell line. The 11 laa protein was only expressed in the insoluble cellular fraction. 
This was possibly caused by a failure of the protein to reach native conformation which 
can lead to the formation of insoluble inclusion bodies and/or degradation via multiple 
proteases. In contrast, the 71 aa protein showed high expression in the soluble fraction. 
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Figure 6.8. Western blot of recombinant HIS fusion tagged proteins. Lanes L: protein 
standard (protein sizes, kDa, are indicated to the right). Lane 1: 111 aa recombinant 
protein indicated by arrow. Lane 2: 71aa recombinant protein indicated by arrow. Lane 
3: 41 aa recombinant protein not detected by western blot analysis arrow indicates 
predicted protein size. 
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This result suggests that the 71aa open reading frame can indeed encode a peptide 
capable of correct native confirmation. This provides some evidence to suggest the 71aa 
open reading frame - rather than the 111 aa or 41 aa open reading frames - encodes the 
functional protein from this unknown gene. It must however be conceded that post-
translational modifications in E. coli are different to those of a eukaryote such as 
Atlantic salmon and further experimentation is required. 
6. 7 Future directions 
Although this study has performed the first steps in characterising this transcript, 
considerable research is still required. The most pressing aspect is to determine which 
open reading frame, if any, encodes the functional protein. To achieve this large scale 
production of the two recombinant proteins and further optimisation of the 41 aa protein 
is currently bemg undertaken. I plan to use these recombinant proteins to produce three 
polyclonal antibodies in rabbits, which will be used to perform western blot analysis on 
Atlantic salmon crude lysate. This will allow me to determine which open reading 
frame encodes the functional protein. If the correct protein sequence can be determined, 
I will then use recombinant proteins to stimulate the Atlantic salmon SHK-1 cell line 
and a gill derived cell line, and profile the response using microarrays. This approach 
has been used successfully to study the role of type I and II interferons (Martin et al. 
2007a) and the proinflammatory cytokine IL-lP (Martin et al. 2007b) and may provide 
some insight into the function of this protein. The use ofRNAi to silence this transcript 
is also planned as future research. Considering this transcript is so highly induced 
during AGD, I propose conducting an experiment in which I silence this transcript in 
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vivo in Atlantic salmon and then challenging the animals (with appropriate controls) 
with AGD to assess the survival response. Gene expression profiling may also be used 
to assess the transcriptome response both before and after challenge. 
To conclude, this study has taken the first steps to further characterise an unknown 
transcript which displays significant up-regulation in, the gill of AGD affected Atlantic 
salmon. Despite the investigation undertaken within this study considerable research is 
still required before a putative function for this transcript could be assigned. 
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Chapter 7: General discussion 
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Preamble 
. - -
AGD is the most significant health issue affecting the culture of Atlantic salmon in 
Tasmania and is of increasing concern in other salmon farming areas (Steinum et al. 
2008). Progress towards reducing the impact of AGD is ongoing. The primary research 
foci in Tasmania are the development of a vaccine and selective breeding for AGD 
resistance. Understanding the molecular mechanisms of AGD resistance would / 
significantly enhance both programs. For instance, the development and integration of 
marker assisted selection (MAS) into the Tasmanian Atlantic salmon selective breeding 
program has the potential to significantly increase the genetic gains obtained from this 
program. Indeed, simulation of two-generation within-family aquaculture MAS 
schemes have indicated that increased genetic gains 'can be achieved through MAS 
selective breeding compared to conventional breeding (Sonesson 2007b ). The enhanced 
genetic gain in the MAS scheme was caused by an increasing frequency of the positive 
quantitative trait loci (QTL) allele within the population (Sonesson 2007b). 
MAS is particularly suitable as a selection strategy for AGD resistance within the 
Tasmanian Atlantic salmon selective breeding program. This is because current 
biosecurity protocols within Tasmania restrict the transfer of potential broodstock from 
the marine grow-out sites back to the freshwater hatcheries. Thus the majority of 
broodstock are never actually exposed to the marine environment or to the causative 
agent of AGD. In this situation selection must be made on sibling information, rather 
than actual broodstock performance. Considering the within-family variation of many 
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traits, selection based on genotype, rather than sibling phenotype, would significantly. 
increase the accuracy of selection. 
In this discussion I will consider the major findings of each research chapter and their 
implications for the development of genetic markers linked to AGD resistance. I will 
conclude by proposing future research directions arising from this research project. 
7 .1 ffigh MH class II variation contrasts diversity in non-coding loci 
The previous reports of reduced genetic variation in the Tasmanian Atlantic salmon 
population (Elliott and Reilly 2003; Innes and Elliott 2006) raised some concern 
regarding the amount of diversity that may be present in functional loci such as the 
immune related major histocompatibili~y (MH) genes. I therefore considered it would 
be prudent to examine the amount of MH variation in this population before 
investigating the relationship between MH polymorphism and AGD resistance. The 
results reported in Chapter 2 demonstrated that a high level of MH class II variation h~s 
been retained in the Australian Atlantic salmon population, despite previous reports of 
reduced non-coding genetic variation (Elliott and Reilly 2003; Innes and.Elliott 2006). 
These results suggested adequate variation was present at the MH class II genes to 
warrant the investigation of the association between MH polymorphism and AGD 
resistance. 
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7 .2 Significance of a weak association between MH class II Sasa-DAA 
polymorphism and AGD resistance. 
Chapter 3 describes a weak, yet statistically significant, association between the 
presence/absence of the MH class II Sasa-DAA-3UTR allele 239 and increased 
resistance to AGD. A significant association was also detected between the Sasa-DAA-
3UTR genotypes 239-259 and 259-259 and increased resistance to AGD. The need for 
caution in the int¥rpretation of these associations has been discussed previously, but to 
reiterate, these associations should be considered as suggestive ra~er than conclusive 
until validated by further research. Further research should concentrate on verifying the_ 
association in a larger sample size across a range of genetic backgrounds. As a 
consequence of this uncertainty, these associations cannot be considered for use within 
a MAS program in their present form. The main limitations surrounding this research 
are described below. 
7.2.1 Limitations of the Sasa-DAA-3UTR and Sasa-UBA-3UTR loci 
A number of strategies have been utilised to assess variation within the MH, including 
single strand confirmation polymorphism (Palti et al. 2001), denaturing gradient gel 
electrophoresis (Miller et al. 2004) and restriction fragment length polymorphism 
(Langefors et al. 2000). However, the identification and characterisation of the micro 
and minisatellite markers in the 3' UT (untranslated) regions of Sasa-UBA (Grimholt et 
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al. 2002) and Sasa-DAA (Grimholt et al. 2000; Stet et al. 2002) genes, offers the most 
efficient method to assess variation at the MH, with the possible exception of direct 
DNA sequencing. These markers have been used to successfully examine MH variation 
and its relationship to disease resistance in Atlantic salmon (Grimholt et al. 2003; 
Kj0glum et al. 2006; Glover et al. 2007; Kj0glum et al. 2008). The use of these markers 
within my research was, however, complicated by the relationship between variation in 
the 3' UT region markers and sequence variation through the peptide binding region 
(PBR). In contrast to that reported for Norwegian cultured Atlantic salmon (Stet et al. 
2002), not every Sasa-DAA allele sequence is represented by a unique Sasa-DAA-3UTR 
allele within the Tasmanian Atlantic salmon population. This situation has also been 
reported at the Sasa-UBA locus (Grimholt et al. 2002). Furthermore, the haplotypic 
variation between Sasa-DAA and Sasa-DAB was also unexpected and further 
complicates the relationship to Sasa-DAA-3UTR. 
Despite the fact the Sasa-DAA-3UTR 239 allele was linked to the sequence Sasa-
DAA * 1001 in all individuals analysed, the relationship between variation at the 3' UT 
regions markers and PBR sequence variation makes the associations reported in Chapter 
3 more uncertain. The fact that at least three co-segregating Sasa-DAB alleles were 
linked to Sasa-DAA * 1001 is one such example. In this situation it would be 
advantageous to compare the effects of different composite haplotypes such as Sasa-
DAA * 1001 /Sas a-DAB *0402 and Sasa-DAA * 1001 /Sas a-DAB* 1502. Such an experiment 
would allow the effects of the Sa:Sa-DAA and Sas a-DAB to be separated and may help 
identify which region is actually associated with the resistance. 
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Through the Tasmanian Atlantic salmon selective breeding program, families of 
Atlantic salmon with known levels of AGD resistance - quantified as both disease 
severity and survival time - have been developed. These families may be utilised to 
examine the association between AGD and MH polymorphism on a significantly larger 
scale compared to the challenge test described in Chapter 3. Given the uncertainty 
between variation in 3' UT region markers and sequence variation in the PBR, a 
combined strategy of direct DNA sequencing, 3' UT region marker genotyping and 
allele specific PCR would be required to resolve all alleles in both broodstock and 
offspring. This strategy has proven successful for other studies (Grimholt et al. 2002; 
Stet et al. 2002; Grimholt et al. 2003) and with the increased power oflarger sample 
sizes could significantly increase the accuracy of this investigation. 
7.2.2 Effects of infection dynamics on the MH 
The difference in dynamics between the challenge trial and natural infection may 
influence the results of my investigation of the effects of the MH on AGD resistance. It 
is possible that the results could be different in a natural infection compared to a 
challenge system. When a pathogen infects a host an interaction will develop between 
the pathogen's ability to cause disease and the host's ability to respond and eliminate 
that threat. The MH plays a pivotal role in this balance and by virtue of its allelic 
variation will cause differences in disease resistance between individuals. In the 
situation when the host is overwhelmed by the pathogen (i.e. due to an inundation of 
pathogens) the host may be unable to respond successfully. Regardless of whether the 
host carries an allele conferring resistance the individual may simply succumb before it 
201 
has the necessary time to stimulate that superior immune response. This is one concern 
when using a challenge model, like that described in Chapters 3 and 4, compared to a 
natural infection (i.e. Chapter 5). Although intended to mimic the natural infection the 
challenge test is considerably more acute and as a consequence fish may not be able to 
respond to the best of their ability. With this in mind, it may be more appropriate to 
examine the relationship between MH variation and AGD resistance in a more natural 
infection. This will be considered in greater depth later in this discussion. 
7.3 AGD resistance as a polygenic trait 
The broad sense heritability estimate for AGD resistance measured through 
histopathology upon first infection in a laboratory challenge was 0.30 ± 0.09 (Taylor et 
al. 2007) and the difference between the most resistant and most susceptible families 
was 19% (Chapter 3). Considering this, a locus, such as the MH, that accounts for 4-5% 
of total variation in resistance (Chapter 3) may actually account for a moderate 
proportion of the genetic variance. Nevertheless, the relatively small contribution of the 
MH on AGD resistance suggests resistance may be under polygenic control and non-
MH genetic effects could also contribute. For example, despite strong associations 
between variation at Sasa-DAA/Sasa-UBA and resistance to infectious salmon anaemia 
(ISA) in Atlantic salmon (Grimholt et al. 2003; Kjeglum et al. 2006), non-MH effects 
are known to contribute significantly (Kjeglum et al. 2005). A similar result was also 
observed for the associations between MH polymorphism and resistance to furunculosis 
(Grimholt et al. 2003; Kjeglum et al. 2005; Kjeglum et al. 2008). The large number of 
genes differentially expressed between Atlantic salmon putatively resistant and 
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susceptible to AGD (Chapter 5) - often involved in different pathways - further· 
suggests resistance is influenced by multiple loci. 
The hypothesis that AGD resistance is under polygenic control is probably not 
unreasonable given that resistance to other infectious diseases is often a polygenic trait 
(Vallejo et al. 1998). For instance;in many disease resistance QTL mapping studies, a 
number of QTLs are identified, each typically accounting for only 2-10% of variation in 
disease resistance (Y onash et al. 1999). A recent QTL mapping study in Atlantic 
salmon identified 10 genomic regions associated with resistance to the monogenean 
ectoparasite Gyrodactylus salaries, accounting for a total 27.3% of variation (Gilbey et 
al. 2006). Multiple loci were also found to be associated with resistance to the 
myxosporean parasite Ceratomyxa shasta in rainbow trout (Nichols et al. 2003). 
Although resistance to each parasite should be tested empirically, these studies do in 
fact suggest that parasite resistance in salmonids is most likely a polygenic trait. 
7 .4 Identifying markers associated with polygenic traits 
Identifying loci linked to polygenic traits is not a simple task. The contribution of 
individual loci affecting a polygenic trait diminishes as the number of influencing 
regions increase. They also become increasingly more difficult to detect because their 
control is obfuscated. This situation highlights the limitations of employing a candidate 
gene approach - like that described in Chapter 3 - to examine a polygenic trait. The 
candidate gene approach can also introduce bias into the study. This is because 
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candidate genes with only a presumed relevant function are examined, and therefore 
mariy unknown genes which may contribute are simply not investigated. 
With the development of genetic markers and maps for Atlantic salmon (Gilbey et al. 
2004; Moen et al. 2004b; Hayes et al. 2007) it has become possible to conduct genome- ' 
wide QTL mapping studies to search for loci that affect disease resistance. Genome-
wide scans using hundreds or thousands of markers are part~cularly appropriate for 
polygenic traits. One of the best examples is the identification and validation of a QTL 
associated with ISA resistance in Atlantic salmon (Moen et al. 2004a; Moen et al. 
2007). QTL mapping studies have also been conducted to identify markers associated 
with resistance to infectious pancreatic necrosis virus in rainbow trout (Ozaki et al. 
2001) and resistance to infectious hematopoietic necrosis in rainbow/steelhead trout 
backcrosses (Rodriguez et al. 2004). 
Although the individual QTL contribution may be small in a polygenic trait, 
aquaculture species such as Atlantic salmon have a "number of attributes that make them 
particularly amenable for the identification of small effect QTLs (Sonesson 2007a). The 
large family size and possibility of repeat crosses (possibly through cryo-preservation of 
gametes) means the statistical power and flexibility of within-family analysis can be 
increased. The use of double haploids, produced through chromosomal set 
manipulations, is considered to be particularly appropriate (Martinez et al. 2002) for 
QTL mapping in fish when the effect of the QTL is low. This is because the QTL will 
be in a homozygous form and its contribution to the trait will be greater than in a full- or 
half-sibling design (Sonesson 2007a). The use of double haploid Atlantic salmon to 
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investigate loci associated with AGD resistance may prove useful under the hypothesis 
that resistance is controlled by multiple small effect QTLs. 
The recent identification of 2507 Atlantic salmon expressed sequence tag (EST) single 
nucleotide polymorphisms (SNPs) through a Canadian and Norwegian initiative (Hayes 
et al. 2007) will also prove invaluable for the identification of loci influencing 
polygenic traits and the ultimate development of marker assisted selection. Marker 
assisted selection based on hundreds of SNPs - also known as genome-wide selection -
is particularly useful for polygenic traits, in which numerous loci influence the trait. 
' ~ 
Examining the association between these SNPs and AGD resistance must be considered 
as a future research direction for identifying loci associated with AGD resistance and 
the ultimate development of a marker assisted selection program for this trait. 
7 .5 The localised host response 
The gill is the primary and only site of infestation by Neoparamoeba perurans. 
Localised cellular alterations, including epithelial cell proliferation, are only observed at 
the site of amoeba attachment (Adams and Nowak 2004a). This localised cellular· 
response was reflected in the transcriptome response compared between the gill, liver 
and anterior kidney. The majority of differential expression was isolated to the site of 
infection: the gill. This result provides fyrther evidence that the host response to AGD is 
extremely localised, at least upon initial infection. This has also been reported when the 
expression of immune-related genes have been examined in the liver and anterior 
kidney of Atlantic salmon (Bridle et al. 2006a) and rainbow trout (Bridle et al. 2006b). 
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The l~calised nature of the host response is further corroborated by reports of lesion 
restricted expression of certain genes (Morrison et al. 2006a; Morrison et al. 2007; 
Young et al. 2008a). The gross presentation of AGD lesions progress from discrete 
focal spots during the early stages of disease to extensive regions of coalescing mucoid 
patches (Adams et al. 2004). By comparing the transcriptome response between areas of 
AGD lesion versus non-lesion gill material, Young et al. (2008a) demonstrated that a 
large proportion of genes are only differentially expressed within the actual lesion. 
AGD lesion restricted expression has also been reported for the dysregulation of 
interleukin-Ip (Morrison et al. 2007). 
Although the evidence presented thus far suggests the host response to AGD remains 
localised to the gill, the presence of anti-Neoparamoeba spp. antibodies in the serum of 
AGD _affected Atlantic salmon has been demonstrated in several studies (Fin~lay et al. 
1995; Findlay and Munday 1998; Gross et al. 2004a; Vincent et al. 2006). While these 
studies suggest a systemic response to AGD is possible, the response appears to be 
heavily influenced by infection history (Vincent et al. 2006). For instance, following the 
first four weeks of infection in a challenge test, Atlantic salmon display no anti-
Neoparamoeba spp. antibody response (Vincent et al. 2006). However, in contrast, 
antibodies can be detected within individuals which have undergone multiple infection 
events (Vincent et al. 2006). This result suggests the host response may be restricted to 
the gill upon the initial infection, however following treatment and subsequent re-
infection a more systemic response may develop. Currently all gene expression analysis 
studies have concentrated on the host response to AGD upon ·first infection (Bridle et al. 
2006a; Bridle et al. 2006b; Morrison et al. 2006a; Morrison et al. 2007; Young et al. 
2008a), with the exception of the study described in Chapter 5. 
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The generation of anti-Neoparamoeba spp. antibodies through multiple re-infection 
events suggests the host response upon first infection may be considerably different to 
the response at later infection events. Although the research presented in Chapter 5 did 
not aim to examine the host response to AGD per se, the study did identify a few 
notable results concerning the differences in immune response between the initial and 
subsequent re-infection events. For instance, when compared to naive Atlantic salmon, 
individuals infected with AGD for the first time demonstrated a down-regulation of 
immune genes, including MH class II invariant chain-like protein and immunoglobulin 
(Young et al. 2008a). In contrast, individuals which have undergone multiple re-
infection events have an up-regulation of these genes compared to naive Atlantic 
salmon (Chapter 5). It is expected the increased expression of the adaptive immune 
genes following multiple re-infection events is at least partially responsible for the 
generation of the systemic anti-Neoparamoeba spp. antibody response. 
7 .6 The difference in host response between initial and subsequent re-infection 
Along with a localised host response, individuals infected with AGD for the first time 
also demonstrated general gene suppression (Chapter 4). Suppression .of the Atlantic 
salmon immune system by Neoparamoeba spp. has also been documented both at the 
cellular level (Gross et al. 2004a; Gross et al. 2005) and at the transcriptome level 
(Young et al. 2008a). Immunosuppression by Neoparamoeba spp. upon initial infection 
may allow parasites to escape immune surveillance and therefore permit the 
development of a localised infection. 
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The general gene suppression observed in Chapter 4 as well as other studies (Young et 
al. 2008a) may be influenced by the changes in cellular architecture associated with 
AGD lesion formation. Indeed, despite a moderate infiltration of inflammatory cells, 
(Adams and Nowak 2004a) the significant proliferation of epithelial cells would cause 
the rroportion of inflammatory cells to be lower in comparison to epithelial cells within 
AGD affected tissue. When this tissue is compared to naive or non-lesion tissue in 
microarray or real-time PCR analysis, certain genes may appear down-regulated simply 
by the change in cell types/~ell ratios. This situation is probably exacerbated when 
lesion restricted expression is examined (Young et al. 2008a) or when individuals with 
very severe infection are compared to naive or less severely infected individuals (i.e. 
Chapter4). 
Surprisingly, comparing the transcriptome response between Atlantic salmon putatively 
resistant and susceptible to AGD following the natural infection (Chapter 5) did not 
reflect the localised host gene suppression reported in Chapter 4 and .recently published 
by Young et al. (2008a). If Neoparamoeba spp. was capable of suppressing the immune 
system- or the gene suppression reported previously was simply an artefact of the 
changes in cellular architecture - I would have expected to see localised gene 
suppression in the AGD susceptible Atlantic salmon when compared to the resistant 
animals. This was not observed. In fact, despite displaying severe AGD pathology and 
in contrast to that reported previously (Young et al. 2008a), the expression of the 
immune genes immunoglobulin and MH class II invariant chain-like protein were 
actually up-regulated in the AGD susceptible Atlantic salmon compared to naive 
animals. This result highlights the difference in the host response between the initial and 
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subsequent re-infections. Considering the evidence presented above the following 
model can be p:r:oposed. Upon initial infection the host demonstrates general localised 
gene suppression (including genes of the immune system). Following treatment and 
subsequent re-infection, however, the host develops a more systemic response which 
includes the increased expression of immune genes and the production of anti-
Neoparamoeba spp. antibodies. 
7.7 Effects of chronic and acute AGD infections 
The evidence discussed above suggests the host response upon initial infection and 
subsequent re-infection will vary. Another complicating factor relates to the difference 
in infection dynamics, principally caused by the difference in amoeba concentration 
between a commercial salmon farm and the laboratory based challenge systems. 
Typically most challenge tests - including that described in Chapters 3 and 4 - use a 
dose of between 450-500 cells L"1 (Morrison et al. 2006a; Young et al. 2008a). This is 
significantly higher than the 10-50 cells L-1 reported in a natural infection in a 
commercial fish cage (Douglas-Helders et al. 2003). AGD within a commercial salmon 
farm therefore resembles a more chronic infection than the acute infection represented 
by the challenge test. 
Considering the differences in infection dynamics between chronic and acute AGD 
exposure, it may be unreasonable to assume that the host response would be identical in 
the two situations. The general gene suppression observed within the gill following the 
acute challenge described in Chapter 4 - as well as in other studies (Young et al. 2008a) 
209 
- may be one consequence of the high dose used in the challenge system. It seems 
plausible that when fish are overwhelmed with an infectious agent they may have a 
restricted ability to mount a successful response against the pathogen. This situation has 
been reported for other parasites. Infection of mice, for example, with low doses of the 
parasitic haemoflagellate, Leishmania major Yakimoff et Schokhor, leads to parasite 
containment while higher doses result in progressive disease (Menon and Bretscher 
1998). In regard to AGD it is likely that when the host is exposed to a lower 
concentration of amoeba (such as in a commercial farming operation) it will have a ' 
better chance of progressing from the initial suppressive response to a more positive 
response. In fact, the localised suppressive response may not occur at all at lower 
amoeba concentrations. However, this is only supposition and it has not been tested. 
It has been demonstrated previously that doses as low as 10 cells L-1 will elicit AGD 
within an experimental system (Morrison et al. 2004) and this more closely reflects the 
amoeba concentration in a natural infection. Further experimentation to analyse the 
transcriptome response to AGD at lower amoeba concentrations such as 10 cells L-1 is 
required to determine immune response in a chronic infection. 
7.8 Innate resistance versus acquired resistance: different traits? 
As stated in Chapter 1, AGD resistance can be quantified in a variety of ways. For the 
-
purpose of this thesis I have defined resistance as reduced gill pathology, quantified 
through either histopathology or gross gill scoring. A complicating aspect concerning 
AGD resistance relates to when the resistance is actually measured. In short, resistance 
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to AGD can be measured immediately following first infection or later following 
multiple exposures (often during which time treatment events may occur). Research 
presented within this thesis has examined both forms of AGD resistance. The genetic 
correlation between resistance upon trrst exposure (innate resistance) and resistance 
following multiple exposures (acquired resistance)- as measured by the Tasmanian 
Atlantic salmon selective breeding program - has generally been low (P. Kube pers. 
comm
9). I hypothesise innate (measured at frrst infection) and acquired (measured after 
multiple exposures) resistance to AGD are in fact different traits. This means a family 
that is selected for innate resistance may not necessarily demonstrate significantly 
higher resistance during later infections. And vice versa, families that are selected for 
acquired resistance may not show increased resistance upon initial infection. 
It seems logical that if innate and acquired resistance are different traits they are most 
likely controlled by different loci. The ability of Atlantic salmon to acquire resistance to 
AGD through multiple infection events was associated with an increased expression of 
certain genes involved in the adaptive immune response. In contrast, considering 
variation in disease severity upon first infection (innate resistance) can be observed 
following only 19 days of acute challenge (Taylor et al. 2007), it seems unlikely that the 
adaptive immune system is entirely or even partially responsible. Similarly, when 
reporting the association between MH variation and resistance to furunculosis, Grimholt 
et al. (2003) questioned whether adaptive immunity was solely responsible, considering 
that most mortalities occurred within 20 days and it was unlikely that a significant 
antibody response could develop in this time. The same situation is probably true for 
innate AGD resistance measured at 19 days post inoculation. This means if marker 
9 Dr Peter Kube, CSIR.O Marine and Atmospheric Research. 
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assisted selection is to be considered for AGD resistance, loci associated with both 
forms of resistance will need to be identified. Selection will then be performed upon all 
the informative markers. 
7.9 Was the MH a good candidate? 
The evidence considered so far suggests AGD resistance is complex and may be 
divided into innate and acquired resistance. The ability of Atlantic salmon to acquire 
resistance to AGD was associated with increased expression of genes involved in the 
adaptive immune system. This raises the question; was the MH a good candidate to be 
associated with innate resistance? Considering the variation in innate resistance was 
observed after only 19 days post inoculation (Taylor et al. 2007) it seems unlikely this 
resistance was caused by a superior adaptive immune response driven by the MH. 
However, bearing in mind that acquired resistance was associated with increased 
expression of genes involved in the adaptive immune system, the MH may be a more 
appropriate candidate to be associated with this form of resistance. Future research 
regarding the relationship between MH and AGD resistance within families from the 
Tasmanian Atlantic salmon selective breeding program should concentrate on acquired 
resistance. 
The recent finding that the genes involved in the MH class I and class II pathways are 
down-regulated within the gill of AGD affected Atlantic salmon (Young et al. 2008a) 
raises some concern regarding how appropriate these loci may be for AGD resistance. 
Interestingly, however, my transcriptome profiling experiments reported no down-
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regulation of MH pathways in the gill of AGD affected Atlantic salmon (despite being 
present on the microarray) following either natural infection or challenge trial. In fact, 
genes involved in the MH class II pathway including two transcripts resembling MH 
class II invariant chain-like proteins were up-regulated in infected putatively susceptible 
fish compared to naive Atlantic salmon. Nevertheless, despite the reported down-
regulation of MH pathways (Young et al. 2008a) MH class II+ cells are still present in 
the gills of AGD affected Atlantic salmon (Morrison et al. 2006b) and therefore the 
ability of different MH class II proteins to present anti-Neoparamoeba spp. antigens 
with varying specificities may still occur. The detection of anti-Neoparamoeba spp. 
antibodies in the serum of AGD a~fected Atlantic salmon indirectly suggests this 
response can occur (Gross et al. 2004a; Vincent et al. 2006). 
7.10,Future directions: progress towards marker assisted selection. 
The main objective ofthis thesis was to identify the molecular mechanisms of AGD 
resistance to assist the ultimate development of a marker assisted selection program. H 
has become clear that AGD resistance is not a simple trait. It may take several different 
forms (both innate and acquired) and is most likely controlled by multiple genes. This 
suggests genome-wide association studies are probably more appropriate than candidate 
gene approaches for these traits. Future research on the molecular mechanisms of AGD 
resistance should now concentrate of on genome scans using SNPs to identify loci 
associated with resistance. This research has become possible through the development 
of both Atlantic salmon SNP resources (Hayes et al. 2007) and families with varying 
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levels of AGD resistance (through the Tasmanian Atlantic salmon selective breeding 
program). 
Further investigation of the unknown transcript, CK880278, is another future research 
direction arising :from this thesis. This transcript was highly induced following AGD 
infection in the challenge trial and natural infection. Although some progress towards 
further characterising this transcript is described in Chapter 6, significant research is 
still required. The main focus n~eds to be determining which open reading frame 
encodes the functional protein. If the protein can be identified, future research could 
concentrate on functional studies including the use ofRNA interference to silence the 
transcript in vivo and perform AGD challenge tests and transcriptome analysis. The use 
of the r~combinant protein to stimulate the Atlantic salmon SHK-1 cell line and perform 
transcriptome analysis is also planned as 'future research. 
7.11 Conclusion 
To conclude, this thesis suggests that AGD resistance is a complex polygenic·trait, 
involving both innate and adaptive mechanisms. Careful consideration needs to be taken 
when examiriing the molecular mechanisms causing these different types of resistance. 
The development of families of Atlantic salmon resistant to AGD by the Tasmanian 
Atlantic salmon selective breeding program will greatly assist in the future research 
aimed to investigate the molecular mechanisms of this trait. The major research focus 
should now concentrate on the use of whole genome scanning and/or SNP analysis to 
identify molecular markers associated with AGD resistance. 
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Appendix 2.1 Frequency of Sasa-DAA-3UTR genotypes within the 30 full-sibling 
families challenge with AGD. The parental column displays the sire (cf) and dam(~) 
genotypes. For each family all possible offspring genotype classes are shown. The 
expected number of offspring within each class is indicated in parenthesis and the 
observed number of offspring indicated to the right. Mendelian inheritance was then 
tested using i' analysis and the x2 and p value are shown. Dashes represent families that 
demonstrated perfect mendelian inheritance and were therefore not tested with i' 
analysis. 
Family Parental Observed no. offspring in each genotype 
·l p 
class 
04003 ~207/229 207/229 229/229 207/207 1.118 0.572 
c)l207/229 8 (8.75) 6 (4.25) 3 (4.25) 
04005 ~229/229 229/259 
c)l259/259 18 (18.00) 
04008 ~2071207 207/239 207/259 
c)l239/259 7 (7.00) 7 (7.00) 
04011 ~239/259 239/259 229/259 229/239 259/259 2.571 0.463 
c)l229/259 5 (3.50) 4 (3.50) 4 (3.50) 1 (3.50) 
04017 ~259/259 229/259 259/259 0.059 0.808 
c)l229/259 8 (8:5o) 9 (8.50) 
04020 ~259/259 229/259 250/259 0.250 0.617 
c)l229/250 9 (8.00) 7 (8.00) 
04022 ~207/259 207/259 259/259 0.889 0.346 
c)l259/259 11 (9.00) 7 (9.00) 
04023 ~229/229 229/259 229/229 1.667 0.197 
c)l229/259 5 (7.50) 10 (7.50) 
04027 ~207/279 207/259 207/207 259/279 207/279 3.308 0.347 
c)l207/259 2 (3.25) 2 (3.25) 3 (3.25) 6 (3.25) 
04028 ~259/279 207/259 207/279 229/259 229/279 7.706 0.052 
c)l207/229 1 (4.25) 8 (4.25) 6 (4.25) 2 (4.25) 
04029 ~229/229 207/229 229/229 2.882 0.090 
c)l207/229 12 (8.50) 5 (8.50) 
04030 ~207/259 207/229 229/259 0.250 0.617 
c)l229/229 9 (8.00) 7 (8.00) 
04031 ~229/229 229/279 229/229 0.067 0.796 
c)l229/279 7 (7.50) 8 (7.50) 
04033 ~207/239 207/229 229/239 
c)l229/229 7 (7.00) 7 (7.00) 
04034 ~239/250 229/239 229/250 0.067 0.796 
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c3'229/229 7 (7.50) 8 (7.50) 
04037 (_(.207/279 207/279 207/207 
c3'207/207 8 (8.00) 8 (8.00) 
04038 (_(.229/279 229/229 229/279 279/279 4.385 0.112 
c3'229/279 6 (3.25) 3 (6.50) 4 (3.25) 
04039 (_(.239/239 239/259 239/298 1.000 0.317 
c3'259/298 6 (8.00) 10 (8.00) 
04042 (_(.259/298 239/259 239/298 0.250 0.617 
c3'239/239 7 (8.00) 9 (8.00) 
04043 (_(.229/229 229/259 229/279 0.067 0.796 
c3'259/279 7 (7.50) 8 (7.50) 
04048 (_(.229/259 229/259 229/279 229/229 259/279 5.000 0.172 
c3'229/279 5 (3.75) 0 (3.75) 5 (3.75) 5 (3.75) 
04049 (_(.250/259 239/250 250/250 239/259 250/259 7.500 0.058 
c3'239/250 5 (4.00) 1 (4.00) 2 (4.00) 8 (4.00) 
04050 (_(.250/259 229/250 229/259 250/259 259/259 0.176 0.981 
c3'229/259 4 (4.25) 5 (4.25) 4 (4.25) 4 (4.25) 
04062 (_(.250/259 250/259 229/250 229/259 259/259 4.500 0.212 
c3'229/259 4 (4.00) 7 (4.00) 4 (4.00) 1 (4.00) 
04065 (_(.229/259 207/229 207/259 229/229 229/259 0.647 0.886 
c3'207/229 3 (4.25) 5 (4.25) 5 (4.25) 4 (4.25) 
04066 (_(.229/229 207/229 229/229 0.059 0.808 
c3'207/229 8 (8.50) 9 (8.50) 
04068 (_(.207/259 207/239 207/259 239/259 259/259 1.500 0.682 
c3'239/259 2 (4.00) 5 (4.00) 5 (4.00) 4 (4.00) 
04078 (_(.229/279 229/259 229/279 259/279 279/279 1.267 0.737 
c3'259/279 4 (3.75) 5 (3,75) 4 (3.75) 2 (3.75) 
04129 (_(.279/298 207/279 207/298 229/279 229/298 1.800 0.615 
c3'207/229 5 (3.75) 3 (3.75) 5 (3.75) 2 (3.75) 
04134 (_(.207/239 207/229 207/259 229/239 239/259 4.222 0.238 
c3'229/259 8 (4.50) 4 (4.50) 4 (4.50) 2 (4.50) 
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Appendix 2.2 Frequency of Sasa-UBA-3UTR genotypes within the 30 full-sibling 
families challenge with AGD. The parental column displays the sire (O') and dam(~) 
genotypes. For each family all possible offspring genotype classes are shown. The 
expected number of offspring within each class is indicated in parenthesis and the 
observed number of offspring indicated to the right. Mendelian inheritance was then 
tested using x2 analysis and the x2 and p value are shown. Dashes represent families that 
demonstrated perfect mendelian inheritance and were therefore not tested with x2 
analysis. 
Family Parental Observed no. offspring in each genotype 
·l p 
class 
04003 ~313/317 313/327 313/335 317/327 317/335 2.059 0.560 
0'327/335 6 (4.25) 4(4.25) 2(4.25) 5(4.25) 
04005 ~317/317 317/327 317/335 0.889 0.346 
0'327/335 11 (9) 7 (9) 
04008 ~327/333 321/327 321/333 327/335 333/335 1.429 0.699 
0'321/335 3 (3.50) 4 (3.50) 2 (3.50) 5 (3.50) 
04011 ~321/327 321/333 , 321/335 327/333 327/335 0.286 0.963 
0'333/335 4 (3.50) 3 (3.50) 3 (3.50) 4 (3.50) 
04017 ~327/333 321/327 321/333 327/327 327/333 0.647 0.886 
0'321/327 5 (4.25) 4 (4.25) 3 (4.25) 5 (4.25) 
04020 ~327/327 313/327 327/327 1.000 0.317 
0'313/327 10 (8) 6 (8) 
04022 ~313/327 313/327 313/321 321/327 327/327 2.000 0.572 
0'321/327 4 (4.50) 3 (4.50) 7 (4.50) 4 (4.50) 
04023 ~317/327 313/317 313/327 317/327 327/327 5.500 0.139 
0'313/327 3 (3.75) 3 (3.75) 8 (3.75) 2 (3.75) 
04027 ~313/327 309/313 309/327 313/333 327/333, 3.308 0.347 
0'309/333 2 (3.25) 2 (3.25) 3 (3.25) 6 (3.25) 
04028 ~327/333 321/327 321/333 327/335 333/335 2.059 0.506 
0'321/335 2 (4.25) 6 (4.25) 4 (4.25) 5 (4.25) 
04029 0'315/317 313/315 313/317 315/327 317/327 1.118 0.773 
~313/327 4 (4.25) ' 6 (4.25) 3 (4.25) 4 (4.25) 
04030 8'313/327 313/317 317/327 2.250 0.134 
~317/317 11 (8.00) 5 (8.00) 
04031 0'327/327 321/327 327/335 0.067 0.796 
~321/327 8 (7.50) 7 (7.50) 
04033 0'313/327 313/327 313/335 327/335 327/327 1.429 0.699 
~327/335 5 (3.50) 4 (3.50) 2 (3.50) 3 (3.50) 
04034 0'327/329 317/327 317/329 327/333 329/333 7.667 0.053 
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~317/333 2 (3.75) 8 (3.75) 4 (3.75) 1 (3.75) 
04037 '3327/327 327/327 327/333 0.250 0.617 
~327/333 7 (8.00) 9 (8.00) 
04038 '3327/327 327/327 
~327/327 13 (13.00) 
04039 '3327/327 321/327 327/333 2.250 0.134 
~321/333 5(8.00) 11 (8.00) 
04042 '3327/335 309/327 309/335 327/327 327/335 0.500 0.919 
~309/327 5 (4.00) 4 (4.00) 4 (4.00) 3 (4.00) 
04043 '3317/335 317/321 317/335 321/335 335/335 3.933 0.269 
~321/335 5 (3.75) 1 (3.75) 6 (3.75) 3 (3.75) 
04048 '3333/333 327/333 333/335 0.067 0.796 
~327/335 7 (7.50) 8 (7.50) 
04049 '3327/333 327/329 327/333 329/333 327/327 0.500 0.919 
~327/329 3 (4.00) 4 (4.00) 5 (4.00) 4 (4.00) 
04050 '3317/327 317/317 317/327 327/327 1.588 0.452 
~317/327 5 (4.25) 6 (8.50) 6 (4.25) 
04062 '3315/315 315/321 315/327 0.250 0.617 
~321/327 7 (8.00) 9 (8.00) 
04065 '3313/335 313/313 313/335 313/327 3271335 0.647 0.886 
~313/327 5 (4.25) 5 (4.25) 4 (4.25) 3 (4.25) 
04066 '3317/333 317/321 317/335 321/333 333/335 7.235 0.065 
~321/335 9 (4.25) 3 (4.25) 3 (4.25) 2 (4.25) 
04068 '3327/333 313/327 313/333 327/327 327/333 2.500 0.475 
~313/327 2 (4.00) 6 (4.00) 5 (4.00) 3 (4.00) 
04078 '3313/327 313/327 313/333 327/327 327/333 4.467 0.215 
~327/333 4 (3.75) 2 (3.75) 7 (3.75) 2 (3.75) 
04129 '3323/333 313/323 313/333 323/327 327/333 4.467 0.215 
~313/327 7 (3.75) 2 (3.75) 4 (3.75) 2 (3.75) 
04134 '3327/333 309/327 309/333 327/333 333/333 2.059 0.560 
~309/333 4 (4.25) 2 (4.25) 6 (4.25) 5 (4.25) 
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Appendix 3.1 Transcripts up-regulated within the AGD resistance Atlantic salmon 
compared to the AGD susceptible individuals with either no BLAST hit (Unknown) or 
a BLAST hit (E<lxl0-1) to a non-annotated UniGene cluster. The transcript accession 
number or TRAITS clone ID is shown along with the fold-change and significance (p ). 
ID ldentit~ P.Value Fold-change 
CK895333 UniGene Ssa.24399 1.57E-09 4.11 
EG999226 UniGene Ssa.31308 2.052E-13 3.85 
gil_cgi_D4H01_car_tra_sub_Op Unknown 4.727E-14 3.15 
CK884295 UniGene Ssa.3495 8.495E-10 3.01 
gil_cgi_D4C10_car_tra_sub_Op Unknown 5.169E-14 2.99 
AM041525 UniGene Ssa.31308 1.289E-10 2.92 
C0469776 UniGene Ssa.26196 1.776E-09 2.68 
CK877715 UniGene Ssa.31308 1.07E-09 2.64 
CK884656 UniGene Ssa.22016 1.932E-10 2.48 
C0470831 UniGene Ssa.22718 6.313E-11 2.44 
CK884239 UniGene Ssa.3495 2.633E-09 2.44 
DW589701 Unknown 3.525E-12 2.28 
CK878732 Unknown 2.072E-11 2.28 
CK880285 UniGene Ssa.6457 1.238E-06 2.28 
CK883288 Unknown 2.65E-07 2.24 
CK877868 UniGene Ssa.25803 1.818E-10 2.21 
AJ424291 UniGene Ssa.20821 1.721E-13 2.21 
CK879778 Unknown 1.36E-08 2.20 
DW591257 UniGene Ssa.12317 7.584E-11 2.15 
EG648661 Unknown 1.578E-15 2.13 
AM041468 UriiGene Ssa.26454 2.714E-12 2.13 
CK887860 Unknown 7.152E-11 2.10 
CK885425 UniGene Ssa.7860 2.61E-10 2.09 
CK879523 UniGene Ssa.2004 1.49E-11 2.09' 
CK874820 UniGene Ssa.4597 3.144E-13 2.09 
CK877700 UniGene Ssa.24719 1.705E-14 2.08 
AJ424229 UniGene Ssa.25476 7.720E-11 2.07 
CK879898 UniGene Ssa.2004 2.25E-12 2.06 
C0471746 UniGene Ssa.33113 5.494E-10 2.05 
CK877148 UniGene Ssa.25762 8.041E-11 2.05 
CK877541 UniGene Ssa.25770 4.82E-13 2.05 
CK880525 UniGene Ssa.33252, 3.583E-04 2.03 
CK879035 UniGene Ssa.25809 5.243E-07 2.03 
AJ424195 UniGene Ssa.15328 7.338E-11 2.00 
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Appendix 3.2 Transcripts down-regulated within the AGD resistance Atlantic salmon 
compared to the AGD susceptible individuals with either no BLAST .hit (Unknown) or 
a BLAST hit (E<lxl0-1) to a non-annotated UniGene cluster. The transcript accession 
number or TRAITS clone ID is shown along with the fold-change and significance (p ). 
ID ldentit~ ~.Value Fold-change 
CK880278 UniGene Ssa.25836 6.809E-22 -22.07 
C0472444 UniGene Ssa.26266 1.012E-11 -7.83 
gil_agi_05E1 O_ab~_tra_sub_Op Unknown 3.473E-16 -7.29 
C0470395 UniGene-Ssa.35702 1.899E-14 -6.68 
CK885324 Unknown 4.613E-13 -3.39 
CK893353 UniGene Ssa.11643 2.052E-11 -3.26 
ova_oyr_04C1 O_gal_sal_std_5p UniGene Ssa.15598 7.798E-13 -2.94 
CK876054 UniGene Ssa.25726 4.708E-16 -2.79 
BM414494 UniGene Omy.4010 2.966E-10 -2.77 
bra_bfo_ 12B08_fou_sal_nrc_5p Unknown 6.292E-14 -2.58 
CK881171 Unigene Ssa.6661 1.567E-07 - 2.42 
CK888199 UniGene Ssa.4452 1.500E-08 -2.31 
CK893980 UniGene Ssa.756 8.427E-15 -2.25 
CK896510 UniGene Ssa.25495 1.630E-10 -2.22 
CN181449 UniGene Ssa.26192 8.333E-11 -2.21 
CK898963 UniGene Ssa.1723 4.539E-07 - 2.17 
CK891700 UniGene Ssa.2450 3.284E-10 - 2.17 
CK899096 UniGene Ssa.26131 2.040E-09 - 2.14 
CK890296 UniGene Ssa.15229 7.812E-15 - 2.12 
mus_snm_06H11_osl_tra_nrc_5p UniGene Ssa.6148 5.649E-02 - 2.12 
AM041585 UniGene Ssa.26445 3.395E-09 -2.08 
EG649380 UniGene Ssa.22205 3.532E-10 -2.08 
bra_bfo_ 16H09_fou_sal_nrp_5p Unknown 1.366E-12 -2.06 
CK891055 UniGene Ssa.20915 7.919E-08 -2.06 
CK889354 UniGene Ssa.445? 2.953E-07 - 2.01 
C0469805 UniGene Ssa.1583 1.456E-13 - 2.01 
CK882496 UniGene Ssa.986 4.424E-12 -2.01 
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Appendix 4.0 Animal ethics approvals. All animal experimentation described within 
this thesis has been approved by the University of Tasmania Animal Ethics Committee 
and conducted under the guidelines of the Australian Code of Practice for the Care and 
Use of Animals for Scientific Purposes 7th edition 2004. 
(www.nhmrc.gov.au/publications/synopses/ea16syn.htm) 
Application title Project No. 
Molecular assessment of resistance to amoebic gill disease (AGO) in Atlantic A0008088 
salmon ( Salmo sa/ar) 
Performance and genetic characterisation of Atlantic salmon in the 
Tasmanian selective breeding programme related to amoebic gill disease 
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